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ABSTRACT
The development of biomaterials with appropriate properties is a requirement in
biomedical research, particularly in tissue engineering. The aim of this thesis was to
develop biocompatible, processable biocomposites for biomedical applications using
graphene and graphene oxide (GO) as filler.
Graphene, a unique two-dimensional carbon structure with excellent electrical,
thermal and mechanical properties has been shown to be an appropriate filler for the
development of composites for biomedical applications. Chemically converted
graphene (CCG) dispersions were synthesized through reduction of GO, also a
suitable filler for developing biocomposites.
Polycaprolactone (PCl), a synthetic biodegradable and biocompatible aliphatic
polyester with high processability and low cost, was chosen for development of
biocomposites in Chapter 3. Two synthetic approaches were taken to develop
graphene/PCl composites, a mixing method where graphene is mixed with the
polymer (mixPCl-CCG), and a covalent attachment method by which graphene
nanosheets are linked to the polymer chains (cPCl-CCG). In both methods, the
addition of graphene resulted in significant improvement in the conductivity and the
mechanical properties of PCl. Covalent links between PCl and CCG resulted in a
homogenous dispersion of CCG sheets in the polymer matrix and higher flexibility
of the cPCl-CCG composites.
The synthesis of graphene/PCl composites was also achieved by a microwaveassisted method in which GO was reduced to graphene during the polymerization
process. Graphene/PCl samples were subjected to enzymatic degradation to study the
effect of graphene addition on the degradation of PCl. The composites were
successfully processed into fibres and 3D structures using an additive fabrication
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approach that demonstrates the excellent processability of the graphene/PCl
composites. The biocompatibility of the composites was also confirmed through cell
culture experiments.
Chitosan, a natural polymer, was used for the development of graphene
biocomposites in Chapter 4. .Lactic acid was utilised as a crosslinking agent to form
the composites. Similar to PCl-CCG composites, graphene/chitosan composites were
prepared through mixing and covalent attachment methods. Graphene/chitosan
composites, prepared by the mixing approach, showed great improvement in their
conductivity and mechanical properties. Furthermore, the swelling rate of the
composites could be controlled on addition of CCG. The composites were also
extruded into multilayer 3D scaffolds using an extrusion printing technique. The
composites and printed scaffolds exhibited excellent biocompatibility with fibroblast
cells. The covalent attachment of the chitosan polymer chains and graphene sheets
did not considerably improve the properties of the polymer compared to noncovalent ones, leaving the process open for further optimization in the future.
The development of a UV-crosslinkable biocomposite was undertaken in Chapter 5.
UV-crosslinkable chitosan (ChiMA) was developed through methacrylation of the
polymer backbone. ChiMA composites were fabricated using both GO and CCG
aqueous dispersions. The addition of either GO or CCG resulted in improvement in
the mechanical properties of the polymer. The incorporation of CCG into the ChiMA
matrix also greatly improved the electrical conductivity of the composites. The
composites showed good biocompatibility with L929 murine fibroblasts, highlighting
their suitability for biomedical applications. The excellent processability of the
ChiMA biocomposites was demonstrated by the fabrication of multilayer 3D
scaffolds via extrusion printing.
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ABBREVIATIONS
CCG

Chemically converted graphene

cCSG

Covalently linked chitosan samples

CGI

Cell growth inhibition

ChiMA

Methacrylated chitosan

CSG

Chitosan samples prepared through mixing method

CSG-(AA)

Chitosan samples prepared using acetic acid

CNC

Computer numerical control

CNT

Carbon nanotubes

cPCl–CCG

Covalently linked graphene/PCl composites

CVD

Chemical vapor deposition

DAPI

4',6-diamidino-2-phenylindole

DCB

Dichlorobenzene

DCC

N,N′-dicyclohexylcarbodiimide

DI

Deionised (water)

DMAc

N,N-dimethylacetamide

DMAP

4-dimethylaminopyridine

DMEM

Dulbecco’s modified Eagle’s medium
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DMF

N,N-dimethylformamide

DSC

Differential Scanning Calorimetry

EDC

1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride

FDA

United States Food and Drug Administration

FDM

Fused deposition modelling

FGS

Thermally reduced GO sheets

FTIR

Fourier transform infrared spectroscopy

GelMA

Gelatin methacrylate

GNP

Graphite nanoplatelet

GNSs

Graphene nanosheets

GO

Graphene oxide

GONPs

Graphene oxide nanoplatelets

H9c2

Cardiomyoblasts

HMDI

Hexamethylene diisocyanate

LA

Lactic acid

LDI

Lysine diisocyanate

MA

Methacrylate anhydride

MeGO

Methacrylated GO

viii

mixPCl-CCG

Graphene/PCl samples prepared through mixing method

mPCl-rGO

Microwave-assisted graphene/PCl composites

MWCNTs

Multiple walls carbon nanotubes

NGF

Nerve growth factor

NHS

N-hydroxysuccinimide was

NMA

N-methylolacrylamide

NMP

N-methyl-pyrrolidone

PBS

Phosphate buffered saline

PCl

Polycaprolactone

PDLLA

Poly (DL-lactide)

PECVD

Plasma enhanced CVD

PED

Precision extruding deposition

PGA

Poly(glycolic acid)

PI

Propidium iodide

PLGA

Poly(lactide-co-glycolide)

PLLA

Poly(L-lactic acid)

PPF

Polypropylene fumarate

PTMC

Poly(trimethylene carbonate)
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RGO

Reduced GO

ROP

Ring-opening polymerization

RP

Rapid prototyping

SDBS

Sodium dodecylbenzene sulfonate

SEM

Scanning electron microscopy

SWCNTs

Single wall carbon nanotubes

TGA

Thermogravimetric analysis

THF

Tetrahydrofuran

TRG

Thermally reduced graphene

WPU

Waterborne polyurethane

XRD

X-ray diffraction
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1. Introduction and Literature Review
1.1. Introduction
Biodegradable and/or biocompatible materials have attracted the attention of
researchers for many years. Reduction of waste volume, complete degradability,
compost ability in the natural cycle and environmental friendliness through reduction
of CO2 emissions are among the major advantages of biomaterials that have sparked
the interest of researchers and the public. With the development of biomedical
science, biomaterials have been recognized as an increasingly important area of
research. In the biomedical field, a biomaterial can be deﬁned as “a material intended
to interface with biological systems to evaluate, treat, augment or replace any tissue,
organ or function of the body”1. The essential property of a biomaterial is its
biocompatibility, which is “the ability of a material to perform with an appropriate
host response in a speciﬁc application”1. In the past twenty years, significant
advancements have occurred in the area of biomaterials. Exhibiting remarkable
biodegradability and biocompatibility, biomaterials such as poly(L-lactide) and
polycaprolactone have been used extensively in a variety of biomedical applications
namely drug delivery systems, bone fixation devices (Figure 1.1a), vascular grafts
(Figure 1.1b), gene delivery systems and tissue engineering2. In view of the diversity
and complexity of the applications, a wide range of biomaterials need to be
developed to properly meet the requirements of each particular biomedical
application. This requirement is the primary motivation in the development of
biocomposites. Biocomposites are usually composed of a biodegradable matrix and a
reinforcing filler3. The structure and properties of the polymers can be optimized by
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the addition of fillers, and hence a wide range of biomaterials with diverse
mechanical and biological properties can be developed.

(b)

(a)

Figure 1.1. (a) Scanning electron micrograph of the outer surface of a poly(L-lactide)
membrane developed to cover bone defects4 and (b) a vascular graft made of
electrospun polycaprolactone micro and nano-fibers5.

1.2. Biodegradable Polymers
Biodegradable polymers can be categorized in different ways. From a degradation
viewpoint, biomaterials can be categorized into two classes, biodegradable and nonbiodegradable. However, categorizing biopolymers based on their origin into natural
and synthetic is the most common way of categorizing them3, 6. Natural biopolymers
appear to be the most appropriate option for biomedical applications because of their
excellent biocompatibility, their biodegradability through enzymatic or hydrolytic
mechanisms and their great ability to copy native cellular environments. However,
some fundamental disadvantages of natural biopolymers, namely the possibility of
viral infections, antigenicity and variation in properties of different batches, are a
major obstacle in fully employing them in biomedical applications6, 7. Biomaterials
can also be functionalized to meet specific requirements based on their final
2

applications. The functional groups can be introduced either to the monomers or the
polymer chains of the polymer (Figure 1.2).

Figure 1.2. Structure of a natural biopolymer (chitosan) functionalised for
nanomedicine applications, adapted from8.

1.2.1. Natural Biodegradable Polymers
Polysaccharides and proteins are typical natural biopolymers used for biomedical
applications9. Polysaccharides are high molecular weight polymeric carbohydrates
composed of one or more monosaccharide repeating units10. Wide availability, low
cost, diversity in structure and the presence of reactive functional groups in the
polymer chain are some of the advantages of using polysaccharides for biomedical
applications11, 12. Proteins are high molecular weight polymers consisting repeating
of units of amino acids linked together via peptide linkages6. An attractive property
of these natural polymers, polysaccharides in particular, is their great swellability
that makes them ideal candidates for developing hydrogels6, 13, 14.
Hydrogels are three dimentional crosslinked polymer networks with a high number
of hydrophilic groups and domains. The polymer chains are crosslinked chemically
or physically in a hydrogel that makes it resistant to being solubilized. Hydrogels
swell due to penetration of solvent into the crosslinked networks15-19.
Hydrogels are suitable materials for developing scaffolds for tissue engineering for
many reasons. Swollen hydrogels exhibit some properties that are very similar to
living tissues and extracellular matrices, such as a soft and rubbery nature and low
3

interfacial tension with biological fluids. The soft and flexible nature decreases the
likelihood of irritation to the surrounding tissues after implantation. Furthermore,
low interfacial tension between hydrogel and body fluid also decreases the negative
reactions from immune system. More importantly, hydrogels are deformable
materials, which make them appropriate for developing injectable delivery vehicles
as well as space filling applications such as filling the complex defect voids created
due to an injury20-26.
To develop a hydrogel, polymer chains are crosslinked via non-covalent or covalent
linkages. Non-covalent attachment between polymer chains has the advantage of
forming the hydrogel matrix without using crosslinking agents. However; it is
possible to develop hydrogels with robust structures and more consistent in vivo
performance through covalently crosslinking the polymer chains17,

22

. Developing

covalently crosslinked hydrogel matrices can be accomplished by using crosslinking
agents or photo-sensitive functional groups. The latter method has attracted wide
interest mainly due to the lack of introduced chemical crosslinking agents, that are
usually cytotoxic, and other reactive species, initiators, or catalysts as well as lower
cost, higher production speed, higher safety and ease of formation22, 27. To develop
UV-crosslinkable polymers, reactive moieties are attached to functional groups of the
polymer followed by exposure to UV irradiation to form crosslinked matrix.
1.2.1.1. Collagen
Collagen is the most abundant protein in the human body and is the main component
of skin and other musculoskeletal tissues. More than 28 types of collagens have been
identified so far and among them, type I-IV are the most common types. Common
sources of collagen are bovine or porcine skin or bovine or
tendons28, 29.
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equine Achilles

Collagen has been heavily investigated for biomedical applications due to its good
mechanical properties, biocompatibility, and enzymatic degradability30. Enzymatic
degradation of collagen within the body takes places via enzymes, such as
collagenases and metalloproteinases. Collagen can be processed through dissolving it
in acidic aqueous solutions and processing it into different forms such as tubes,
sponges, films, nanofibrous matrices as well as injectable viscous solutions and
dispersions31-37. Collagens have been used as suture materials for a long time;
however, a high risk of infection and inflammation was found to be associated with
their use, so they were replaced by synthetic sutures38. Despite the progress in the
fabrication of different collagen based biomaterials there are several concerns
regarding their biomedical applications. The high cost of pure collagen, variable
physico-chemical and degradation properties and the risk of the transmission of
infectious diseases due to the allogenic or xenogenic origin of the material are
serious concerns that limit the application of collagen in biomedical fields6.
1.2.1.2. Gelatin
Gelatin is denatured collagen that can be derived from the hydrolysis of collagenous
animal tissue. The hydrolysis process converts the tough fibrous Gollagen into an
unoriented water-soluble protein that is mainly used as a foodstuff39. The structure of
gelatin consists of 19 amino acids joined by peptide linkages39. To make a hydrogel
suitable for biomedical applications, gelatin can be simply crosslinked using a
variety of crosslinking agents. The crosslinked gelatin is a hydrogel with the
capability of absorbing a large amount of water6. Owing to their processability,
biodegradability and excellent swelling properties, crosslinked gelatins have been
largely used for drug delivery and tissue engineering applications40-42. To eliminate
the adverse effects of crosslinkers on cell growth, a photo-crosslinkable gelatin
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(GelMA) has been developed recently by addition of methacrylate to the amine
containing side groups of gelatin. This material has been found to be a promising
polymer for fabricating 3D tissue structures43, 44.
1.2.1.3. Alginate
Alginate is a linear, binary copolymer of (1-4) glycosidically linked -D-mannuronic
acid and -L-guluronic acid monomers. The cell wall of brown algae is the most
common source of alginate. Alginates are extracted from algae using a basic
solution. The extracted material is then reacted with acid to form alginic acid45, 46.
Due to its great swelling behavior, alginate is usually used as a hydrogel in
biomedical area. Alginate hydrogels can be developed simply through a mild
reaction condition38 and these materials are suitable for fabrication of tissue
engineering scaffolds47, drug and cell delivery devices and even wound healing
patches48. Even though alginates are non-toxic and biocompatible, using them in
biomedical applications has several drawbacks. Alginate is very weak mechanically,
so it should be blended or copolymerized with other degradable polymers before
being used as a structural tissue engineering scaffold38. More importantly, it shows
poor enzymatic degradability and cellular adhesion38. Some of these disadvantages
can be minimized through structural modification of alginate, but much work needs
to be done on its structure to make it a desirable material for biomedical applications.
1.2.1.4. Chitosan
Chitosan is a semi-crystalline natural polymer with good biocompatibility and
biodegradability that has been used in a variety of applications such as artificial skin,
tissue engineering and drug delivery49. This natural polymer is a derivative of chitin
that is a fully acetylated polymer that forms the exoskeleton of arthropods. In terms
of structure, chitosan is a linear polysaccharide consisting of  (1-4) linked D-
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glucosamine with N-acetylglucosamine groups that are randomly located on the
chain depending upon the degree of deacetylation of the polymer6,

49

(Figure 1.3).

The structure of chitosan is very similar to the polysaccharides present in the human
body such as glycosaminoglycans and hyaluronic acid.

Figure 1.3. Structure of chitin and chitosan6.

In vitro enzymatic degradation of chitosan takes place mostly by chitosanase,
lysozyme and papain enzymes50. The lysozyme is the main enzyme that degrades
chitosan in vivo51 which occurs though hydrolysis of the acetylated residues. The
degree of acetylation and crystallinity of the polymer are the major factors that
control the degradation rate of chitosan52. Highly deacetylated chitosans show slow
degradation rates that usually take several months in vivo.
Chitosan dissolves in weakly acidic solutions and forms a cationic polymer with a
high charge density that makes it a suitable material for developing polyelectrolyte
complexes with anionic polymers51. Owing to its excellent processability,
biodegradability and biocompability, chitosan has been extensively investigated in
biomedical fields. Studies have shown that chitosan is a suitable natural polymer for
use in wound healing applications53,

54

. It has been shown that chitosan has a

stimulatory effect on macrophages and chemoattractive effects on neutrophils in
vitro and in vivo55-57. Apart from its antibacterial and hemostatic properties, in vivo
enzymatic degradation of chitosan leads to increases in the number of oligomers that
7

can activate the macrophages. Foreign body reactions to chitosan are found to be
minimal in vivo and there is little or no possibility of fibrous encapsulation upon
implantation of chitosan58. Based on a study on chitosan implants, Azab et al.58 have
shown that chitosan gels induce much lower inflammatory response compared to
Vicryl®, a well-known biodegradable surgical suture. Due to the presence of strong
positive charges, chitosan can be used as an efficient mucoadhesive in bioadhesive
drug and vaccine delivery systems, as these positive charges can interact with the
negatively charged mucous membrane59.
Chitosan is a hydrophilic polymer with excellent swelling properties that makes it an
ideal candidate for developing hydrogels for biomedical applications, particularly for
fabricating drug delivery and tissue engineering devices17, 22, 60, 61. The presence of
reactive amino and hydroxyl groups in the backbone of chitosan provides the
opportunity of crosslinking the polymer chains and developing hydrogel matrices22.
There are several reports on developing chitosan hydrogels in a variety of geometries
and formulations25. The chitosan chains can be either physically associated or
chemically crosslinked to form the hydrogel22. Crosslinked chitosan hydrogels are
the preferred candidate in many drug delivery applications as the rate of drug release
can be controlled by varying the crosslinking density51.
Utilizing UV-crosslinkable chitosan as hydrogels has attracted attention due to the
elimination of cytotoxic chemical crosslinkers, lower cost, higher production speed,
higher safety and ease of formation22. UV-crosslinkable chitosan can be synthesized
via attachment of a UV-sensitive functional group to the backbone of the chitosan
polymer chains. The polymer can then be crosslinked via exposure to UV irradiation.
Acrylates

are

commonly used

moieties

for

developing UV-crosslinkable

polysaccharides62. (Meth)acrylates are the preferred groups due to their better
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biocompatibility, high photocuring rate and better mechanical properties of the
resulting functionalized polymers62.
Amsden et al.63 synthesized photopolymerizable hydrogel for tissue engineering
scaffolds and drug delivery depots using glycol chitosan. The chitosan was converted
to a photopolymerizable prepolymer through graft methacrylation using glycidyl
methacrylate in aqueous media. After addition of Irgacure 2959 photoinitiator, the
prepolymer was crosslinked in solution using UV irradiation and under various
conditions. It was shown that the mechanical properties were improved by increasing
the degree of methacrylation. The cytotoxicity tests showed that the crosslinked
samples are non-cytotoxic.
In other work, injectable hydrogels were developed by synthesizing a water-soluble
photocrosslinkable chitosan by Gao et al.64 Chitosan was reacted with ethylene glycol
acrylate methacrylate by a Michael-addition reaction between –NH2 of chitosan and
C=C of acrylate to develop a photocrosslinkable hydrogel solution. After addition of
the photoinitiator, the solution was UV-irradiated up to 15 min to obtain the
photopolymerized hydrogel. The biocompatibility of the photocrosslinkable chitosan
was studied using a Vero cell line and the samples were found to be non-cytotoxic.
1.2.2. Synthetic Biodegradable Polymers
It should be possible to overcome many of the problems associated with natural
polymers and develop materials for specific applications through specific synthesis
of polymers. Synthetic materials possess more predictable behavior and batch-tobatch uniformity compared to natural polymers6, 7. Aliphatic polyesters, that are
representative of the synthetic biodegradable polymers, are the most commonly used
synthetic materials for biomedical applications6. There are also some other synthetic
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biodegradable polymers such as polyurethane that have widely been used in
biomedical purposes particularly as medical implants.
1.2.2.1. Aliphatic Polyesters
Aliphatic polyesters are usually the first biopolymers to come to mind when looking
at synthetic biodegradable polymers, as they have been around for several decades.
Polyesters can be synthesized through polycondensation of diacids and diols, selfpolycondensation of hydroxyacids, or by the ring-opening polymerization of cyclic
diesters, lactones, glycolides, and lactides6,

7, 65

. Some polyesters can also be

synthesized through bacterial bioprocessing66. The synthesis of aliphatic polyesters
through the polycondensation of diols and dicarboxylic acids dates back to 193065.
The first synthesized aliphatic polyesters showed poor properties such as low
hydrolytic stability, low melting point and low molecular weights, so they were not
considered as functional polymers; however, their high hydrolytic instability was
taken as an advantage as they could be used extensively in biomedical applications
such as absorbable sutures67. Researchers gradually overcame some of the problems
with the initial aliphatic polyesters by developing new synthetic methods and
catalytic systemsaffording high molecular weight polymers with narrow molecular
weight distributions68-70. Lactide, glycolide, and caprolactone are the major
monomers used to synthesize aliphatic polyesters (Figure 1.4) for biomedical
applications71.
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polylactide

polycaprolactone

poly(trimethylene carbonate)

Figure 1.4. Structure of common aliphatic polyesters.

1.2.2.1.1. Poly(glycolic acid) (PGA)
Poly(glycolic acid) or polyglycolide is among the first of the synthetic biopolymers
studied for biomedical applications6. High tensile modulus, high melting point
(>200oC), high crystallinity (45–55% crystallinity) and low solubility in organic
solvents are the main distinctive characteristics of this polymer. Although the low
solubility and the high melting point of PGA negatively affects its processability,
some properties such as cell viability, good degradability and mechanical properties
make PGA a suitable candidate for fabrication of scaffolding matrices for tissue
regeneration. Polyglycolide is the main component in the first United States Food
and Drug Administration (FDA) approved biodegradable synthetic suture, the
DEXON® 72. Owing to its high crystallinity and good mechanical properties, PGA
has also been used for bone internal ﬁxation devices6. In terms of biodegradability,
poly(glycolic acid) follows a typical bulk degradation mechanism that takes place
through hydrolysis and mass loss within 6–12 months6. Its high price, low solubility,
high degradation rate and generation of acidic products after degradation are among
the inherent disadvantages that limit the application of PGA in biomedical fields6.
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1.2.2.1.2. Polylactides
Lactide is a chiral molecule that can be polymerized into four types of polymer, poly
(L-lactic acid), poly (D-lactic acid), poly (DL-lactic acid) and meso-poly(lactic
acid)6. Among these, poly(L-lactic acid) and poly(DL-lactic acid) are the most
popular polymers for biomedical applications. Poly(L-lactic acid) (PLLA) is a semicrystalline polymer ( 37% crystallinity) with a melting point of around 170 oC, a Tg
of about 60–65 oC and an excellent mechanical properties73, 74. The high modulus of
this polymer ( 4.8 GPa) makes it a suitable candidate for use in orthopaedic
products73. PLLA is also widely used in fabrication of high strength fibres to develop
suture and scaffolding materials75, 76. One of the drawbacks of PLLA is its very low
degradation rate. The in vivo resorption of PLLA usually takes 2 to 5.6 years71, 77.
As opposed to PLLA, Poly (DL-lactide) (PDLLA) is an amorphous polymer as Land D-lactide units follow a random distribution in the polymer structure6. The glass
transition temperature of PDLLA is 55–60 oC. Compared to PLLA, PDLLA has a
lower strength and faster degradation rate (12–16 months)78 that makes it an ideal
material for developing drug delivery devices.
1.2.2.1.3. Poly(lactide-co-glycolide) (PLGA)
Poly(lactide-co-glycolide) or PLGA is a co-polyester that can be synthesized by copolymerization of glycolide and lactide. Both L- and DL-lactides can be used for
polymerization6, 74. Various studies have been done on developing different types of
PLGA, and polymers with different ratios are manufactured commercially and used
in different fields of biomedical applications6. Fabrication of scaffolding structures,
meshes, suture duramater substitutes, skin replacement materials and controlled
drug/protein delivery systems are among the wide range of PLGA applications in
biomedical fields79-83. Good biocompatibility, processability and cell adhesion
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properties make PLGA an ideal candidate for tissue engineering applications, an
example is PLGA based three-dimensional scaffolds fabricated using micro- and
nanofabrication approaches81, 82, 84, 85.
Preparation of drug delivery vehicles for controlled drug/protein release can be
regarded as the most popular application of PLGA, mainly because of its rapid
degradation rate compared to other polyesters. A variety of structures such as
microspheres, nanospheres, microcapsules and nanofibers have been made from
PLGA for the drug delivery purposes81, 85. However, degradation mechanism of the
polymer can negatively affect the release efficiency and nature of the material within
the delivery vehicle, prompted researchers to look for surface eroding polymers that
would be more efficient in drug delivery systems86.
PLGA is a bulk degrading polymer that degrades through hydrolysis of the ester
bonds83. The degradation rate of the PLGA depends on different parameters such as
molecular weight, ratio of the monomers and the matrix structure83. It has been found
that the intermediate co-polymers degrade at faster rate compared to homopolymers,
when 50/50 poly(DL-lactide-co-glycolide) degrades in around 2 months while the
degradation time for the ratio of 85/15 is within 5-6 months71.
1.2.2.1.4. Polydioxanone
Resorbable multifilament sutures made from polylactides and glycolides can cause
scratches when penetrating the tissues, and as a result increase the possibility of
infections. Therefore, extensive studies have been undertaken to improve the sutures
structure, that have led to the fabrication of the first monofilament suture (PDS®)
from polydioxanone in 1980s87. PDS, that is a semicrystalline polyester with a very
low glass transition temperature ( -10 oC to 0 oC), can be synthesized by the ring
opening polymerization of p-dioxanone88. Besides being used as sutures, PDS has
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also been used for fabricating orthopaedic devices such as ﬁxation screws for small
bone and osteochondral fragments89. PDS is considered as a slow degrading polymer
as it takes 6–12 months for its complete mass loss38. High cost, high melting point
(115

o

C) and more importantly inducing foreign body reaction90 makes

polydioxanone a less favorable polymer for biomedical applications.
1.2.2.1.5. Polycaprolactone
Polycaprolactone (PCl) is a biodegradable semi-crystalline polyester with some
unique properties that make it the material of choice for biomedical fields91. It has a
low melting point (55–60 oC), dissolves in a wide range of organic solvents and is
able to form miscible blends with different type of polymers38. All these properties
make it a highly processable material suitable for biomedical applications.
Furthermore, it can be easily synthesized from -caprolactone, a relatively
inexpensive monomeric unit. There are two approaches to synthesize PCl: the
condensation of 6-hydroxycaproic (6-hydroxyhexanoic) acid and the ring-opening
polymerization (ROP) of ε-caprolactone91. ROP is the preferred method as it
provides the possibility of synthesizing the polymer with a higher molecular weight
and a lower polydispersity91. PCl is extensively investigated in drug delivery
applications and numerous micro- and nano-sized drug delivery vehicles are
developed from PCl92. Fabrication of scaffolds for tissue engineering is another
important application of this biopolymer6, 93-95.
PCl undergoes hydrolytic degradation that takes 2-3 years to complete, so it is
considered as a slow degrading biopolymer96-99. The amorphous phase of the
polymer degrades first followed by cleavage of ester bonds that results in mass
loss92, 98. At higher temperatures, the degradation of the polymer chain takes place
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through end chain scission while the polymer degrades by random chain scission at
lower temperature (Figure 1.5).

Figure 1.5. Cleavage of the PCl during the degradation91.

The slow degradation rate of PCl, beside its high permeability to many drugs and
non-toxicity, was regarded as an advantage when it initially was used a long-term
drug/vaccine delivery vehicle. An example of using PCl as a long term delivery
vehicle is its incorporation in fabricating the contraceptive device Capronor®
developed for the long-term zero order release of levonorgestrel99, 6. It has been
shown that the degradation rate of PCl can be improved through developing copolymeric systems. Huang et al.100 have shown that hydrophilicity and degradability
of the PCl can be improved through copolymerization with PEG and/or PLA. In
another study, Bramfeldt et al.101 synthesized a ternary copolymer of PCl with PEG
and PLA that exhibit improved hydrophilicity and rate of degradation. PCl
applications are not just limited to using them as matrix.
PCl shows great compatibility with many organic materials and polymers so it can be
used as a compatibilizers in many polymer formulations102-105. Due to its low Tg, PCl
shows high chain flexibility that makes it a suitable material to be used as soft blocks
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for segmented polyurethanes102. In recent years, and following the development of
modern fabrication techniques such as 3D printing, PCl has become of great interest
more than before. Due to its high processability and low price, PCl is the polymer of
choice for printing tissue engineering and drug delivery structures93, 106-108.
1.2.2.1.6. Poly(trimethylene carbonate)
Poly(trimethylene carbonate) (PTMC) is an elastomeric aliphatic polyester that can
be synthesized through the ROP of trimethylene carbonate38,

109

. PTMC exhibits

excellent flexibility but poor mechanical properties, which limits its application in
biomedical fields38. Because of its low molecular weight, PTMC has mostly been
used in developing drug delivery vehicles6. In terms of degradation, PTMC is
significantly different from the previously described polyesters. As opposed to the
other polyesters that are bulk degrading polymers, PTMC undergoes surface
degradation with a degradation rate that is much higher in vivo than in vitro. The
higher in vivo degradation rate in PTMC is probably due to the contribution of an in
vivo enzymatic degradation process110. The low mechanical performance of PTMC
can be improved to some extent by developing co-polymers with other cyclic
lactones38. Several PTMC co-polymers have been developed and used as flexible
suture materials and orthopaedic devices. An example of this is the polyglyconates
that are block co-polymers of trimethylene carbonate and glycolides6, 111, 112.
1.2.2.2. Polyurethanes
Polyurethanes and poly(ether urethanes) are biostable and biocompatible polymers
that are generally prepared by the polycondensation reaction of diisocyanates with
alcohols and/amines113. Due to their excellent mechanical properties, polyurethanes
are broadly used as long term medical implants38, 114. However, these polymers are
not biodegradable and more importantly, common diisocyanates are found to be
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toxic115. Several attempts have been made to synthesize biodegradable polyurethanes
using biocompatible aliphatic diisocyanates114. Developing co-polymers with
polyesters is the most common way in developing biodegradable polyurethanes.
Degradable poly(ester urethanes) were developed by reacting lysine diisocyanate
(LDI) with polyester diols or triols based on D,L-lactide, and caprolactone116. The
aliphatic polyesters such as lactide/glycolide copolymers or polycaprolactones form
the soft segments of these biodegradable polyurethanes while the hard segments are
formed by polypeptides117. Degrapol® is a biodegradable elastic poly(ester urethane)
that is being used to fabricate highly porous scaffolds for tissue engineering118.
1.2.2.3. Poly(propylene fumarate)
Poly(propylene fumarate (PPF) is an injectable biodegradable co-polyester
developed for orthopaedic applications119. Initially, this polymer was not considered
as a suitable material for orthopaedic applications because of its low molecular
weight and poor mechanical properties. However, a special feature of this polymer is
its crosslinkable properties that can be used to improve its mechanical performance38.
There are unsaturated fumarate groups on the polymer back bone which can be used
to further crosslink the polymer119. PPF is liquid before crosslinking so it is not
suitable for osteogenic tissue engineering38. As a result, this polymer is usually
mixed with ceramics such as hydroxyapatite or alumoxane to make it stronger and
more-bioactive for developing scaffolds38.
1.2.2.4. Polyphosphazenes
The synthesis of polyphosphazenes dates back to the late 1960s120, 121; however, it
was just a few decades ago that the first biodegradable polyphosphazenes were
developed122. Polyphosphazenes are polymers with a backbone of alternating
phosphorus and nitrogen atoms containing two organic side groups attached to each
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phosphorus atom123. It is possible to alter properties of the polymer by changing the
pendent groups and many different synthetic approaches to polyphosphazenes have
been explored123, 124. Polyphosphazenes are widely used in controlled-release systems
and tissue engineering

125, 126

due to their good processability and large variety of

their side groups. However, this polymer shows poor tensile strength that is between
2.4–7.6 MPa127. Polyphosphazenes are usually blended with polyesters to enhance
mechanical strength and provide a moderate pH microenvironment for developing
tissues38. The complex synthesis of polyphosphazenes is another disadvantage when
using them in biomedical applications38.
The most commonly used polymers in biomedical applications as well as their
structures, applications and major specifications are summarized in Table 1.1.

Table 1.1. Most commonly used polymers in biomedical applications.
Polymer

Major applications

Major
advantages/disadvantages

Collagen

Development of suture

High risk of infection

materials and biomedical

and inflammation, high

devices.

cost, variable physicochemical

and

degradation properties.

Triple helix of various proteins.
Adapted form128.

Gelatin
An

irreversibly

Tissue
hydrolyzed

form

of

engineering,

development

collagen.

hydrogels.

Alginate

Development

Excellent

of

properties.

of

Poor

swelling

enzymatic

hydrogels, drug and cell

degradability,

delivery

adhesion

devices

and

wound healing patches,

cellular
and

mechanical properties.

tissue engineering.
Chitosan

Artificial
engineering,
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skin,

tissue
drug

Good

processability,

antibacterial

and

Poly(glycolic acid) (PGA)

delivery, development of

hemostatic properties,

hydrogels, wound healing

excellent

applications.

properties.

Suture anchors,

Low

medical devices,

(high

drug

delivery,

tissue

engineering.

swelling

processability
melting

point

and low solubility in
organic solvents), high
degredation rate.

Polylactides

Poly(lactide-co-glycolide) (PLGA)

Orthopedic implants,

Slow degradation rate

drug delivery.

and high melting point.

Development of medical

Good

devices,

properties, high cost

orthopedic

Implants

and

replacement
drug

Polydioxanone

cell

adhesion

skin

and low processability

materials,

(does not melt due to

delivery,

tissue

highly

amorphous

engineering.

structure).

Development of sutures

Slow degradation rate,

and orthopaedic devices.

high cost, high melting
point
and

induces

foreign

body reaction.
Polycaprolactone

Suture coating,
orthopedic

High

processability

implants,

(low melting point and

tissue engineering, drug

good solubility in a

delivery.

wide range of organic
solvents),

low

price

and slow degradation
rate.
Poly(trimethylene carbonate)

Tissue engineering, drug

Poor

delivery, development of

strength.

mechanical

flexible suture materials
and orthopaedic devices.

Polyurethanes

Long
implants,
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term

medical
tissue

Limited

degradation,

could be toxic, requires

engineering.

copolymerization with
other polymers.

where X = various monomers

Poly(propylene

fumarate

(PPF)

Development

of

Limited processability

implants,

as it is an injectable

detal, foam coatings, drug

polymer might cause

delivery,

mild

orthopedic

tissue

engineering.

Polyphosphazenes

inflammatory

response.

Fixation

and

replacement,

bone
medical

Good

processability,

Poor

devices, drug delivery,

properties,

tissue engineering.

synthesis.

mechanical
complex

1.3. Carbonaceous Materials as Fillers
A wide range of biomaterials have already been used in developing structures for
biomedical applications. However, it is hard to find a polymer that meets all the
requirements for developing the perfect material for biomedical applications. As a
result, researchers have developed biocomposites that are typically composed of a
biodegradable matrix and a filler, which is used to compensate for the deficiencies of
the matrix3. Nano-clays, hydroxyapatite and carbonaceous materials are the major
fillers that have widely been used in to improve the properties of biomaterials129, 130.
Several studies seek to improve the mechanical properties of biodegradable polymers
using hydroxyapatite95, 131-134; however, the improvements were not large enough to
meet the criteria for bone engineering field135,

136

. Clay silicates have also been

incorporated into polymers to improve their mechanical properties137-140; however, it
is hard to make a homogenous dispersion from clay silicates as the particles tend to
agglomerate inside the polymer matrix due to their highly hydrophilic nature129.
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Carbonaceous materials such as carbon nanotubes (CNT), fullerenes, graphite,
graphene oxide (GO) and graphene have recently attracted the attention of
researchers as composite fillers for biomedical applications. The building block of
carbonaceous materials is a layer of sp2 hybridized carbon atoms covalently bonded
in a honeycomb lattice141 known as graphene129, 142. Stacked layers of graphene make
graphite, graphene can be rolled up to make CNTs or wrapped into spheres to form
fullerenes. All these carbonaceous fillers owe their properties to graphene (Figure
1.6).
(a)

(b)

(c)
(d)

Figure 1.6. (a) Graphene and other well-known forms of carbon that all derive from
graphene: (b) graphite, (c) CNT and (d) fullerene, adapted from 142.

Carbonaceous materials show excellent electrical, mechanical, and thermal
properties that make them ideal fillers to develop materials of high performance for
biomedical applications. Furthermore, carbon nanomaterials can be utilized for
developing microenviornments with structural and compositional similarities to
biological extracellular matrices that would be beneficial in the fabrication of
scaffolds for tissue engineering143. Some carbonaceous fillers such as CNT and
graphene offer an additional advantage of conductivity that can be utilized for the
electrical stimulation of scaffolds to improve the cell growth143.
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1.3.1. Carbon Nanotubes
Carbon nanotube (CNT) is a rolled up carbon sheet bonded to each other via sp2
bonds. There are two basic types of CNTs: single wall (SWCNTs) or multiple walls
(MWCNTs) (Figure 1.7). The length of CNTs vary between 50 nm to 1 cm and their
diameters ranges from 1−2 nm for SWNTs and 10−100 nm for MWNTs144. CNTs
are usually synthesized via carbon-arc discharge, laser ablation of carbon or chemical
vapor deposition144. CNTs have been widely used in tissue engineering, drug
delivery and regenerative medicine130. However, in spite of their excellent properties,
the application of CNTs is very controversial in biomedical fields, mainly due to
their toxic nature145, 146.

Figure 1.7. Schematic of SWCNT and MWCNT147.

1.3.2. Fullerenes
Carbon 60 or ‘Buckminsterfullerene’ is a zero-dimensional (0D) graphitic material
containing 60 carbon atoms arranged in the form of a hollow ball148. Fullerene was
discovered by the Kroto and Smalley research group in 1985149 and has mostly been
used to improve the thermal stability of polymers150. Fullerenes can be synthesized
through chemical vapor deposition (CVD), laser, plasma and electric arc
discharge148. During the last decade, fullerene has been used in several tissue
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engineering applications151-154. However, the biocompatibility and toxicity of
fullerene has always been a questionable issue155. In spite of its remarkable
properties, fullerene is not a favored filler in biomedical fields, mostly due to its high
production costs, low yield, low water solubility and toxicity155.
1.3.3. Graphene
Graphene is a planar monolayer of carbon material arranged in a honeycomb lattice
with a carbon–carbon bond length of 0.142 nm141. Figure 1.8 shows the scanning
electron micrograph of a single sheet of graphene as well as flat graphene crystal.

Figure 1.8. (a) Scanning electron micrograph of single-atom-thick sheets of
graphene142, (b) flat graphene crystal in real space (perspective view) and (c) the
same for corrugated graphene156.
Graphene has attracted the attention of researchers worldwide due to its
extraordinary optical properties, thermal conductivity (3000-5000 W m-1K-1)157,
electron mobility at room temperature (250,000 cm2Vs-1)158,

159

and outstanding

mechanical properties (with Young’s modulus of ~ 1 TPa)160. It has been shown that
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graphene has great potential for developing transparent conducting electrodes, single
reinforced composites and energy storage devices.
Although graphite has been used by human beings for 6000 years, it was in the 1960s
that graphene was studied for the first time via isolating as a single-atom plane of
graphite161,

162

. High conductivity of the graphene attracted the attention of

researchers at that time; however, research on graphene moved slowly as synthesis of
this nanosheet was found to be experimentally difficult163. Different approaches were
taken to synthesize this 2D carbon structure, including the same methods used for
developing CNTs164-166, but none of them were able to prepare a high quality
graphene. There was not much progress on graphene researches until 2004, when
Andre Geim and Konstantin Novoselov successfully produced high quality graphene
crystals using the simple method of peeling off the graphite flakes using scotch tape,
and as a result they were awarded the 2010 Nobel Prize in Physics167. Since then, the
research on graphene has skyrocketed, the synthesis of graphene was further
developed and optimized and the graphene was used in different fields of science.
This discovery used to be called ‘‘graphite layers’’ and then the term was changed to
“graphene” following a recommendation by the relevant IUPAC commission168. The
excellent properties of graphene make it an ideal reinforcing filler for the preparation
of polymer composites169, 170. Recent studies have shown that graphite nanoplatelet
(GNP) or graphene has great potential to be used as a low cost and scalable substitute
for CNT171.
1.3.3.1. Synthesis of Graphene
The exfoliation of graphite, chemical vapor deposition (CVD) and the chemical
conversion of GO are the major routes for the synthesis of graphene163 particularly
when it is intended as a filler for biomaterials. There are also other techniques for the
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preparation of graphene such as total organic synthesis172 and the unzipping of
CNTs173; however, they have not become popular mostly due to the lack of
dispersibility and large-scale production issues.
1.3.3.1.1. Exfoliation of Graphite
The mechanical exfoliation of graphite is in fact the first technique utilized for the
preparation of graphene174. This technique involves exfoliation of graphite into
graphene sheets using sonication or centrifugation.
Hernandez et al.175 demonstrated a route to produce graphene in large quantity by
exfoliation of graphite in N-methyl-pyrrolidone (NMP) using bath sonication. The
authors synthesized monolayer graphene with around 1 wt.% yield that could
potentially be improved to 7–12 wt.% with further processing. The presence of
individual graphene sheets were confirmed by Raman spectroscopy, transmission
electron microscopy and electron diffraction. Semi-transparent conducting films and
conducting composites were also fabricated using the graphene. The high cost and
the high boiling point of the solvent are the drawbacks of this process.
The use of surfactant is another way to prepare stable graphene dispersions through
the exfoliation of graphite. Lotya et al176 reported the production of graphene through
the exfoliation of graphite in water using the surfactant sodium dodecylbenzene
sulfonate (SDBS). Based on their findings, more than 40% of the synthesized
graphene flakes had less than 5 layers with around 3% of flakes consisting of
monolayers. Although the graphene dispersion is stable for up to 6 weeks, the larger
flakes tend to precipitate over more than 6 weeks, leaving only the small flakes
dispersed.
In another study, Green and Hersam177 reported the preparation of a stable graphene
dispersion by using the bile salt sodium cholate. In this work, graphene flakes with
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controlled thicknesses could be isolated in suspension using density gradient
ultracentrifugation (Figure 1.9). The synthesized graphene dispersion contained
monolayer graphene sheets with thicknesses varying between 1 to >2nm. However,
the graphene concentration of the dispersion was quite low ( 90 μg ml−1), making this
graphene dispersion an impractical choice for developing composites.

Figure 1.9. Schematic illustration of the graphene exfoliation process. Combination
of graphite and sodium cholate are exfoliated to few-layer graphene flakes, adapted
from177.

Li et al.178 demonstrated the preparation of a stable graphene dispersion in N,Ndimethylformamide (DMF) using expanded graphite. After a brief heating at 1000
o

C, the commercial expanded graphite was treated with NaCl crystallites and oleum.

The exfoliated graphite was then dispersed in DMF and was treated with
tetrabutylammoniumn

and

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
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[methoxy(polyethyleneglycol)-5000 (DSPE-mPEG). After centrifuging, the single
layer graphenes retained in the supernatant was used for fabrication of large
transparent conducting films by Langmuir–Blodgett assembly in a layer-by-layer
manner. A typical resistance for ̴ 100-nm-wide graphene at room temperature was
reported as 10–30 kΩ.
Although graphite is an inexpensive and abundant source for producing graphene, it
cannot be easily exfoliated into graphene sheets179 and the exfoliation usually results
in dispersions with low graphene content.
1.3.3.1.2. Chemical Vapor Deposition (CVD)
Chemical vapor deposition (CVD) is a promising technique for synthesizing high
quality defect-free graphene. Using the CVD method, single or few layer graphene
sheets can be grown on metal substrates with mediate-high carbon solubility, such as
Ni and Cu174, 180. In a typical CVD method, carbon diffuses into the metal substrate
followed by a precipitation of carbon on the substrate surface upon cooling the metal
(Figure 1.10). The graphene layers can then be detached from the substrate and
transferred to other substrates180.

Figure 1.10. Schematic illustrating the proposed growth mechanism of graphene on
Cu substrates by CVD180.

The first reports on preparation of “monolayer graphite” using CVD dates back to
around the 1970s181-183. However, the first successful synthesis of monolayer
graphene using the CVD technique was reported by Somani et al.184 in 2006 when
they synthesized few-layer graphene films using camphor as the precursor on Ni
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foils. Following Somani’s method, many other studies have been done to synthesize
graphene layers with controlled thickness on different substrate types185-191.
Wang et al.192, 193 reported an enhanced CVD method for graphene synthesis that is
called “plasma enhanced CVD” (PECVD). In this approach, a radio frequency
PECVD system was used to synthesize graphene on various substrates at 680 OC.
The synthesized graphenes are described as sheet-like carbon nanostructures ≤ 1 nm
thickand with a defective graphite structure. The advantage of this enhanced CVD
method is its short deposition time (<5 min) and lower growth temperature compared
to conventional CVD.
Producing graphene layers using silicon carbide (SiC) surfaces is a popular synthesis
method in the semiconductor industry. Graphene can then be directly used to develop
electronic devices194-196 SiC surfaces tend to graphitize under vacuum at elevated
temperatures. Sublimation of silicon atoms under ultrahigh vacuum at 1200 oC
followed by removal of Si results in the rearrangements of carbon atoms to give
graphene layers on the substrate.
Other metal surfaces such as Ru, Ir, Ni, Co and Pt have also been used as substrates
for producing graphene layers following the same method. The details are discussed
in a review by Wintterlin and Bocquet197. Lack of control over the graphene
thickness and non-uniform growth of single layer graphene198 are the major issues
that limit the real application of CVD method.
1.3.3.1.3. Chemical Conversion of Graphene Oxide
The graphene synthesis methods discussed so far are not efficient enough methods
for producing large-scale solution-based graphene199. Furthermore, it would not be
easy to disperse the synthesised graphene homogenously inside different polymer
matrices179. It has been proven that solvent dispersed graphene is an appropriate form
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of graphene for many applications such as developing paper-like structures,
transparent conductive films and, more importantly, homogeneous polymer
composites179, 200-202.
Solution-based chemical reduction of GO is the most promising technique for the
synthesis of graphene on an industrial scale185, 198, 203, 204 .The chemical conversion of
graphite to GO and subsequently to chemically converted graphene (CCG), or socalled “reduced GO”, has been found to be a viable approach to make graphene in
large scale appropriate for different applications particularly for developing
composites.
GO can be synthesised by the oxidation of graphite by using oxidants such as
sulfuric acid, nitric acid and potassium permanganate following a method proposed
by Hummers and Offeman205 in 1958. This approach, which is commonly known as
the “Hummers method”, is the most prevalent technique in synthesis of GO from
graphite.
According to Hummers and Offeman, the preparation of GO is briefly as follows:
graphite flakes were mixed with sodium nitrate and cold sulphuric acid followed by
addition of potassium permanganate. The mixture was then diluted and treated with
hydrogen peroxide to reduce the residual permanganate and manganese dioxide to
colourless soluble manganese sulphate. The suspension was then filtered to obtain a
yellow-brown filter cake. After washing with water, the resultant GO was dispersed
water to approximately 0.5% solids.
The synthesised GO is a heavily oxygenated pseudo-two-dimensional solid in bulk
form. The carbon sheets in GO contain hydroxyl and epoxy groups located on sp3
hybridized carbon on the basal plane as well as carbonyl and carboxyl groups
situated at the sheet edges on sp2 hybridized carbon. The functional groups acts as
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reactive sites that can be used for performing a variety of surface modifications on
GO as well as developing GO and CCG reinforced composites.
Due to the presence of these functional groups, GO is a highly hydrophilic material
that can be easily exfoliated in water. Therefore, it is possible to prepare a stable
homogenous dispersion of GO in water and some organic solvents163206 that contains
mostly single layer sheets (Figure 1.11).

Figure 1.11. Digital pictures of GO dispersion in water and 13 organic solvents
through 1 hour bath ultrasonication206.

Although GO nanosheets have been shown to be effective fillers to reinforce
polymers129, they are electrically insulating185,

203

. Electrical conductivity is

necessary for some applications of biomaterials as it has been shown that electrically
conducting substrates can induce and direct improved cell growth of electroresponsive cells under electrical stimulation207-209.
The functional groups of GO disrupt the conjugated electronic structure of the carbon
sheets and make them insulators with irreversible defects and disorders185,

203

.

However, it is possible to partially restore the conductivity of GO close to the level
of graphite via thermal or chemical or thermal reduction185, 210, 211.
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The preparation of graphene nanosheets using chemical conversion methods has
several advantages over the other techniques. The most important benefit of using
this method is the high yield of graphene sheets (>80%). The other benefit is the
synthesis of graphene in aqueous media, so the dispersion can be easily used for
producing thin films or paper-like structures. Furthermore, chemically converted
graphene can be integrated more easily into the polymer matrices179, 212.
There are several reducing agents that have been used for the chemical reduction of
GO and among them, hydrazine is the most favoured. As opposed to other reducing
agents, hydrazine does not react with water and it has been found to be the most
appropriate reducing agent for the preparation of thin layers of graphene
nanosheets185. The schematic of oxidation of graphite to GO and reduction to
graphene (reduced GO) is represented in Figure 1.12
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Graphite

GO

CCG
(Reduced GO)

Figure 1.12. Schematic of oxidation of graphite to GO and reduction to graphene
(reduced GO)163.

The chemical conversion of GO to CCG was first demonstrated by Stankovich et al.
in 2007185. A suspension of exfoliated GO sheets in water was precipitated with
hydrazine hydrate followed by filtration and washing to give thin graphene-based
sheets with high specific surface area.
Li et al. reported a facile approach to the large-scale production of aqueous CCG
dispersions without polymeric or surfactant stabilizers (Figure 1.13)204 by reduction
(hydrazine,  95 oC, 1 hr) while the pH of the solution was adjusted with ammonia
solution during the reduction. The electrostatic repulsion among the charged groups
results in the formation of a stable well-dispersed CCG dispersion.
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Figure 1.13. Schematic of the preparation of aqueous CCG dispersions, adapted
from204

The homogenous CCG dispersion was then passed through a membrane filter to
make graphene paper. Figure 1.14 demonstrates the height profile of the CCG sheets
(a) as well as the produced CCG paper (b). This scalable method for the preparation
of a homogenous CCG dispersion has attracted much interest and since then this
CCG dispersion has been widely used.

(a)
(b)

Figure 1.14. (a) Tapping mode AFM image of CCG sheets with a height profile (blue
curve; scale bar, 1 nm). AFM shows that the resulting CCG sheets with a thickness
of 1nm (b) A 10 µm thick CCG film or paper prepared by vacuum filtration of a
CCG dispersion, adapted from204.
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There are many biopolymers that are not soluble in water, so it is important to
develop CCG dispersions using organic solvents. Park et al.213 demonstrated the
preparation of colloidal suspensions of CCG sheets in several solvents. GO,
synthesized by the modified Hummers method, was first dispersed in water and was
sonicated for 1 hour. Then, DMF was added to the solution (DMF/H2O = 9 /1) and
the GO dispersion was reduced with hydrazine monohydrate (1 μL/3 mg GO) for 12
h at 80 °C. The resulting black suspension was neutral with a pH of 7. The
researchers used the same method to prepare homogeneous CCG dispersion in NMP,
ethanol, DMSO and acetonitrile. No stable dispersion of CCG could be developed in
THF, diethylether, toluene and dichlorobenzene (DCB). The Hansen solubility
parameters (Table 1.2)
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were used to predict which solvents would form good

colloidal suspensions with CCG. The solvent having the sum δp (polarity cohesion
parameter) + δh (hydrogen bonding cohesion parameter) in the range of 13-29 MPa1/2
could make a good dispersion with CCG. On the other hand, CCG cannot be
dispersed well in solvents with δp + δh less than 10 (e.g. DCB, diethylether, and
toluene) or much higher than 30 (water). Paper samples were fabricated by filtration
of the CCG suspension in DMF/H2O. The paper samples dried at 150 oC showed an
electrical conductivity of (1.64 ± 0.10)E4 S m-1.

Table 1.2. Hansen solubility parameters of selected solvents, adapted from 213
Solvent

δp +δh (MPa1/2)

Solvent

δp +δh (MPa1/2)

Acetone

17.4

PC

22.1

Acetonitrile

24.1

Diethylether

8.0

THF

13.7

Toluene

3.4

DMF

25.0

DCB

9.6
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NMP

19.5

Benzene

2.0

DMSO

26.6

Chloroform

8.8

Ethanol

28.2

Methanol

34.6

Pyridine

28.2

Water

58.3

Pham et al.215 investigated the effect of temperature on GO reduction by hydrazine
and the dispersibility of the resulting CCG in polar organic solvents. . Based on their
findings, the GO samples reduced at low temperature ( 30 oC) show higher
dispesibility in organic solvents. A free-standing paper was made from the CCG
dispersion that possesses an electrical conductivity of more than 2.2E4 S m-1.
Beside the chemical reduction of GO, it is also possible to synthesize a graphene
dispersion through dispersing thermally reduced GO in a solvent. McAllister et al.216
exfoliated and reduced GO by heating it to 1050 oC. However, the thermal reduction
procedure caused structural defects as well as 30% mass loss in GO that can
negatively affect its mechanical and electrical properties. Furthermore, the thermal
elimination of carboxyl, hydroxyl and epoxy groups from GO is a heat-releasing
multi-step process that is not environmental friendly, particularly in scaled up
operations174.
Microwave energy has also been utilized for the thermal reduction of GO to prepare
graphene dispersions211,
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. However, the same drawbacks of the conventional

thermal reduction, i.e. elimination of all functional groups and the introduction of
structural defects is also observed in the microwave-assisted reduction of GO.
Furthermore, the low conductivity of the final product ( 2-3 S cm-1), poor
dispersability of the reduced GO in some solvents, sparking and violent fuming
during the microwave reaction, the release of harmful gaseous species217 and the
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requirement for expensive lab-scale microwave equipment are the other hurdles that
make microwave reduction of GO less attractive.
1.4. Graphene Oxide and Graphene Biocomposites
The superior properties of GO and graphene have always been the focus of major
interest in the past few years163. These properties can be harnessed to improve the
thermal, electrical and mechanical properties of polymers by developing GO or
graphene composites. Moreover, recent studies have shown that GO and graphene
are not only biocompatible but they can also be beneficial in cell growth208, 209, 218.
All these features make GO and graphene the fillers of choice for developing
biocomposites.
1.4.1. Methods of Synthesis
Solution mixing and in situ polymerization are the most commonly used techniques
for developing GO and CCG biocomposites163. Melt mixing is another composite
preparative method that involves the dispersion of a filler inside a polymer matrix in
its molten state. However, the development of GO or CCG biocomposites by this
method has not attracted researchers, mainly due to the poor dispersity of the filler
inside the polymer matrix, particularly in polymers with high viscosity, as well as the
impracticality of this method for processing polymers with high or unknown melting
point163. Some researchers have also recently investigated the microwave-assisted
polymerization of GO or graphene biocomposites to overcome some of the
limitations of the the conventional polymerization.
1.4.1.1. In Situ Polymerization
GO or graphene is dispersed inside the monomer and the dispersion polymerized via
free radical, ring opening, emulsion or condensation reactions to develop
GO/graphene composites163. It is possible to covalently bond GO or graphene
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nanosheets to polymer chains using in situ polymerization. Other reports describe
non-covalently bonded composites including PMMA–GO219, polypropylene–GO220
and polyethylene-graphite221 using in situ polymerization.
Kim

et

al.222

adopted

three

different

synthetic

methods

to

develop

graphene/polyurethane nanocomposites. For in situ polymerization, polymerization
and blending were carried out in DMF. The addition of graphene improved the
mechanical and electrical properties of polyurethane less than by solution
blendingdue to inhabitation of interchain hydrogen bonding in the polyurethane
matrix.
Lee et al.223 demonstrated the preparation of waterborne polyurethane (WPU)
nanocomposites using thermally reduced GO sheets (FGS) by an in situ method. The
reaction was carried out at 80 oC for around 6 hours. The electrical conductivity of
the composite with 4 wt.% FGS is reported as 10-3 S cm-1 that is 105 folds higher than
pure WPU. The Young’s modulus is also increased by more than 300% in
composites with 4% FSG; however, the tensile strength decreases on addition of
graphene even at 1 % graphene contents.
Hua et al.224 prepared composites of poly(-caprolactone) (PCl) and GO by ring
opening polymerization of -caprolactone using GO as the initiator; however, there
does not appear to be strong evidence to support the initiating effect of the GO given
that the GO mixed with -caprolactone and catalyst was heated at 120 °C for 20 hrs
and the catalyst can initiate the reaction. DSC results showed that the addition of GO
increased the crystallization temperature of the polymer due to the nucleating effect
of GO on the crystallization of PCl. Surprisingly, the TGA analysis of all composites
showed that the decomposition temperature of the PCl in the composites was
significantly reduced and the increase in the GO content had no effect on the
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decomposition temperature. This is in contrast to other studies of GO biocomposites
that show no change or an improvement in polymer decomposition with GO
addition225, 226. The authors provide no explanation for this.
In a similar approach, Wang et al.227 prepared PCl-GO composites via in situ
polymerization (Figure 1.15). GO was synthesized following the Hummers method.
The tensile strength and elongation at break of the synthesized pure PCl is reported
as 3 MPa and 140% respectively, and 7 MPa, 80% on addition of GO. The
improvement in the tensile strength is indicative of the reinforcing effect of the GO
on PCl.

Figure 1.15. Grafting of PCl onto graphene sheets via in-situ polymerization of
PCl227. Blue lines represent the PCl polymer chains.

1.4.1.2. Microwave-assisted Polymerization
Microwave energy can be utilized to overcome some of the shortcomings of the
conventional polymerization method such as complexity of the reactions, long
reaction times, high cost of the monomers and the requirement for high-temperature
reactors for polymerization129.
Using microwave, the reaction time can be shortened, the yield can be increased and
the side reactions can be reduced.
Microwave irradiation applies an electromagnetic field that forces the alignment of
dipole and ion fields resulting in rotation, friction, and the collision of molecules.
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Due to the direct interaction of microwave energy with the molecules, a rapid
internal heat will be generated in the reaction mixture228-230.
There are several reports in the literature demonstrating microwave-assisted
polymerization of biopolymers such as PCl231-238, PLA239,

240

and PTMC241, 242. The

common feature in these reports is faster reaction times compared to conventional
methods.
The microwave-assisted ring-opening polymerization of -caprolactone, was first
reported by Albert et al.231 (Figure 1.16) Thermal and microwave-activated ringopening polymerization of PCl at different -caprolactone/titanium tetrabutylate
molar ratios were compared, indicateing that -caprolactone can be polymerized
successfully with titanium tetrabutylate catalyst via microwave activation at 180 oC.
No significant difference was observed between viscosities and molecular weights of
the polymers synthesized through thermal and microwave-assisted methods.
Subsequent related work reported enhanced polymerization rates and significant
decreases in reaction times compared to conventional polymerization methods228.

Figure 1.16. Schematic diagram of the microwave polymerization reactor system as
employed by Albert et al.231
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The microwave-assisted synthesis of graphene composites has been used in the
preparation of graphene–metal salts243 and graphene–semiconductor composites244.
However, to the best of our knowledge, there is no report on the microwave-assisted
synthesis of GO/CCG composites of biopolymers.
1.4.1.3. Solution Blending
Solution blending or solvent casting is the most commonly used method for
developing GO and graphene composites particularly for biomedical applications.
The polymer should be soluble in common solvents such as water, acetone, DMF,
chloroform, DCM163. Solution blending involves solubilization of the polymer into a
homogeneous solvent-dispersed GO or CCG dispersion that is a suitable solvent for
the polymer. The polymer chains cover the CCG or GO sheets during blending and
the sheets become interconnected after removing the solvent129. During blending,
some graphene sheets might agglomerate or some bubbles might be created in the
dispersion. In this case, ultrasound power can be used to exfoliate the agglomerated
sheets, to remove the bubbles and to homogenize the polymer/filler dispersion.
Solution blending is an inexpensive, facile method for the preparation of composites.
More importantly, it is possible to disperse nanofillers homogeneously with high
efficiency inside the polymer matrix via this method. These advantages have made
solution blending an attractive and suitable technique for developing biocomposites.
1.4.2. Development of Biocomposites for Tissue Engineering
A suitable material for biomedical applications particularly for developing structures
for tissue engineering should be biocompatible, processable and possess appropriate
mechanical properties. Conductivity can be an advantageous property as well. The
significance of utilizing graphene and GO as fillers for biocomposites is discussed in
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sections 1.3 and 1.4. Here, the previous work on the preparation of graphene and GO
biocomposites using natural and synthetic polymers is reviewed.
Xu et al.245 prepared PLLA composites using CNTs and graphene nanosheets
(GNSs) for isothermal crystallization studies through solution blending. It was found
that both CNTs and GNSs could perform as heterogeneous nucleation agents,
shortening the induction period of crystallization and accelerating the crystallization
rate, but the induction ability of CNTs was found to be stronger than that of GNSs. It
is of note that the authors claimed that they produced GNSs using Hummers method
but what they have appeared to have synthesized is in fact GO sheets rather than
graphene.
In other work on PLA, Tong et al.246 prepared graphene/polylactide nanocomposites
with improved properties using thermally reduced graphene (TRG) and
functionalized polylactide. They showed that the addition of graphene improved the
tensile strength of the polymer. However, It was not clear at what TRG concentration
these mechanical improvements were achieved. The conductivity of the samples
increased by increasing the TRG content with the composites with 1 wt.% TRG
reported as  1E-7 to 1E-6 S m-1.
Yoon et al.225 and Park et al.226 reported the preparation of PLGA/GO composites.
Their results show that the addition of graphene improves the thermomechanical,
surface chemical and mechanical properties of PLGA. Yoon et al.225 demonstrated
that the composites are biocompatible with HeLa cells and show improvement in cell
proliferation and viability, indicating that the addition of GO nanosheets enhanced
the biocompatibility of the PLGA composite films (Figure 1.17). An in vitro
biodegradation test by Park et al.226 showed that the GO composites degraded at a
slower rate compared to neat PLGA.
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Figure 1.17. The FE-SEM images of the HeLa cells grown on (a) PLGA, (b)
PLGA/GO (1 wt.%), and (c) PLGA/GO (2 wt.%) films225.

The other biodegradable synthetic polymers used for the preparation of
biocomposites are degradable polyurethane247 and polypropylene fumarate (PPF)248.
In both polymers, the addition of GO resulted in an improvement in the mechanical
properties of the matrix. The GO/PU composites were found to be biocompatible for
fibrosis cells. No data was obtained on the biocompatibility of GO/PPF composites.
Kai et al.249 investigated the effect of GO and graphite as the enforcing fillers on the
properties of PCl. A decrease in the elongation at break and an increase in the yield
stress and the Young's modulus were observed with increasing the GO content in
composites. Yield stress increased from ~ 15 to more than 26 MPa in PCl/GO-s10
with 10 wt.% GO. For the same composite, the Young’s modulus increased from 350
MPa to more than 1000 MPa indicating reinforcing effect of the GO on the matrix.
However, the elongation at break decreased sharply on addition of 10 wt.% GO from
~ 850% to ~ 12%.
Although it was shown by Kai et al.249 that the addition of GO could improve the
mechanical properties of the matrix, there was a lack of some essential material
characterization data such as SEMs, FTIR and Raman spectroscopy that could
provide some information about the morphology of the developed materials as well
as the interaction between GO and the matrix. This work focused on investigating the

42

thermal and mechanical properties of the composites; however, no data was provided
about their thermal stability and decomposition temperature. Processability and
biocompatibility of the materials was also not evaluated.
In other work, the mechanical properties and bioactivity of electrospun PCl/GO
composites were studied by Wan and Chen250. A 0.6 wt.% GO dispersion was used
to develop composite films and electrospun nanofibrous membranes (Figure 1.18).
As previously shown, incorporating GO improved the mechanical properties the PCl
films. In a PCl nanofibrous membrane, the presence of 0.3 wt.% GO nanoplatelets
enhanced the tensile strength, Young’s modulus and energy at break of the polymer
by 95%, 66% and 416%, respectively, while improving its bioactivity during
biomineralization processes.

Figure 1.18. SEM images of PCl and PCl/GO (0.3 wt.%) nanofibrous membranes,
adapted from 250 .

Zhang and Qiu251 prepared graphene/PCl composites using TRG and studied
morphology, crystallization and dynamic mechanical properties of the materials. GO
powder was thermally reduced at 1050 °C for 30 s, sonicated in chloroform and then
dispersed with a chloroform/PCl solution to prepare composites with 0.5 and 2 wt.%
graphene content. The characterization results indicate that addition of TRG
significantly improved both non-isothermal and isothermal melt crystallization of
PCl. The dynamic mechanical study showed that the storage modulus of the
nanocomposites is greatly improved by ~ 203% and 292%, respectively, on addition
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of 0.5 and 2.0 wt.% TRG at −80 °C as compared with pure PCl. Conductivity, tensile
properties and biocompatibility of the developed composites were not investigated in
this work.
Sodium alginate252 and gelatin253are examples of natural polymers whose mechanical
properties were improved on incorporation of GO. Wan et al.253 showed that the
tensile strength, modulus and energy at break of gelatin can be increased by 84%,
65% and 158% respectively, with the addition of 1 wt.% of GO. The authors also
claim that the addition of GO nanosheets improved the bioactivity of gelatin.
In other work on developing gelatin composites, Wang et al.254 reinforced gelatin
films using reduced GO (RGO). The authors claim that they could reduce GO using
gelatin and chitosan as reducing agents by heating the GO dispersion with chitosan
or chitosan/gelatin solution for 6 h at 90 °C to obtain RGO suspensions. The
resulting RGO increased the tensile strength of the RGO/gel films in both the dry and
wet states, but decreased their elongation at break. The tensile stress of RGO/gel
increased by 82% and 198% in its dry and wet state respectively, when the RGO
content was 0.7%. Cell cultures showed that the composites were biocompatible with
fibroblast cells.
Developing UV-crosslinkable composites could provide many advantages in
biomedical fields. Apart from the elimination of chemical crosslinkers, that might not
be biocompatible, UV-curable material provides the option of in vivo polymerization
that could be beneficial in different ways such as fixing irregularly shaped trabecular
bone defects and fabricating flexible fracture fixation plates255-257. For example, the
surgeon can inject the formable polymers into complex 3D voids in vivo and, after
filling the required dimensions, the polymer can be exposed to UV, becoming rigid
following completion of polymerization. Desired mechanical properties and
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degradation rates can also be achieved by changing the crosslinking percentage. The
schematic of a photopolymerization/photocrosslinking processe is illustrated in
Figure 1.19. Considering that natural polymers exhibit poor mechanical properties
and no conductivity, GO and CCG can be utilized to improve the properties of the
polymers via developing UV-crosslinkable composites.

Figure 1.19. Schematic of the photopolymerization/photocrosslinking processes257,
adapted from258.

Shin et al.259 developed UV-crosslinkable GO composites by incorporating GO into
gelatin methacrylate (GelMA), which is a UV-crosslinkable matrix material. GelMA
was synthesized via methacrylation of gelatin using methacrylate anhydride (MA).
The composite was exposed to UV layer by layer to prepare multi-layer GO/GelMA
hydrogel constructs (Figure 1.20). It has been shown that incorporation of GO and
increase in UV exposure time could improve the mechanical properties of the
hydrogels. The compressive strength of composites with 2.0 mg ml-1 GO
concentration was found to be around 91 kPa; however, GelMA hydrogels exhibited
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a higher failure strain (∼90%) than that of the GO/GelMA composites (∼55%) that
can be attributed to the rigid reinforcements induced by addition of GO.
The cell study showed that GO has promoted cell adhesion, spreading, and
proliferation. Furthermore, the biocompatibility of composites was confirmed by the
absence of cytotoxicity.

Figure 1.20. Schematic of the fabrication of multilayer cell-laden hydrogel
constructs259.

In later work by the same researchers, Cha et al.260 synthesized covalently linked
UV-crosslinkable GO/GelMA hydrogels using methacrylated GO (MeGO). MeGOGelMA hydrogels exhibited improved mechanical toughness with increased MeGO

46

content. Elastic modulus and ultimate stress increased 2.7 and 11 fold respectively,
when the MeGO content was increased up to 3 mg ml−1. The biocompatibility of
MeGO-GelMA hydrogels was also confirmed by evaluating the viability and
proliferation of encapsulated fibroblasts.
Fan et al.261 fabricated graphene/chitosan composite films and explored their
mechanical properties and biocompatibility. Graphene sheets used in their
experiments were prepared by a direct-current arc-discharge method. The graphene
sheets were first dispersed in acetic acid aqueous solution by ultrasonication, then
chitosan was dissolved in the graphene suspension and films fabricated by solutioncasting to give composites with 0-2.3 wt.% graphene content. The schematic of the
process is illustrated in Figure 1.21. The mechanical properties of the
graphene/chitosan composite films were measured by the nanoindentation method.
The hardness of chitosan film is increased from 300 to 500 MPa and the elastic
modulus is also increased from 3 to 7 GPa on addition of 2.3 wt.% graphene. The
composites were found to be biocompatible with L929 cells. There is no data about
conductivity, elongation at break and stress-strain curves of the composites. The
nanoindentation method used for measuring mechanical properties in this work is
mostly suitable for very thin films or nano-micro structure materials; moreover,
maximum load and sample elongation is limited and handling of sample is a
challenge when using the method262.
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Figure 1.21. Schematic of preparation of graphene-reinforced chitosan film261.

The preparation of GO/chitosan composites using an aqueous dispersion of GO and
acetic acid has been reported by Yang et al.263 and Han et al.264. In both studies, the
addition of graphene considerably increased the tensile strength and Young’s
modulus of the samples; however, the processability and biocompatibility of the
developed material was not investigated. Han et al.264 claimed that the tensile
strength of the composite with 18 wt.% GO increased from 80 MPa to 137 MPa in
the dry state and from 15 MPa to 45 MPa in the wet state; nevertheless, considering
other work in the literature, incorporating that much filler results in a composite with
extremely low elongation at break that would be difficult to handle.
Shao et al.265 developed GO crosslinked chitosan nanocomposite films using elevated
temperatures after casting a mixture of GO, aqueous acetic acid solution and
chitosan. The authors claimed that GO and chitosan are crosslinked via drying the
composite films at 120 oC overnight. DSC results showed that the GO crosslinked
chitosan had enhanced thermal properties. The tensile strength was enhanced from 
43 MPa in pure chitosan to more than 100 MPa on addition of 5 wt.% GO.
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Several studies have been undertaken on the development of biocomposites using
GO and graphene and are summarized in Table 1.3 with details about their
mechanical properties, conductivity, processability and biocompatibility. Most of the
work used GO as filler, largely due to its ease of preparation in solvents compared to
reduced GO. A modified Hummers method is the most commonly used way to
prepare GO. Few of these papers report comprehensive characterization of the
biocomposites particularly in terms of processability and biocompatibility. It is also
apparent that limited work has been done on the development of biocomposites using
graphene itself. Owing to its superior mechanical properties to GO266, graphene can
provide a greater enhancement of the mechanical properties of a matrix.
Furthermore, graphene can make the composite conductive, which is an added value
as the developed composites can be used as conductive substrates for electrical
stimulation of cells.
In addition, solution blending was found to be the preferred method for the
preparation of graphene/GO biocomposites while other possible approaches such as
microwave assisted synthesis, formation of covalent bonding between the filler and
matrix and development of UV-crosslinkable composites have rarely been
investigated.
Table 1.3. Summary of the literature on the development of graphene/GO
biocomposites for tissue engineering.
Mechanical
PropertiesPolymer

Filler

improvement

Conductivity

Processability

Biocompatibility

NA

NA

NA

NA

TS: ~ 23%

1E-7 to 1E-6

(unknown)

S m-1

NA

NA

relative to the
neat polymer
(filler content)

245

PLLA

PLA246

CNT/GNS
TRG
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PLGA225

GO

YM: ~180%
(2 wt.%)

NA

NA

NA

NA

Biocompatible
with Hela cells

TS: ~ 150%
PLGA226

GO

YM: ~ 370%

NA

(5 wt.%)
TS: ~200%,
PU247

GO

Biocompatible

YM: ~ 89%

NA

NA

(0.3 wt.%)

with fibrosis
cells

CM: >71%
PPF248

GO

(0.1 wt.%)
FYS: >263%

NA

NA

NA

NA

NA

NA

Nanofibrous

Improvement in

membranes

bioactivity

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

(0.05 wt.%)
TS: ~73%,
PCl249

GO

YM: ~186%
(10 wt.%)
TS: ~94%,

PCl250

GO

YM: ~112%

NA

(2 wt.%)
PCl251

Sodium
alginate252

TRG

SM: 292%
(2 wt.%)
TS: ~59%,

GO

YM: ~392%
(6 wt.%)
TS: 84%

Gelatin253

GO

YM: 65%
(1 wt.%)

Improvement in
bioactivity

TS: 82% dry
Gelatin254

rGO

state and 198%
wet state (0.7

Biocompatible
with fibroblast

wt.%)
UVGelMa

259

crosslinkable

Microfabricated
Not enough data

NA

GO
UVGelMa260

crosslinkable
graphene

Chitosan261

graphene

arrays of cellladen gels

Biocompatible
with fibroblasts

EM: 170%
US: 1000%
(3 mg ml−1)

Nanoindentation
method
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NA

NA

NA

NA

Biocompatible
with fibroblasts

Biocompatible
with L929 cells

TS: 122%
263

Chitosan

GO

YM: 64%

NA

NA

NA

NA

NA

NA

NA

NA

NA

(1 wt.%)
TS: 35% dry
Chitosan264

GO

state and 200%
wet state
(18 wt.%)
TS:  174%

265

Chitosan

GO

(5 wt.%)

Abbreviations: TS: tensile strength, YM: Young’s modulus, CM: compressive modulus, FYS: flexural
yield strength, SM: storage modulus. EM: elastic modulus, US: ultimate stress and NA: not available.

1.4.3. Fabrication of Scaffolds for Tissue Engineering
The everyday life of a large number of people in the world is severely affected by the
loss or failure of an organ or tissue because of an accident. The common treatment
for these cases is the transplantation of the damaged organ or tissue, which is not
always feasible mostly due to a shortage of donors. The other therapy methods such
as synthetic prostheses and medical devices are not very effective and usually do not
provide an appropriate alternative for the damaged or lost organ267. Scientists have
done extensive research on the development of new biomaterials and therapy
techniques.
Tissue engineering is a promising and effective approach for the treatment of the lost
or damaged organs and tissues without having the limitations of the other treatment
methods268-270. In tissue engineering, the patient’s own cells will be cultured on a
temporary 3D scaffolds, followed by transferring of the scaffold into the damaged
part of the patient’s body. The cells proliferate and repair the damaged area by
forming a new tissue or organ. The scaffold then will be degraded and excreted out
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of the patient’s body6,

267, 268, 271

. Figure 1.22 shows how different methods of

treatment of injured or diseased tissues and organs are evolved to tissue engineering.

Figure 1.22. Schematic showing the evolution of tissue engineering16.

3D porous scaffolds play a pivotal role in tissue engineering techniques. Scaffolds
are the supports on which the cells proliferate and develop their extracellular
matrices271-273. Therefore, the materials developed for fabricating scaffolds should
meet some specific requirements. The material should be biocompatible and does not
cause any toxicity or inflammation in vivo. It should be biodegradable, degrading
over a reasonable time. The surface of the material should be suitable for the
adhesion and proliferation of cells. The material should be processable, able to be
fabricated into 3D structures and the resulting structures be mechanically strong6, 267,
274, 275

. An attractive additional feature is conductivity, as recent studies have shown

that electrical stimulation of electro-responsive cells can enhance their growth and
differentiation207-209.
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There are several methods to fabricate 3D scaffolds for tissue engineering, namely
gas foaming, fiber bonding, phase separation, porogen leaching and freeze drying
(lyophilisation)267. However, these conventional methods suffer from several
drawbacks, such as poor mechanical properties and reproducibility as well as lack of
precise control over the size, geometry, distribution and interconnection of pores.
1.4.3.1. 3D Printing of Scaffolds
3D extrusion printing, which is based on rapid prototyping (RP) technology, is a new
fabrication technique that provides a fast and precise method to fabricate scaffolds276.
Using 3D printing, more control is available on the scaffold parameters; therefore the
limitations of the conventional scaffolds are overcome. PR technology can be
utilized to customize the scaffolds to closely mimic the biomechanical properties of
the damaged organs and tissues274- 276.
The principle of extrusion printing is based on extrusion of a solution or melt through
a nozzle and development of a 3D structure from a 3D computer model. The
software slices the computer model into number of layers and the structure is printed
layer by layer (Figure 1.23)277. 3D extrusion printing is becoming increasingly
favourable in the biomedical field owing to its ability to use a wide range of
biomaterials, high precision and the capability of printing scaffolds in a cell-friendly
environment276.
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Figure 1.23. Overview of rapid prototyping technology, adapted from277.

Among the synthetic polymers, PCl is an appropriate candidate for developing
scaffolds for tissue engineering due to its good biocompatibility and processability.
Wang et al.106 developed a printing system called precision extruding deposition
(PED) to fabricate interconnected 3D scaffolds. The equipment consisted of a
material mini-extruder system, temperature controllers and the system control
software. The molten PCl was extruded by a tuning precision screw to print the
scaffolds layer-by-layer. The typical pore size of the fabricated 39 layers scaffold
ranged from 200 to 300 µm. The compression tests showed that the compression
modulus of the scaffolds varied between 150 and 200 MPa. The biocompatibility of
the structures was confirmed by growing cardiomyoblasts (H9c2) on the scaffolds.
Park et al.108 demonstrated fabrication of PCl scaffolds with interconnecting pores
using a 3D bioplotter (Envisiontec GmbH, Gladbeck, Germany). PCl was plotted as
layer by layer deposition using nozzles with different diameters on a stage. A saltleaching PCl scaffold was also fabricated as a control group. SEM showed that the
3D plotted scaffolds had a highly porous structure, while the pores of the salt-leached
scaffold were poorly interconnected. The compressive modulus of the printed
scaffolds was found to be around 3.5–10.3 MPa, which is much higher than that of
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salt-leached scaffold. Cell studies showed that the plotted scaffolds provided more
opportunity for cells to penetrate into the scaffold than a salt-leached one, indicating
that printed structures are better options for tissue engineering applications.

Figure 1.24. Schematic of the 3D melt-plotting technique used by Park et al.108

Mattioli-Belmonte et al.278 developed PCl-CNT composites and printed the
composites into 3D scaffolds (Figure 1.25). The printing was carried out using a
syringe based deposition method by printing the composite solution layer by layer on
a polymeric spacer. The authors showed that the geometry of the scaffolds is
influential on the mechanical properties. The elastic modulus of the nanocomposite
could also be varied between 10 and 75 MPa by changing the CNT content. The
PCl–CNT nanocomposites were able to sustain osteoblast proliferation and modulate
cell morphology.
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Figure 1.25. Light microscopy of PCl/CNT nanocomposite scaffolds with different
topologies and their respective CAD drawings (a) hexagonal, (b) square, (c)
octagonal cell grids and (d) 3D bone-like scaffold, adapted from 278.
Chitosan, a biopolymer of natural origins, is another suitable candidate for
developing 3D scaffolds due to its biodegradability and processability. Geng et al.279
demonstrated the direct writing of chitosan scaffolds using a robotic system. The
chitosan gel, prepared by dissolving chitosan in 2% v/v acetic acid, was transferred
into a plastic syringe barrel and injected by pressurized air. NaOH solution was used
as a coagulant and dispensed via another syringe using a motorized plunger. The
scaffolds were printed layer by layer based on computer-generated models (Figure
1.26). The printed chitosan scaffolds exhibited excellent uniformity, with good
strength and reproducibility. The scaffold cell compatibility was also evaluated by
culturing pBMSc’s on the scaffolds. pBMSc’s adhered and spread well on the
surface of the scaffold, showing typical polygonal morphology.
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Figure 1.26. Scaffold fabrication process by dual dispensing: (a) fabrication of first
layer; (b) start of dispensing for second layer; and (c) finishing of fourth layer,
adapted from279.

1.5. Thesis Outline
As discussed in the previous sections, GO and graphene are excellent fillers for
improving the properties of biodegradable polymers for biomedical applications.
However, few of the studies described comprehensively evaluated the effect of the
addition of GO and CCG on the biocompatibility, processability and different
properties of the common biodegradable polymers.
In this thesis, the development of novel processable biocomposites using GO and
CCG for use in biomedical field has been undertaken and the processability and
biocompatibility of the developed biocomposites have been demonstrated. Two
polymers were considered for this study, one of natural origins (chitosan) and the
other a synthetic material (PCl). The synthesized graphene/GO biocomposites were
characterized with a wide variety of characterization methods to evaluate the effect
of the carbonaceous filler on the properties of the polymer. The biocompatibility of
the synthesized biocomposites was examined through cell study. As the materials are
intended to be used in biomedical fields, particularly tissue engineering, the
processability of the biocomposites was investigated via the printing of 3D
structures.
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The structure of the thesis is as follows. The introduction to the general area and a
review of the related literature is presented in Chapter 1. Chapter 2 describes the
general experimental methods used in this work. The review of the literature
highlighted the lack of a comprehensive study on the use of conducting graphene
nanosheets in PCl composites. Therefore, the development of graphene/PCl
composites is investigated in Chapter 3. The composites were prepared through two
synthesis

methods,

mixing

and

covalent

attachment.

Microwave-assisted

polymerization, which is a quick, alternative method to conventional synthesis, is
also employed for the first time to develop graphene/PCl composites. The enzymatic
degradation of the biocomposites is also investigated.
Chitosan, a naturally derived polysaccharide, is a promising material for the
development of biomaterials. However, the lack of sufficient data about
graphene/chitosan composites in the literature motivated a comprehensive study on
this subject in Chapter 4. The biocomposites were prepared via two synthesis routes,
mixing and covalent attachment.
Due to the importance and wide application of UV-crosslinkable materials in the
biomedical field, the fesibility of developing UV-crosslinkable biocomposites was
investigated using the natural polymer, chitosan and GO and CCG as filler in
Chapter 5. The synthesis procedure, characterization, biocompatibility study and
processability of the composites is covered in this chapter. The conclusion and
possible future work are discussed in Chapter 6.
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2. Experimental
2.1. Materials
ε-Caprolactone

(97%), N,N-dimethylformamide

(DMF), N,N′-dicyclohexyl-

carbodiimide (DCC), 4-dimethylaminopyridine (DMAP), 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC), N-hydroxysuccinimide (NHS),
Dulbecco’s modified Eagle’s medium (DMEM), methanol, dichloromethane, (3aminopropyl)triethoxysilane 99%, tin 2-ethylhexanoate (95%), polycaprolactone
(PCl) (Mn 80,000), chitosan powder (medium molecular weight), methacrylic
anhydride, hydrazine monohydrate (N2H4 64-65 %, reagent grade, 98%), phosphorus
pentoxide (P2O5) and triethylamine were sourced from Sigma-Aldrich and used as
received. DL-lactic acid, (80-85% aqueous solution) was purchased from Alfa Aesar.
Graphite powder was obtained from Bay Carbon. Acetic acid, sulphuric acid,
hydrochloric acid, 30% hydrogen peroxide (H2O2), ethanol and ammonia solution
28% were purchased from Ajax Finechem. Dichloromethane, potassium persulfate
(K2S2O8) and potassium permanganate (KMnO4) were obtained from Chem-supply.
1-[4-(2-Hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-1-propane-1-one
2959) was

purchased

from

Ciba.

Milli-Q water with

(Irgacure

a resistivity of

18.2 mΩ cm−1 was used in all preparations.
2.2. Material Synthesis
2.2.1. Synthesis of Graphene Oxide
Graphene oxide (GO) was synthesized from natural graphite powder using a
modified Hummers’ method in two steps to achieve better oxidation of graphite

1, 2

.

The whole precude was performed under a fume hood and the temperature of the
reaction was controlled accurately by a digital thermomether. In the preoxidation
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step, K2S2O8 (5g) and P2O5 (5 g) were added successively into an 80 °C solution of
concentrated H2SO4 (30 ml), followed by addition of 10 g graphite powder. The
reaction was carried out in a three neck flask located into a dish containing silicone
oil to be able to accurately control the reaction temperature. The mixture was stirred
at 80oC for 4.5 h. After cooling to room temperature, the mixture was carefully
diluted through dropwise addition of cold distilled water with continuous monitoring
of the temperature. Then, the resultant sample was filtered and washed until the
washings became pH neutral and air-dried. In the second oxidation step, the graphite
powder was put into 230 ml cold (0 °C) concentrated H2SO4 and 30 g KMnO4 was
added gradually with stirring and cooling, so that the temperature of the mixture was
kept below 12 °C. The reaction was carried out by putting the reaction flask into a ice
bath containing ice to control the temperature, ensure that the exothermic reaction
was controlled. The temperature of the mixture was increase to 35 °C by gradual
addition of warm water to the ice bath, stirred for 2 hrs and followed by careful
addition of 920 ml deionised (DI) water maintaining the temperature at 35 °C with
the water bath. The mixture was then diluted with 0.5 L DI water and stirred for 15
min. Successively, 1.5 L of DI water was added to the mixture to terminate the
reaction followed by dropwise addition of 30% H2O2 (25 ml) . The colour of the
mixture changed to bright yellow at this stage. The mixture was washed and
centrifuged with 1 M HCl solution (2.5 L) in order to remove metal ions. Finally, the
GO product was washed with DI water through centrifugation (Sigma 4-15
Centrifuge) until the washings became neutral.
2.2.2. Synthesis of Aqueous Chemically Converted Graphene
Synthesis of aqueous chemically converted graphene (CCG) was carried out
following Dan Li’s method3. To prepare 200 ml of aqueous CCG with 0.5 mg ml-1
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concentration, 200 ml of GO dispersion with 0.5 mg ml-1 concentration was prepared
and sonicated using a probe sonicator (Branson Digital Sonicator -S450D, 500 W, 40
% amplitude) for 40 min. 40 µl hydrazine and 0.5 ml of ammonia were mixed and
diluted with 10 ml DI water and the mixture was added to the GO dispersion. The
dispersion was heated up and was kept under constant stirring at 95oC for 1 hr that
resulted in preparation of stable aqueous CCG dispersion.
2.2.3. Preparation of CCG Powder
30 g GO was diluted with 1 l DI water and sonicated for 80 min. Then, 200 μl
hydrazine and 2 ml ammonia was added and the solution was heated at 90 OC for 1
hr. 1.5 ml hydrazine was added to the solution and the mixture was heated and kept
at 90 OC for 2 hrs under constant stirring. After cooling to the room temperature,
H2SO4 (aqueous 30%) was added to the solution until pH neutral. The agglomerated
CCG powder was filtered and dried in vacuum oven at 50 oC for 2 days.
2.2.4. Preparation of DMF-dispersed CCG
DMF-dispersed CCG was prepared using the procedure developed by Dr. Gambhir4.
To prepare 450 ml of DMF-dispersed CCG with 0.5 mg ml-1 concentration, 300 mg
dried CCG powder was added to 150 ml DMF (moisture content ≤ 350 ppm by KarlFischer). 50 µl triethylamine was added and the solution was extensively sonicated
using a probe sonicator (4 × 40 minutes) with continuous cooling and under a dry
nitrogen purge. Then, 300 ml DMF and 500 µl triethylamine was added and the
suspension was further sonicated under nitrogen for another 4 × 40 minutes. The
dispersion was centrifuged for 30 minutes at 3000 rpm to separate any agglomerated
graphene sheets.
2.2.5. Development of Graphene/PCl Composites
The composites were prepared by Dr. Eoin Murray (in the IPRI, UOW laboratories)
and Sepidar Sayyar. To prepare graphene/PCl samples using the mixing method
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(mixPCl-CCG), PCl was mixed in an appropriate amount (based on the desired
percentage of CCG in the product) of a 0.5 mg ml-1 solution of DMF-dispersed CCG
at 75 °C for 3 hrs followed by cooling the mixture to room temperature. The polymer
blends were then precipitated in cold methanol, filtered and dried in a vacuum oven
at 50 °C.
To prepare covalently linked graphene/PCl composites (cPCl–CCG), PCl was mixed
in an appropriate amount of DMF-dispersed CCG with 0.5 mg ml-1 at 75 °C for 1 hr.
DMAP (0.1% w/v) was added followed by the slow addition of DCC (0.4% w/v) and
stirred at 75 °C for a further 4 hrs before cooling to room temperature. The polymer
composites were then precipitated in cold methanol, filtered and dried in a vacuum
oven at 50 °C.
2.2.6. Microwave-assisted Preparation of PCl/rGO Composites
The microwave-assisted synthesis of PCl and PCl composites was carried out in in a
CEM Discover 2.45-GHz microwave oven by Dr. Eoin Murray (in the IPRI, UOW
laboratories). To synthesize PCl, 5 ml of ε-caprolactone was mixed with 10 µl of tin
2-ethylhexanoate in a round bottom flask. After stirring the mixture, the flask was
evacuated then purged with nitrogen. The mixture was reacted under flowing
nitrogen using microwave irradiation (100 W max) at a constant temperature of 140
°C. The resultant solid material was dissolved in dichloromethane and precipitated in
cold methanol, filtered and dried in a vacuum oven at 50 °C.
To develop microwave-assisted graphene/PCl composites (mPCl-rGO), an
appropriate weight of dried GO flake was sonicated in ε-caprolactone until well
dispersed (by Sepidar Sayyar). Following the addition of tin 2-ethylhexanoate (0.2%
v/v) the reaction vessel was evacuated then purged with nitrogen. The mixture was
reacted under flowing nitrogen using microwave irradiation (100 W max) at a
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constant temperature of 140 °C for 1 hr. The polymer composite was then dissolved
in dichloromethane and was precipitated in cold methanol, filtered and dried in a
vacuum oven at 50 °C.
2.2.7. Development of Chitosan Film and Graphene/Chitosan Samples
In the mixing method, chitosan powder (2% w/v) was added to DI water or an
appropriate amount of the aqueous CCG dispersion followed by slow addition of
lactic acid (with 2:1w/w ratio relative to chitosan) under stirring. The mixture was
stirred for 1 hr and sonicated for 2 hrs to obtain a homogenous dispersion. The
solution was cast onto a petri dish and dried at 50 °C. The excess lactic acid was
removed by washing the samples in several steps with ethanol/phosphate buffered
saline (PBS) solutions decreasing the ethanol/PBS ratio stepwise until the films were
in PBS alone. The sample was then well washed with DI water and was dried in
vacuum oven at 50 °C until no further weight loss was observed.
To prepare covalently linked chitosan samples (cCSG), chitosan powder (2% w/v)
was added to DI water or required volume of aqueous CCG followed by slow
addition of lactic acid (with 2:1w/w ratio relative to chitosan) under stirring. The
solution was then sonicated for 20 min. NHS (0.2 % w/v) was added and the solution
was stirred for 30 min followed by addition of EDC (0.5% w/v). After stirred for 3
hrs and a mild sonication, the mixture was poured into a petri dish to evaporate water
and dried at 50 °C.
2.2.8. Synthesis of ChiMA
Development of methacrylated chitosan (ChiMA) was carried out by dissolving
chitosan in aqueous acetic acid solution ( 8% acetic acid) to give a chitosan solution
with around 3 wt.% chitosan content. The solution was stirred at 60 oC for 20 min.
Then, methacrylate anhydride (16% w/v) was added slowly to the chitosan solution
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and the mixture was stirred at 68oC overnight. After cooling down to room
temperature, the pH of the mixture was set to 7 by using ammonia and the mixture
was dialyzed in DI water for 4 days. The solution was then freeze dried to make solid
ChiMA that is in the form of a white spongy material and is water soluble. The
degree of methacrylation of chitosan was determined and calculated using 1H NMR
spectroscopy (Figure 2.1) by Dr. Sanjeev Gambhir (in the IPRI, UOW laboratories).
The calculations were carried out by comparing the integrated area of the H2–H6
peaks of chitosan at 2.8 to 4.0 ppm to that of the methylene peaks at 5.6 and 6.0
ppm5, 6. The degree of methacrylation was found to be around 70%.

Figure 2.1. 1H NMR of ChiMA. The peaks at 2.8–4.0 ppm are attributed to the
protons in the gluocosamine ring. The methylene peaks on the ChiMA are located at
5.6 and 6.0 ppm.

2.2.9. Development of ChiMA Film, GO/ChiMA and CCG/ChiMA Composites
ChiMA (2% w/v) was dissolved in an appropriate amount of DI water, aqueous GO
or aqueous CCG dispersion under stirring and sonication. The mixture was stirred
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overnight until the ChiMA was fully dissolved in the dispersion. Photoinitiator
(Irgacure 2959) (0.2% w/v) was added under stirring and mild sonication with bath
sonicator. Then, the mixture was stirred for 2 hrs. After bath sonication for 5 min, the
solution was cast into a petri dish and was dried at room temperature overnight in the
dark to avoid any crosslinking. The dried film was then exposed to UV light
(Hanovia UV-lamp 125 Watt) for 10 min for UV-crosslinking. The crosslinked
sample was well washed with DI water and dried in a vacuum oven at 50 oC.
2.3. Characterization
2.3.1. Thermogravimetric Analysis
Thermogravimetric Analysis (TGA) of samples was performed using a TGA Q500,
TA Instruments. All samples, except lactic acid, were dried in vacuum oven
overnight at 50 oC followed by periodical measurement of their weight until no
weight change was observed.10 mg of sample was loaded into the TGA pan and the
temperature was increased with a ramp rate of 5 oC min-1 up to 900 oC under a
nitrogen atmosphere.
2.3.2. Differential Scanning Calorimetry
Differential Scanning Calorimetry (DSC) analysis was performed on a DSC Q100,
TA Instruments. 5-8 mg of sample presealed in an aluminum pan was first heated to
above the melting temperature of the polymer, cooled to 0 °C at 10 °C min -1, and the
temperature was then increased to above 100 °C at 10 °C min-1.
2.3.3. Scanning Electron Microscopy
Scanning electron microscopy (SEM) images were collected with a field-emission
SEM instrument (JEOL JSM-7500FA). Typical conditions for the analysis of the
samples were an accelerating voltage of 15 kV at working distance of between 5 mm
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and 10 mm. The sample preparation for SEM analysis is as follows for different
samples:
2.3.3.1. CCG
CCG samples for SEM were prepared by depositing CCG sheets on a silanized
silicon wafer (300 rim SiO2 layer) to ensure good adhesion and dispersion of CCG
sheets. A silane solution was prepared by mixing (3-aminopropyl)triethoxysilane
with DI water (1:9 v/v) followed by the addition of one drop of hydrochloric acid.
After washing with water and ethanol and drying at room temperature, the silicon
wafer was silanized by immersing it in the silane solution for 30 min followed by
washing with DI water and drying at room temperature. The silanized silicon wafer
was then immersed into a diluted CCG dispersion (50 µg ml-1) for a few seconds and
then was transferred into DI water. The wafer was dried at room temperature before
SEM analysis.
2.3.3.2. Polymer and Composite Films
To prepare PCl samples for SEM analysis, hot pressed films of each sample with
around 1 mm thickness were prepared. The samples were cut into 0.5 × 0.5 mm
pieces for surface images. To prepare sample for cross sectional images, the films
were frozen in liquid nitrogen and were fractured. The samples were mounted on a
SEM sample holder using silver paint and were sputter-coated (EDWARDS Auto
306) with a thin layer of platinum (~ 10 nm thickness).
To obtain SEM images from the film surfaces of chitosan and ChiMA, the samples
were cut into 0.5 × 0.5 mm pieces and were mounted on a SEM sample holder holder
and were sputter-coated (EDWARDS Auto 306) with a thin layer of gold (~ 12 nm
thickness). To prepare samples for cross-sectional images, samples were frozen in
liquid nitrogen and were fractured before mounting on sample holder and coating.
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To prepare samples for SEM from freeze dried materials, the freeze-dried CSG-0.5
structure and ChiMA were frozen in liquid nitrogen and were fractured followed by
coating with a thin layer of gold (~ 12 nm thickness)
2.3.3.3. Fibres
Fibres were frozen and fractured in liquid nitrogen for cross-sectional images. The
samples were mounted vertically (for cross-sectional images) and also horizontally
(for surface images) on a SEM sample holder using silver paint and were sputtercoated (EDWARDS Auti 306) with a thin layer of platinum (~ 3 nm thickness).
2.3.4. X-ray Diffraction
The X-ray diffraction (XRD) studies on DMF-dispersed CCG were carried out using
a powder XRD system (Philips1825) with Cu Kα radiation (λ = 0.154 nm), operating
at 40 keV and with a cathode current of 20 mA. The spectra were obtained between
angles of 5° and 40° with typical scan speeds of 0.5° min-1 utilised. The sample was
prepared through depositing 500µl DMF-dispersed dispersion with 0.5 mg ml-1
concentration on a quartz substrate followed by evaporating the solvent at room
temperature.
The XRD analysis of PCl, chitosan, ChiMA and their composites as well as graphite
and GO was performed on a GBC MMA x-ray spectrometer using a Cu x-rays.
Spectra were obtained between angles of 5° and 40° with typical scan speeds of 0.5°
min-1 utilised. GO sample was prepared through depositing 500 µl aqueous
dispersion with 0.5 mg ml-1 concentration on a quartz substrate followed by
evaporating the solvent at room temperature. Graphite and chitosan powder were
stuck on the quartz substrate using ethanol. For PCl, chitosan and ChiMA films and
their composites, a 1.5 × 1.5 cm film was mounted on the quartz substrate using
ethanol.
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2.3.5. Raman Spectra
Raman spectra were obtained on a Jobin Yvon Horiba HR800 confocal Raman
microscope using a 632.8 nm laser line with a 300-lines mm-1 grating through a 100
× magnification wide angle objective. The laser was calibrated against a SiO2 signal.
2.3.6. Fourier Transform Infrared Spectroscopy
Fourier transform infrared spectroscopy (FTIR) spectra were measured on a
Shimadzu IRPrestige-21 infrared spectrometer equipped with a Pike Technologies
MiricleA germanium crystal ATR attachment. To measure FTIR spectra of powdery
samples (e.g. chitosan, CCG and GO), the sample was mixed with potassium
bromide (KBr) powder with 1:10 ratio and the blend was pressed into the FTIR
sample holder. The FTIR spectra of the films were recorded using an ATR
attachment.
2.3.7. Conductivity
The electrical conductivity of the samples was measured using both two-point probe
and four point probe methods. The bulk conductivity of the samples was measure by
a two-point probe method using a multimeter (Fluke 287 True-RMS). The opposing
sides of the samples were silver painted to provide better contact with the probes.
The conductivity was then calculated using the following equations:
𝜌=𝑅

𝜎=

𝐴
𝑙

(1)

1
𝜌

(2)

where ρ is the resistivity (Ω/□), R is the resistance (Ω), A is the cross-sectional area
of the specimen (cm), l is the length of the specimen (cm), and σ is the conductivity
(S cm-1).
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The conductivity of films with high surface resistance (>10 MΩ) was also measured
by a two-point probe method. The film was cut into specific dimensions and was
fixed on a glass slide. A line of silver paint was then painted at the edges of the film
to ensure better contact between the film and the probes. The sheet resistance was
then measured by putting the probes on the silver painted edges of the opposite sides.
The sheet resistance was converted to conductivity using the following equations:

𝑙
𝑤

(3)

1
𝑅𝑠 𝑡

(4)

𝑅 = 𝑅𝑠

𝜎=

where R is the resistance value from the multimeter (Ω), Rs is the sheet (sample)
resistance (Ω), l is the sample length (cm), w is the sample width (cm), t is the
sample thickness (cm) and σ is the conductivity (S cm-1).
The conductivity of the films with surface resistance lower than 10 MΩ was
measured using a four-point probe technique by a Jandel RM3 Conductivity Meter
with a linear four-point probe having a 0.65 mm pin distance. The output from the
equipment, sheet resistance Rs, was converted to conductivity using Equation (4).
2.3.8. Swelling Studies
The swelling percentage of the chitosan and ChiMA samples was measured by
immersing the samples (50-100 mg) in DI water and weighing them at different time
intervals. The samples were first fully dried in vacuum oven at 50 °C until no further
weight loss was observed. Then, the samples were immersed in 20 ml DI water. At
different time intervals, the samples were removed from the DI water, patted dry
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with a wiper (KIMTECH Science Kimwipes) and weighed at room temperature. The
swelling %, Esr, was calculated using equation (5)7, 8:
Esr = [(Ws - Wd)/ Wd] ×100

(5)

where Esr is the percent swelling of the sample (%), Ws denotes the weight of the
sample in swollen state and Wd is the initial weight of the sample.
2.3.9. Zetasizer and Zeta Potential
Particle size and zeta potential of GO and CCG dispersions were measured using a
Malvern Zetasizer Nano-ZS particle analyser and a Malvern Clear Transparent Zeta
Cell. 1 ml of diluted GO or CCG dispersion used for the measurements.
2.3.10. Mechanical Properties
The mechanical properties of the samples (films and fibres) were measured using a
Shimadzu tensile tester (EZ-S). The samples were mounted between two grips and
were subjected to tensile test with a constant rate. Tensile strength and elongation at
break of the samples were recorded by TRAPEZIUMX software. The Young’s
modulus was calculated from the slope of the initial part of the curve, where the
relationship between stress and strain is linear. The mean and standard deviation of
tensile strength, elongation at break and Young’s modulus was reported for n=5
samples.
2.3.11. Biocompatibility
2.3.11.1. Cell Culture on PCl Films and Fibres
The cell culture experiments were carried out by Dr. Brianna Thompson (in the IPRI,
UOW laboratories). Materials were prepared for cell culture by attachment of
chamber slides directly onto the surface using silicon glue, and sterilisation by
soaking the surfaces with 70% ethanol before air drying in a biological safety
cabinet. The sterilised materials were soaked in DMEM with penicillin/streptomycin
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for 24 hrs before the cells were plated. L-929 cells (a mouse fibroblast cell line) were
seeded in DMEM supplemented with 10% foetal bovine serum at 5000 cells cm-2 of
PCl-CCG composite, and incubated at 37 °C in 5% CO2 for 48 hrs (Figure 2.2). After
48 hrs, the cells were removed from the incubator and stained with calcein AM and
propidium iodide for 10 minutes before imaging with a Zeiss AxioImager
microscope. Image analysis for cell counting was performed using Image Pro Plus,
and cell numbers were averaged over at least 3.6 mm2 of the culture surface, with
microscope images taken from random, separate areas of the culture well.
Biocompatibility of the fibers was tested using electroactive rat pheochromocytoma
cells (cell line PC-12) grown on the extruded materials after preparation of materials
(sterilisation with 70% ethanol and soaking in Dulbecco's modified eagle medium
(DMEM) overnight). 1 ml of media (DMEM + 10% horse serum + 5% fetal bovine
serum) containing 20,000 cells was placed into each well, and the cells were allowed
to settle for 24 hrs, before the media was changed to differentiation media (DMEM +
2% horse serum + 50 ng/ml nerve growth factor (NGF)). The cells were incubated at
37 oC in 5% CO2 for 5 days before fixation with paraformaldehyde, staining with
phalloidin-Alexa 488 (Invitrogen) and 4',6-diamidino-2-phenylindole (DAPI), and
microscopy.
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Figure 2.2. A setup for cell culture biocompatibility test on composite films.

Biocompatibility of mPCl-rGO samples was performed by culture of a rat fibroblast
cell line (L-929) on films and printed scaffolds made from the material. A Pico
Green assay was used to compare the number of cells after 4 days of growth on the
materials to growth on tissue culture plastic. In short, cells were seeded at 1500 cells
cm-2 in a 12 well plate coated with mPCl-rGO and PCl, and incubated for 4 days
before the media was removed, and cells lysed in 0.1% sodium dodecyl sulphate in
1x Tris-EDTA buffer. The amount of DNA in the lysed cell solutions was analysed
by addition of the Pico Green reagent, as per the manufacturers instructions, and the
fluorescence of the solutions converted to a cell number using a standard curve
solution of known cell density.
For imaging of cells on the scaffold surfaces, L-929 cells were seeded onto 2 × 2 cm
6-8 layer scaffolds in 6 well plates at approximately 1 × 106 cells per ml in 1 ml and
allowed to attach for 30 minutes in the incubator before the media in the well was
topped up to 2 ml. The scaffolds were returned to the incubator for 4 days before
fixation of the cells with 3.7% paraformaledhyde in PBS and staining with
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Alexa488-phalloidin (Life Technologies) and DAPI (Life Technologies), and
imaging using a Leica TCS-SP5 confocal microscope, and a Leica DM IL LED. Zstacks were acquired on the confocal microscope with a slice height of 1.1 µm were
taken over 250 µm height and Imagesurfer 1.24 was used to render 3D isosurface
images of the cells growing on the scaffolds.
2.3.11.2. Enzymatic Degradation of PCl Samples
The PCl samples were enzymatically degraded using pseudomonas lipase. The
experiments were performed by Dr. Brianna Thompson (in the IPRI, UOW
laboratories). 5 mm discs of each material were cut out of a  0.2 mm thick
compression melted sheet and incubated in the lipase solution at 37 oC (Figure 2.3).
Samples were withdrawn and rinsed with DI water at regular time points over 72 hrs.
All time points were done in triplicate.
(b)

(a)

Figure 2.3. (a) PCl discs (5 mm) and (b) PCl sample in lipase solution.

2.3.11.3. Growth of Mammalian Cells in Diluted CSG Dispersion
L-929 cells (mouse fibroblast cells) were seeded into 96-well plates at 3200 cells
cm-2 and allowed to settle for 24 hrs, after which the media was changed to
DMEM+5 % foetal bovine serum with 5 % (v/v) CSG dispersions (giving a final
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concentration in solution of 0.1 % w/v chitosan and 0.02 % w/v graphene). The cells
were cultured for a further 5 days, and then imaged and the viability of the cells
analysed by flow cytometry. Briefly, the cell media was removed and the cells
exposed to 100 µL 0.025 % trypsin/EDTA for 2 mins before 20 seconds of trituration
and addition of 1 µl of 1 mg ml-1 propidium iodide, with immediate analysis of cells
by flow cytometry (BD Accuri C6 flow cytometer, BD Biosciences). The % live
cells and the density of cells were estimated using this method. The experiments
were performed by Dr. Brianna Thompson (in the IPRI, UOW laboratories).
2.3.11.4. Growth of Mammalian Cells on CSG Films and Scaffolds
Discs of deacidified CSG films of various graphene contents with a 6 mm diameter
were punched under swollen conditions, and the discs were placed into 96-well
plates. Cylinders made out of MED610 (Objet, USA), a biocompatible UV-curable
polyacrylate, were used to hold the discs in place and provide a barrier to cell
attachment during L-929 seeding at 6000 cells cm-2 (Figure 2.4). The cells were
grown for 48 hrs, and then underwent live/dead staining (by addition of 1 µM calcein
AM (Invitrogen) and 1 µg ml-1 propidium iodide (Sigma). Additionally, cells seeded
at a higher density (12000 cells cm-2) were fixed after 24 hrs with 4 %
paraformaldehyde and stained with Alexa488-phalloidin (Invitrogen) to image the
cytoskeleton and observe the migration of cells under the MED610 barriers. For cell
culture on scaffolds, L-929 cells were prepared at 1E6 cells ml-1 and 300 µl of this
solution was used to seed each 1.5 × 1.5 cm CSG-0.5 scaffold, after scaffolds were
deacidified using the procedure described for films. Cells were cultured for 24 hrs
before fixation with 4% paraformaldehyde and staining with Alexa488-phalloidin
(Invitrogen) and DAPI (Invitrogen). Confocal microscopy was performed using a
Leica SP5 confocal microscope, and image processing was performed using Image J
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(Research Services Branch, National Institute of Mental Health). The experiments
were performed by Dr. Brianna Thompson (in the IPRI, UOW laboratories).

Figure 2.4. A setup for cell growth biocompatibility test.

2.3.11.5. Cell Growth Inhibition in ChiMA Films
Cell growth inhibition (CGI) assay was conducted on ChiMA films to determine the
effects of material extracts on the growth of mammalian cells. The experiments were
carried out by Dr. Johnson Chung in the IPRI Laboratories. Test materials were
prepared to give 0.1-0.2 g ml-1 of extraction vehicle as suggested in AS ISO-109939.
L929 murine fibroblasts were used as a model cell line for this assay and seeded at a
density of 5× 104 cells ml-1 (2 ml) into tissue culture dishes (35 mm) and incubated
(37 ºC, 5% CO2) for 24 hrs. Vials containing the materials for extraction were also
incubated for 24 hrs alongside with the tissue culture dishes. The materials were
extracted in DMEM. After 24 hrs, the media were removed and replaced with the
extraction fluid (1ml) followed by incubation for a further 48 hrs. Samples that were
not exposed to extraction media (null) were replenished with fresh media instead.
Following the incubation period (48 hrs), trypsin was used to detach the cells from
the dish and the cell number and viability were determined using an automatic cell
counter (Countless™, Invitrogen).
CGI was expressed as a ratio of the number of cells in test material to the number of
cells in Null control. A ratio of 0.7 or higher was considered an ‘acceptable level’ of
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cell growth inhibition within this assay. Materials were performed in triplicates and
the assay was repeated in triplicates.
2.3.11.6. Growth of Cells on ChiMA Films
The cell growth experiments were carried out by Dr. Johnson Chung (in the IPRI,
UOW laboratories). Discs of washed ChiMA films with a 6 mm diameter were
punched and placed into 96-well plates. Cylinders made from MED610 (Object,
USA), a biocompatible UV-curable polyacrylic, were used to hold the disc in place
for cell attachment post seeding. Murine fibroblast (L-929s) were seeded at 6000
cells cm-2, and cultured in DMEM supplemented with 1% penicillin/streptomycin
(P/S) for 48 hrs. To determine the viability, samples were stained with 1 µM calcein
AM and 1 µg ml-1 propidium iodide (PI). Samples were imaged using an upright
semi-automated fluorescence microscope (AxioImager, Zeiss).
2.3.12. Rheology
Rheological properties of PCl samples were studied using a rheometer (AR-G2 TA
Instrument) with a stainless steel plate geometry of 25 mm diameter. The lower plate
temperature was set at 70 oC and the dynamic frequency sweep tests were performed
with frequency ranging from 0.1 to1000 rad s-1.
2.4. Fabrication
2.4.1. Preparation of Graphene/Polycaprolactone Extruded Fibres and Printed
Scaffolds
cPCl-CCG composites were extruded to fibres and scaffolds using a KIMM SPS1000
bioplotter extrusion printing system by Mr. Rhys Cornock in the IPRI laboratories
(Figure. 2.5), in which the extrusion assembly is mounted on a three-axis stepping
system above a level stage for full mechanised control of its XYZ axes via an
associated computer system with customised software. Materials are extruded
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through interchangeable tips with internal diameters of 100-500 μm attached to a
pressurised stainless steel barrel enclosed in a temperature controlled jacket. For
extrusion of these composite materials, the barrel temperature was set to 125 oC and
the applied pressure varied between 250-500 kPa. To obtain simple, rounded fibres
printing was done without a substrate. To obtain more complex 3-D scaffolds a
layer-by-layer, additive fabrication approach onto a glass substrate was used.

Figure. 2.5. Schematic of KIMM SPS1000 bioplotter extrusion printing system (by
Rhys Cornock).

2.4.2. Preparation of CCG/Chitosan Extruded Fibres and Printed Scaffolds
Extrusion printing of various CSG blends was conducted by Dr. Johnson Chung (in
the IPRI, UOW laboratories) on aqueous dispersions at a concentration of 2 %
chitosan in water using a custom modified computer numerical control (CNC)
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milling machine (Sherline Products, CA). The system was equipped with a three-axis
positioning platform and controlled by the software interface (EMC2), supplied by
the manufacturer. An attachment for syringe deposition was built and connected to a
controllable gas flow regulator (1-100 psi). The regulator was controlled using a
Pololu SciLabs USB-to-serial microcontroller and with an in-house software
interface. Thirty layers of each CSG dispersion were printed onto a glass slide
positioned in a precipitating bath of isopropyl alcohol. Scaffolds were fabricated
from a 200 µm diameter nozzle fitted to a disposable syringe (Nordson EFD) at a
feed rate of 150 mm min-1 and with a strand spacing of 0.6 mm giving a final size of
1.5 × 1.5 cm.
2.4.3. Preparation of GO/ChiMA and CCG/ChiMA Printed Scaffolds
ChiMA scaffolds were printed using a KIMM SPS1000 bioplotter extrusion printing
system by Dr. Johnson Chung in the IPRI, UOW laboratories. The bioplotter was
equipped with an attachment for syringe deposition connected to a controllable gas
flow regulator (1-100 psi). The ChiMA solution was extruded through a 200 µm
diameter nozzle fitted to a disposable syringe (Nordson EFD) at a feed rate of 150
mm min-1. The 1 × 1 cm scaffolds with a strand spacing of 0.6 mm were printed onto
a glass slide positioned in a precipitating bath of isopropyl alcohol. The number of
layers of the scaffolds could be varied between 10 to 30 layers.
2.4.4. Other Processability Tests
As discussed earlier, a suitable material for biomedical applications should possess
high processability, which means it should be able to be processed into different
forms using different methods. To further study the processability of the synthesised
graphene/PCl composites, the possibility of wet-spinning, spray coating and filtering
of the composite was investigated. Wet-spinning is a common and fascile spinning
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method that has been used for making fibres for biomedical applications particullary
for drug delivery systems10. Filtering and spray coating are the other methods utilized
to prepare thin films and suitable platforms for cell culture and the other biomedical
applications11, 12.
2.4.4.1. Wet-spinning of PCl/CCG Composites
To prepare the wet-spinning solution, cPCl-CCG composites with 0.5 wt.% and 1
wt.% CCG content were dissolved in 10 ml dichloromethane and sonicated for 2 hrs.
Methanol and methanol/water solution (70:30 vol. % mixtures) were used as
coagulant. To spin the fibres, the composite solution was added to a 5 ml syringe and
was injected, with a flow rate of between 5 -10 ml hr-1, into a rotating beaker
containing the coagulant. The composites coagulated well in the coagulation bath
that resulted in formation of homogenous and flexible fibres. The spinning was
carried out by Dr. Javad Foroughi in the IPRI laboratories at UOW.
2.4.4.2. Preparation of Film by Spraying
To make a film by spraying the composite, 0.2 g composite was dissolved in 12 ml
dichloromethane and sonicated for 1 hr. A glass slide was fixed on a hotplate and the
hotplate temperature was set at 37 oC. The solution was sprayed on the slide with a
constant pressure rate to form a film.
2.4.4.3. Preparation of Film by Filtering
cPCL-CCG 1% was dissolved in 10 ml dichloromethane and sonicated for 1hr, then
the solution was vacuum filtered using a membrane filter (0.1 µm VVPP, Durapore )
for 18 hrs. A homogenous and flexible graphene/PCl film was formed using this
method.
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3. Preparation and Characterization of Graphene/PCl
Composites
3.1. Introduction
For biomedical applications like tissue engineering, it is of great importance to
develop materials that are processable and exhibit good mechanical properties,
biodegradability and biocompatibility1. An added advantage can be gained by
making the material conducting, as it has been recently proven that electrical
stimulation can improve the growth of electro-responsive cells such as nerve and
muscle cells2-4. Choosing a suitable matrix is the first step in developing such a
material, which should be followed by selecting an appropriate filler that can
compensate for the deficiencies of the matrix without affecting its inherent
properties.
Among

the

biopolymers

suitable

for

tissue

engineering

applications,

polycaprolactone (PCl) has been the material of choice, mainly due to its easy
processability and its low cost5, 6. PCl has been widely investigated as a drug delivery
vehicle and scaffold in tissue engineering for these reasons. However, this
biopolymer has low tensile strength and is not conducting, and it is in improving
these properties where the addition of a filler can be beneficial.
Polymer nanocomposites filled with nanosized carbonaceous fillers exhibit a
remarkable balance of performances in terms of mechanical properties, fire
retardancy, electrical conductivity and barrier properties7.
The addition of an electrically conducting filler, such as carbon nanotubes (CNTs) or
graphene, to biopolymers can give rise to materials useful for many potential
applications, such as conducting substrates for the electrically stimulated growth of
cells. A number of studies have reported the preparation of PCl/CNT composites 8-11.
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However, there are some drawbacks in using CNTs as a filler such as their high
production cost and more importantly, their harmful effects on cells, mammals and
other species that is shown through in vitro and in vivo studies12, 13.
Graphene, the two-dimensional carbon nanofiller with excellent mechanical and
electrical properties14,

15

, is inexpensive and relatively easy to produce and, as

opposed to CNTs, is biocompatible with cells16, 17. However, maintaining the single
sheet nature of graphene during the formation of the polymer composite is a
challenge that requires careful choice of solvent. Besides being able to dissolve the
polymer, the solvent should have a polarity and boiling point appropriate for the
preparation of a homogeneous dispersion of graphene sheets.
The development of graphene dispersions has been a key area of interest in our
laboratories since the first aqueous dispersion of graphene was synthesised by Prof.
Dan Li in 2009. This work was published in Nature Nanotechnology18 and until now,
it has been cited in the literature more than 2500 times. Dan Li’s method provides a
stepping stone for the preparation of solvent dispersed graphene for developing
polymer composites. On that basis, Dr. Sanjeev Gambhir, a senior researcher in our
laboratories, developed a chemically converted graphene (CCG) dispersion in N,Ndimethylformamide (DMF) that is not only anhydrous but also extremely stable19.
This DMF-dispersed graphene appeared to be an ideal dispersion to use for the
development of PCl composites.
In the study described in this chapter, we have used DMF to prepare graphene
dispersions as this solvent allows the dissolution of both PCl monomers and
polymers as well as shows excellent dispersive ability for graphene19. As indicated
above, the DMF-dispersed CCG exhibits far greater conductivity than graphene
oxide, resulting in conducting composites. The preliminary experiments showed that
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PCl can be dissolved in DMF-dispersed graphene without disturbing the stability and
structure of the dispersion. Moreover, the resulting composite was flexible and
conducting. To the best of our knowledge, there have been no previous reports on the
use of conducting graphene nanosheets in PCl composites.
In the first step of this work, we explored the preparation of PCl-CCG composites
using two different methods; a mixing method producing binary mixtures of
graphene in a polymer matrix and a chemical method resulting in polymer that is
covalently linked to functionalities on the periphery of the graphene sheet. Generally,
the common method of preparing composites is through mixing the polymer with a
filler. However, the presence of carboxyl groups in graphene sheets suggested the
possibility of covalently linking the sheets with PCl through estrification. The
formation of covalent links between the polymer chains and graphene sheets has the
potential to improve mechanical properties and conductivity of the composites.
Apart from developing composites through mixing and covalent attachment methods,
alternative techniques can also be investigated to develop the composites. In this
regard, the possibility of producing the composite through simultaneous
polymerization of polymer and reduction of graphene oxide (GO) was studied. By
using the microwave irradiation, graphene/PCl composites (mPCl-rGO) could be
produced through simultaneous reduction of graphene oxide nanosheets during the
microwave-assisted ring-opening polymerisation of caprolactone. It could result in a
composite with well dispersed conducting graphene sheets covalently attached to a
polymer matrix.
The resulting graphene/biopolymer materials also had the potential to retain the
biocompatibility and processability of the polymer while harnessing the conductivity
and mechanical properties of the graphene filler. Therefore, the biomedical
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properties of our samples were investigated by Dr. Brianna Thompson (in the IPRI,
UOW laboratories). PCl has a low rate of hydration and hydrolytic cleavage, so its
full degradation can take several years in a simulated body fluid like phosphate
buffered saline (PBS). However, it is common to degrade PCl at faster rates by using
enzymes20-22. Therefore, enzymatic degradation method was adopted to study the
degradation rate of PCl-CCG composites and some properties of the degraded
samples.
The development of scaffolds from biomaterials is critical for tissue engineering23.
The fabrication of scaffolds using printing techniques is a relatively new approach
that promises to overcome the limitations of conventional scaffold fabrication
methods, such as producing an interconnected structure for the ingrowth of cells or
for controlling the pore size for cell migration and diffusion24. The availability of
extensive extrusion and printing facilities in our laboratories presented the
opportunity to explore the printing of our graphene/PCl composites. To study the
feasibility of printing our material, graphene/PCl composites were extruded/printed
in the form of 2 and 3-dimensional structures for the first time by Mr. Rhys Cornock
(in the IPRI, UOW laboratories).

3.2. Preparation and Characterization of Graphene Oxide and Chemically
Converted Graphene
3.2.1. Preparation of Graphene Oxide and Chemically Converted Graphene
Stable dispersions of CCG in DMF (0.5 mg ml−1) were prepared by sonicating CCG
flakes, first synthesised from GO, in DMF (Figure 3.1) using the procedure
developed by Dr. Gambhir19. GO was produced from natural graphite powder using a
modified Hummers’ method and then the GO was reduced to CCG using hydrazine
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(NH2NH2) following Dan Li’s method18. The aqueous CCG dispersion was further
reduced using excess quantities of hydrazine followed by acidification to
agglomerate and precipitate the CCG flakes from the aqueous dispersion19. In the
next step, the CCG flakes were filtered, washed and dried to give graphene powder.
The dry graphene powder was then added to DMF followed by addition of
triethylamine (N(CH2H5)3), that helps the homogenous dispersion of CCG, and the
mixture was sonicated with continuous cooling under a dry nitrogen purge for up to 5
hours19. The procedure resulted in a stable homogeneous dispersion of CCG in DMF
with a CCG concentration of 0.5 mg ml-1.

Figure 3.1. Synthesis of DMF-disperse CCG.

3.2.2. Characterization of Graphene Oxide and Chemically Converted
Graphene
Following the successfully synthesis of the GO, aqueous CCG and DMF-dispersed
CCG, characterisation of these materials was undertaken to determine the structure
and properties of the nanocarbons and thus be able to understand how their properties
are affected by composite formation.
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3.2.2.1. Stability and Particle Size of the Dispersions
A Malvern Zetasizer was used to monitor the stability of aqueous and DMFdispersed CCG dispersions and to measure the particle size of GO, aqueous and
DMF-dispersed CCG dispersions. For the experiments, 1 ml of the dispersions were
diluted and transferred into a quartz cuvette for Zeta potential test.
The zeta potential of the aqueous and DMF-dispersed CCG was found to be -39 mV
and -31 mV respectively (Figure 3.2a). The zeta potential for both samples is < -30
mV and they remain stable for up to 100 days indicating good stability of the
dispersions.
The average size of the sheets as estimated by Zetasizer in the GO and CCG
dispersions is similar, varying between 436 to 464 nm with the GO dispersion
containing slightly larger sheets Figure 3.2b. The results indicate that the longer
sonication time used for dispersing graphene nanosheets in DMF has not affected the
average size of graphene sheets in DMF dispersion. Although it is common to use
Zetasizer to measure the size of the graphene sheets in a dispersion18, 25, the results
might not be accurate as the Zetasizer measurement is based on the assumption that
the particles are spherical. The results, therefore, provide a relative comparison of
particle sizes.
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(b)

(a)

Figure 3.2. (a) Dispersion stability of CCG samples and (b) average particle size of
GO and CCG samples.

3.2.2.2. Scanning Electron Microscopy
Scanning electron microscopy (SEM) images of aqueous and DMF-dispersed CCG
are shown in Figure 3.3. To prepare the SEM samples, one drop of each CCG
dispersion was deposited on a silanized silicon wafer and the solvent was evaporated
overnight. SEM images show that both aqueous and DMF-dispersed graphene
samples contain graphene sheets in different sizes. The dispersions contain very
small graphene sheets (<100nm) due to fragmentation occurring during sonication.
The size of the larger sheets varies between 100 to 500 nm.
(a)

(b)

Figure 3.3. Scanning electron microscopy of (a) aqueous CCG, (b) DMF-dispersed
CCG.

98

3.2.2.3. Thermogravimetric Analysis
To study the thermal properties, 10 mg of dried samples were put in a sample pan
and of a thermogravimetric analysis (TGA) apparatus, as described in Chapter 2, and
the temperature was increased with a ramp rate of 5oC min-1 to 900oC under a
nitrogen atmosphere.
Figure 3.4 shows the thermal behaviour of graphite, GO, aqueous CCG and DMFdispersed CCG. Graphite sample showed virtually no loss on heating to 900 °C due
to lack of oxygen groups and other defects in its structure. GO shows around 10%
mass loss below 100 °C and a rapid major weight mass loss from 120 to 250 °C. This
is due to the evaporation of absorbed water and the reduction of and removal of
surface epoxide and hydroxide defects. The gradual mass loss above 250 °C is
attributed to further removal of the functional groups. CCG samples show much
higher thermal stability owing to graphitization, deoxygenation and reduction in
basal defects of GO. An initial weight loss of 18 % can be observed on aqueous CCG
sample at 180oC that can be due to the evaporation of water intercalated within the
graphene. This intercalated solvent does not appear to exist in DMF-dipersed CCG
sample, that can be attributed the reduction in the sheet spacing due to further
chemical reduction during the synthesis process.
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Figure 3.4. Thermogravimetric curves of graphite, GO and CCG samples

3.2.2.4. X-ray Diffraction
X-ray Diffraction (XRD) is a useful technique to obtain information about the
structure, crystallinity, orientation of crystallites and phase composition in crystalline
and semi-crystalline materials. The peaks in a XRD pattern correspond to
diffractions from the crystallographic planes, by which the interplanar distances of
the crystalline material can be calculated26. The XRD technique can be utilised to
measure the interlayer or basal plane d-spacing of carbon materials and to identify
intercalation of atomic or molecular species in their lattice27. Therefore, XRD is a
well-established technique to evaluate the oxidation of graphite to GO and reduction
of GO to CCG.
X-ray diffraction (XRD) spectra of graphite, GO and DMF-dispersed CCG are
illustrated in Figure 3.5. The samples were prepared either using a powder (graphite)
or through depositing 500 µl of the relevant dispersion on a quartz substrate followed
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by evaporating the solvent at room temperature and the spectra collected as described
in Chapter 2.
Graphite shows a strong peak at around 26.7o (002) that is typical of well-ordered
graphene crystal planes in graphitic systems28. This peak corresponds to an interlayer
distance (d-spacing) of 3.34 Å. After oxidation to GO, the peak in graphite is
replaced with a new intense diffraction peak at about 10.6o (d-spacing of about 8.35
Å) in GO. The increase in d-spacing of GO is attributed to the intercalation of water
molecules between two layers as well as hydrophobic nature of GO29. After chemical
reduction, CCG displays a weak and broad x-ray diffraction peak at around 2θ ~ 24o,
corresponding to a d-spacing of about 3.69 Å. The decrease in the average interlayer
spacing in the CCG sample is attributed to deoxygenation and reduction in the basal
defects of GO30. The interlayer spacing of the peak in CCG is close to the d-spacing
peak value of graphite but the CCG peak is broad, representing the formation of
much more disordered graphene sheets compared to graphite31.

Figure 3.5 X-ray diffraction patterns of graphite, GO and DMF-dispersed CCG.

3.2.2.5. Raman Spectra
The Raman spectroscopy was carried out on dried GO and CCG flakes using a 632
nm laser line and a 300-line grating as described in Chapter 2. Figure 3.6 shows the
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Raman spectra of GO and CCG samples from both water and DMF. All three spectra
are dominated by the D (1329-1346 cm-1) and G (1586-1602 cm-1) bands. The G
peak corresponds to the E2g vibrational mode within aromatic carbon rings. D band is
assigned to K-point phonons of A1g symmetry32. This band relatively measures the
amount of sp3 carbons and is related to the amount of disorder in the graphitic
material33. There is an increase in the D to G band intensity ratio (ID/IG) after
reducing GO to CCG. The ID/IG ratio in GO is around 1.2 that increased to 1.52 and
1.66 in aqueous and DMD-dispersed graphene respectively. This increase ID/IG ratio
is attributed to a decrease in the average size of the sp2 domains upon reduction of
the GO followed by formation of new graphitic domains that are smaller in size but
more numerous in number compared to those ones in GO29.

Figure 3.6. Raman spectra of GO and CCG samples.
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3.2.2.6. Fourier Transform Infrared Spectroscopy
FTIR spectra of GO and CCG are presented in Figure 3.7. The dried GO and CCG
flakes were mixed with KBr powder with a 1:10 ratio and the blend was pressed into
the FTIR sample holder before putting into the FTIR test chamber and the spectra
obtained, as detailed in Chapter 2.
The most characteristic peaks of GO are C–O stretching band at 1053 cm-1, C–OH
stretching at 1226 cm-1, O–H deformation vibration at 1412 cm−1 and C=C stretching
at 164134-35. Broad and intense signal at 3440 is attributed O–H stretches34-35. All
oxygen peaks, carboxylic acid, phenyl hydroxyl and epoxide groups are eliminated
or decreased significantly after reduction of GO. The infrared transmission of CCG is
decreased remarkably compared to that of GO, indicating formation of electrically
conducting carbon30, 36.

Figure 3.7. Infra-red spectra of GO and CCG.

3.2.2.7. Conductivity
Conductivity of graphene films, prepared through vacuum filtration of graphene
dispersions, was measured using a four-point probe and the results are presented in
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Figure 3.8. The preparation of graphene films was carried out by Dr. Sanjeev
Gambhir. The average conductivity of the aqueous and DMF-dispersed CCG films
was found to be around 25 and 28 S cm-1 respectively.

Figure 3.8. Conductivity measurements of CCG films.

3.3. Preparation and Characterization of Graphene/PCl Composites through
Mixing and Covalent Attachment Methods
3.3.1. Discussion of Composite Preparation
In this section, we investigated the possibility of developing graphene/PCl
composites using two approaches, the mixing method and the covalent attachment
method. The composites were prepared with different graphene contents that are 0.1,
0.5,1, 5 and 10 wt.%. The composites are labelled according to their preparation
method and the weight percentage of their graphene content. All prepared samples
are listed in Table 3.1. The labels mixPCl-CCG x% and cPCl-CCG x% represent the
composites prepared though the mixing and covalent attachment methods
respectively. The x is the weight percentage of the graphene content in the
composites e.g. cPCl-CCG 5% represents the covalently linked composite with 5
wt.% graphene content.
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Table 3.1. PCl samples with different graphene concentrations prepared via mixing
and covalent attachment methods.
Preparation Method Graphene contents

Sample label

(wt.%)

Mixed

Covalent Attachment

0
0.1
0.5
1
5
10
0
0.1
0.5
1
5
10

PCl
mixCl-CCG 0.1%
mixPCl-CCG 0.5%
mixPCl-CCG 1%
mixPCl-CCG 5%
mixPCl-CCG 10%
PCl
cPCl-CCG 0.1%
cPCl-CCG 0.5%
cPCl-CCG 1%
cPCl-CCG 5%
cPCl-CCG 10%

A schematic diagram of the preparation of composites is shown in Figure 3.9.

Figure 3.9. Preparation of PCl-CCG composites through mixing and covalent
attachment methods.
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Graphene/PCl binary mixtures (mixPCl–CCGs) were prepared by mixing PCl in an
appropriate amount of a 0.5 mg ml−1 DMF-dispersed graphene at 75 °C for 3 h,
whilst in the preparation of covalently linked graphene/PCl composites (cPCl–CCGs)
the mixture of PCl and graphene was followed by addition of N,N′dicyclohexylcarbodiimide (DCC) as coupling agent and 4-dimethylaminopyridine
(DMAP) as catalyst. In the mixing method, no strong link is formed between the
graphene sheets and polymer chains, and the graphene sheets are entangled with the
polymer chains. On the other hand, in the covalent attachment method, the polymer
chains get covalently linked to the peripheral carboxyl groups of the graphene sheets
by esterification in the presence of DCC and DMAP. Covalent linkages between
graphene sheets and polymer chains can make the material stronger and even
tougher. Addition of polymer to graphene dispersions has always been the main
challenge in the process of composite preparation. The polymer should be added to
the graphene dispersion slowly to avoid agglomeration and disturbance of the
graphene dispersion. The other challenge was to find the optimum matrix/filler ratio.
It was immediately apparent that the resulting black graphene/PCl composites
became less flexible with increasing graphene content. The addition of graphene was
found to improve the tensile strength and conductivity of the polymer as found in the
characterisation sections below, however exceeding 5 wt.% graphene content made
composite too brittle to handle for many of the characterisations. Consequently, no
samples were prepared with more than 10% graphene.
3.3.2. Characterization of Graphene/PCl Composites
3.3.2.1. Thermogravimetric Analysis
TGA was used to help understand the composition of the composites through
characterizing the thermal properties of the PCl and PCl-CCG composites. TGA data
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were obtained by heating 10mg of samples to above 900 °C under nitrogen at a rate
of 5 °C min −1.
Figure 3.10 shows the thermal behaviour of pristine PCl as well as cPCl-CCG and
mixPCl-CCG composites with 0.1, 0.5, 1 and 5 wt.% graphene contents. Based on
the results, the addition of graphene, whether in a binary mixture or a covalently
linked composite, has very little effect on the decomposition temperature of
polycaprolactone. All samples show thermal stability up to 380 °C and
thedecomposing rapid decomposition, which is assigned to the degradation of the
polymer chains. The residual weight after full decomposition of the polymer can be
assigned to the graphene content as CCG weight losses are minimal in this
temperature range. The graphene percentage calculated from TGA analysis of the
composites prepared by covalent attachment method (cPCl-CCG) is consistent with
the percentage of graphene added to the reaction initially and indicates good
attachment of the polymer. However, the graphene percentage in the mixtures
(mixPCl-CCG) is very different to that added to the reaction mixture. This is
consistent with the observation of polymer being washed out of the composite during
precipitation.
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(a)

(b)

Figure 3.10. Thermogravimetric curves of (a) cPCl-CCG and (b) mixPCl-CCG
composites with different graphene contents. The residual weight after full
decomposition of the polymer represents the actual amount of graphene in
composites.
3.3.2.2. Differential Scanning Calorimetry
The correlation between the heat flow and the temperatures of the materials can be
studied by using differential scanning calorimetry (DSC). DSC test was done on
pristine PCl, cPCl-CCG and mixPCl-CCG composites with 0.1, 1 and 5 wt.%
graphene contents. The samples (5–8 mg) were first dried in vacuum oven overnight
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to remove the solvents residues, then they were presealed into aluminum pans for the
tests.
The melting point of PCl was found to be around 57 oC. DSC curves showed that the
addition of graphene to polycaprolactone either covalently or as a mixture did not
significantly affect the melting point of the PCl composites, which remains at 55-60
°C (Figure 3.11).
Addition of graphene was found to have increasing effect on the crystallization
temperature for all of the composites. On addition of just 0.1 wt.% graphene the
crystallization point increases massively from 19 ºC in pristine PCl to 33 ºC. This
phenomenon can be attributed to the nucleating effect of graphene on PCl
crystallization. Increasing the addition of graphene further increases the
crystallization temperature and broadens the crystalization peak, indicating confined
mobility of polymer chains and suppression of the crystal structure in the composite.
The crystallization temperature reaches 35 oC in PCl composites with 5 wt.%
graphene content.
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(a)

(b)

Figure 3.11. Differential scanning calorimetry curves of (a) cPCl-CCG and (b)
mixPCl-CCG composites. The addition of graphene generally has little effect on the
melt temperature but increases the crystallization temperature of the composites.
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The nucleating effect of graphene nanosheets on the crystallisation of PCl is also
confirmed by polarised optical microscopy on cooling materials below the
crystallisation temperature (Figure 3.12). It has been shown that nano-fillers in a
polymer matrix, even at low concentrations, can act as nucleating agent and increase
the crystallization temperature and rate of the matrix 37, 38. Figure 3.12 shows that
spherulites of pure PCl are much larger in size and less densely packed than the
graphene doped material. In the PCl-CCG sample, the spherulites form and grow
around the graphene particles that results in formation of much more heterogeneous
nuclei with considerably smaller spherulites, indicating that graphene sheets are able
to act as nucleating agents. The heterogeneous nucleation corresponds to increased
nucleation density followed by addition of graphene37, 38.
The dramatic change in the crystallization of PCl on addition of graphene is in
agreement with what is reported in literature. As an example, based on what is
reported by Kalaitzidou et al.39 even a very low loading of exfoliated graphite (0.01
vol%) acts as a nucleating agent for polypropylene and changes the crystallization
behaviour of the polymer.
(b)

(a)

Figure 3.12.Polarised optical microscopy images taken below the crystallisation
temperature of pure (a) PCl and (b) cPCl-CCG showing the difference in spherulite size
and density.
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3.3.2.3. Scanning Electron Microscopy
Scanning electron microscopy (SEM) was employed to study the dispersion of the
nanofillers in the polymer matrix and to investigate the morphology of the
composites. Films of each sample with around 1 mm thickness were prepared and
were frozen in liquid nitrogen, fractured and sputter-coated (EDWARDS Auto 306)
with a thin layer of platinum (~ 10 nm thickness).
Figure 3.13 represents the cross-sectional images of PCl and PCl-CCG composites
with 0.5 and 5 wt.% graphene content. It is obvious that the two samples have
different fracture surfaces that correspond to the alignment and bonding of the
graphene nanosheets into the polymer matrix40-41. The graphene filler appears
dispersed more homogenously inside the polymer matrix in the cPCl-CCG
composites, that is due to the covalently linked polymer on the graphene sheet
forcing the retention of sheet separation even on precipitation. In the mixed
composite (mixPCl-CCG), the polymer can be washed out from between sheets
resulting in the observed agglomeration and poor alignment of graphene sheets inside
the polymer matrix.
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(a)

(b)

(c)

(d)

(e)

Figure 3.13. Scanning electron microscopy cross-sectional images of (a) PCl, (b)
mixPCl-CCG 0.5%, (d) mixPCl-CCG 5%, (c) cPCl-CCG 0.5% and (e) cPCl-CCG
5% composites. The bright regions can be attributed to graphene sheets because of
their greater conductivity.

3.3.2.4. X-ray Diffraction
X-ray diffraction patterns (XRD) is a useful technique to characterize the
crystallinity and structural properties of the samples. This technique can be used to
study possible changes in the crystalline phases of the polymer due to addition of
graphene or preparation method. Films of each sample with around 1 mm thickness
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were prepared and were frozen in liquid nitrogen, fractured and mounted on a XRD
sample holder for the test.
Figure 3.14 shows the XRD of polycaprolactone and PCl-CCG composites with 1
wt.% and 5 wt.% graphene contents. The polymer diffraction pattern is typical of PCl
with two major peaks at 21.3 and at 23.78 2θ42, 43 that are attributed to be (110) and
(200) planes respectively, of an orthorhombic crystalline structures of PCl44. The
shorter shoulder like peak at around 22.1 is assigned to (111) plane. CCG displays a
weak and broad x-ray diffraction peak at around 2θ ~ 24o (Figure 3.5) than is not
visible after addition of polymer.
Addition of graphene did not significantly affect the XRD patterns, except for a
slight decrease in the peak at 2θ = 21.3° indicating a slight decrease in the
crystallinity of the PCl/graphene composites similar to the effect observed by DSC.
Therefore, it can be assumed that the chemical structure of the polymer is not
significantly altered with increasing graphene content. Furthermore, both covalently
linked and mixed composites show the same crystalline structure, suggesting that
composite preparation method has no effect on the crystalline conformation of PCl.
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Figure 3.14. X-ray diffraction patterns of PCl-CCG composites. The peaks can be
attributed to the polymer.

3.3.2.5. Raman Spectra
Raman spectroscopy is a fast and non-destructive method for structural
characterization of carbonaceous materials.
Figure 3.15 shows the effect of increasing graphene content on the Raman spectra of
PCl/graphene composites synthesized by covalent attachment and mixing methods.
Pristine PCl and composites with 0.5 and 5 wt.% graphene content were studied. The
samples were hotpressed into films with around 1 mm thicknesses and were fractured
after freezing on liquid nitrogen. The Raman test was run on surface and cross
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section of the samples using a 632 nm laser line and a 300-line grating and no
difference was found between the surface and cross-section spectra.
The Raman spectrum of PCl shows the characteristic peaks at 1726 cm-1 (ν C=O
stretching mode), 1060 cm-1 and 1106 cm-1 (skeletal vibration) and 1281–1305 cm−1
attributable to CH2 groups. The other peaks at 1470–1418 cm-1 (δCH2) , and 912 cm-1
(νC–COO) also represent the crystalline domains45,

46

. On increasing addition of

graphene, two significant peaks at 1328 and 1598 cm-1 corresponding to D and G
band of graphene sheets become more dominant and the peaks due to PCl are less
visible as the intensity of the characteristic D and G bands of graphene are greater
than that of PCl. In samples with highest graphene contents, only the D and G band
graphene peaks are visible.
The ratio of the intensities of the graphene D and G bands (ID/IG) decreases slightly
with increasing graphene content. This can be attributed to a decrease in the
crystalline size of the composite on increasing the graphene content47, 48

Figure 3.15. Raman spectra of PCl-CCG composites. The two significant peaks at
1328 and 1598 cm−1 correspond to D and G band of graphene sheets.
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3.3.2.6. Fourier Transform Infrared Spectroscopy
Fourier transform infrared (FTIR) is a useful analytical technique to study the
material composition. This technique was employed to analyse the possible changes
in the polymer structure and specifically try and identify the new ester bonds formed
during covalent attachment.
Figure 3.16 shows the FTIR spectra for PCl, graphene oxide, graphene and PCl
composites with 5 wt.% graphene content. The FTIR spectra were obtained on 1 × 1
cm hotpressed films using ATR attachment.
In the FTIR of pristine PCl49, the strong band around 1724 cm−1 is due to the
carbonyl stretching mode, the band at 1292 cm−1 has been assigned to the backbone
C˗˗C and C˗˗O stretching modes, and the peaks between 1100-1300 cm-1 are coupled
modes attributed to C˗˗C˗˗H and O˗˗C˗˗H bending in the crystalline PCl. Peaks at
2943 and 2866 cm-1 are attributed to asymmetric CH2 stretching and symmetric CH2
stretching respectively and the band at 1188 cm−1 attributed to OC˗˗O stretching.
In the composites, the graphene appears to have little effect on the PCl spectra and
therefore, has not altered the major structure of the matrix even with graphene
content as high as 5 wt.%. It is hard to confirm the covalent attachment between the
polymer chains and graphene sheets from these spectra. The covalent attachment
takes place through formation of ester bonds and there are no new the FTIR peaks for
ester bonds above 1700 cm-1 which is not unexpected since aromatic esters are
typically around 1727 cm-1, similar to that observed for PCl.
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Figure 3.16. Infra-red spectra of GO, CCG, pristine PCl, and both mixPCl-CCG and
cPCl-CCG composites.

3.3.2.7. Conductivity
The bulk conductivity of the composites was measured using a two point probe
method. The samples were cut into 5 × 5mm cylindrical pieces and the opposing
sides of the samples were silver painted to provide better contact with the probes. As
evident from Figure 3.17, addition of graphene has significantly improved the
conductivity of the polycaprolactone. The conductivity of the neat PCl is less than
10E-13 S.m-1 that could be increased to 10E-1 S m-1 on addition of around 5 wt.%
graphene in mixPCl-CCG composite. It is possible to further increase the
conductivity of the polymer by addition of more graphene content; however, it will
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result in considerable sacrifice of mechanical properties. The elongation at break of
the composites decrease to less than 50% and the samples gradually become brittle
by increasing the graphene content to more 10 wt.%. mixPCl-CCG samples show
better conductivity than covalently linked cPCl-CCG; however, as it was mentioned
in Section 3.3.2.1, a fraction of the composite was washed out of the mixPCl-CCG
samples during the precipitation due to poor attachments among polymer chains and
graphene sheets. As a result, the graphene content in mixPCl-CCG composites is
higher to that of added to the reaction mixture. As an example, based on the TGA
findings, the graphene content of mixPCl-CCG 1% is around 5 wt.%, and this value
is around 17 wt.% in mixPCl-CCG 5%. Therefore, the higher conductivity in mixed
samples can be due to presence of higher graphene contents in their matrices.
The higher conductivity in mixed samples can also be attributed to agglomeration of
the graphene nanosheets inside the polymer matrix resulting in a shorter conducting
path length and formation of conducting domains surrounded by non-conducting
regions50.

Figure 3.17. Conductivity measurements of PCl-CCG composites at different
graphene contents
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3.3.2.8. Mechanical Properties
Tensile testing was performed to investigate the effect of CCG on the mechanical
properties of PCl. Typical stress–strain curves of PCl and PCl composites are shown
in Figure 3.18, and the detailed data of the mechanical properties are listed in Table
3.2. To prepare samples for mechanical properties tests, the samples were hot pressed
at 100 °C to obtain a 0.1 mm thick film. The film then was cut to strips with a width
of 3 mm and a length of 20 mm. Pure PCl shows the typical stress-strain curves of
ductile materials started with linear deformation behaviour up to the yield point,
which is considered the upper limit of elasticity, followed by a plastic response that
is irreversible. The addition of graphene has not changed the ductility of the
composites even at higher graphene contents, indicating good level of graphene
dispersion in the polymer matrix even in the composites prepared by mixing method.
The pure PCl showed a high strain at break up to 1200%, but had low tensile yield
strength and Young’s modulus of around 10 MPa and 94 MPa respectively. In
general, the addition of graphene improves the strength of the composites but
decreases the elongation at break as the interaction between graphene and the matrix
restricts the movement of the polymer chains. Figure 3.18 shows the increase in
tensile yield strength in both covalently linked and mixed method materials. In
covalently attached composites, the addition of just 0.5 wt.% graphene increased
tensile yield stress by almost 30% and doubled it on addition of 5%. Similarly the
Young’s modulus increases from 94 MPa in pristine PCl to 199 MPa to 259 MPa
across the same range.
In the composites prepared by the mixing method, the improvement in the tensile
strength on the addition of graphene is less than that shown by the covalently linked
composites, while the elongation at break decreased far more significantly. As
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mentioned before, based on the TGA findings, the graphene content in mixPCl-CCG
composites is higher to that of added to the reaction mixture. Therefore, for a mixture
containing 5 wt.% graphene, the elongation at break is decreased to around 70%
while the tensile strength is increased to 15 MPa, as compared to 166% and 17 MPa
for a similar covalently linked material. The increased strength and plasticity of the
covalently-linked material is due to the far better dispersion of graphene nanosheets
throughout the sample, along with strong covalent attachments between the graphene
sheets and polymer chains and better alignment of graphene sheets in the polymer
matrix compared to mixed composites.

(a)
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(b)

Figure 3.18.Stress-Strain curves of (a) cPCl-CCG and (b) mixPCl-CCG composites
showing the large increase in tensile strengths and reductions in elongation at break.
Table 3.2. Mechanical properties of PCl, covalently-linked cPCl-CCG and mixPClCCG.

Polycaprolactone

Covalent

Mixture

Graphene
Content
(wt.%)
0

Tensile
Yield
(MPa)
10 ± 0.2

Young’s
Modulus
(MPa)
94 ± 12

Elongation at
Break (%)

0.1

10 ± 0.4

90 ± 4

842 ± 57

0.5

13 ± 0.2

199 ± 14

788 ± 38

1

16 ± 0.2

236 ± 6

286 ± 18

5

17 ± 0.8

259 ± 22

166 ± 12

0.1

13.4 ± 0.3

260 ± 26

321 ± 53

0.5

14.5 ± 0.6

219 ± 12

282 ± 28

1

15 ± 0.9

277 ± 23

69.5 ± 11

5

20 ± 0.3

359 ± 7

48.4 ± 12
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1212 ±86

3.3.2.9. Biocompatibility
The biocompatibility experiments were carried out by Dr. Brianna Thompson and
Dr. Eoin Murray (in the IPRI, UOW laboratories).
Figure 3.19 shows the cell culture results achieved from seeding fibroblast (L-929)
cells on PCl samples. No differences were observed in the growth of L-929 cells on
mixPCl-CCG

compared

to

cPCl-CCG

materials.

Cell

density

increased

approximately 8 times from the seeding density on all materials (including tissue
culture plastic – data not shown), indicating that addition of graphene or the method
of composite preparation has no significant effect on the proliferation of cells.
Generally speaking, good adherence and proliferation of fibroblast cells was
observed on films cast from PCl, cPCl-CCG 0.5% and cPCl-CCG 5%. Furthermore,
not any toxic compounds were leached through the culture period, implying that the
material surfaces are suitable for attachment of cells.

Figure 3.19. Live L-929 cells stained with calcein (green) and prodidium iodide (red)
on sheets of (a) PCl, (b) cPCl-CCG 0.5% and (c) cPCl-CCG 5%. The scale bars
indicate 100 µm.
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To further evaluate the biocompatibility of PCl samples, three different cell types,
namely fibroblast (L-929), neural (PC-12) and muscle (C2C12) cell lines were
seeded onto the PCl samples. Pristine PCl and tissue culture plastic were also used as
control. As it can be seen in Figure 3.20, all cells follow the same proliferation
pattern as in tissue culture plastic. However, for all cell lines, the cell number was
slightly higher on tissue culture plastic for the first 48 hours.
To adhere PC-12 cells on a surface, the surface usually should be coated with
collagen; otherwise the adhesion would be poor on the surface51. Here it was showed
that cells can adhere to our materials without any surface coating, indicating that the
materials are suitable to support the adhesion and proliferation of even cells lines that
typically exhibit poor materials compatibility.
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(a)

(b)

(c)

Figure 3.20.Growth curves of three cell lines on PCl, tissue culture plastic and cPCl–
CCG materials.(a) Neural cells (PC12 cell line),(b) fibroblasts (L-929 cell line) and
(c) muscle cells (C2C12 cell line) all adhered to and proliferated on the materials for
72–96 hours. Each point represents the average of three measurements, and the error
bars indicate one standard deviation.
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3.3.2.10. Rheological Behaviour
Rheological behaviour of mixPCl-CCG and cPCl-CCG composites with 0.5, 1 and 5
wt.% graphene content was investigated. Dynamic frequency sweep tests were
performed on the composites at 70oC with frequency ranging from 0.1 to1000 (rad.s1

). To prepare the samples, the hotpressed films were cut into circular shapes with

1cm diameter.
Figure 3.21 show the curves of complex viscosity (η*) vs frequency (ω) for the pure
PCl and PCl-CCG composites. Pure PCl shows typical Newtonian behaviour up to
frequency of 10 rad.s-1 and levels off slightly after that due to reduction of polymer
chains entanglements and decrease in viscosity caused by the increasing shear rate52 .
In both mixed and covalently linked PCl composites, the samples show shearthinning behaviour by increasing the graphene contents that becomes very significant
in composites with 5 wt.% graphene. However, cPCl –CCG 0.5% shows a pattern
that is similar with that of pure PCl, indicating that there is a percolation threshold
for formation of three-dimensional graphene networks in the polymer matrix as well
as the transition from liquid-like to solid-like viscoelastic response that lies between
0.5 to 1%.
Non-Newtonian behaviour of the composites that starts from low shear rates is
attributed to orientation of graphene sheets in the polymer matrix under the shear
force that can disturb the chain entanglements of the matrix, resulting in profound
shear thinning behaviour of the composites at higher graphene contents53,

54

.

Furthermore, complex viscosity increases with increasing graphene content that is
due to the physical interactions between the graphene sheets and the polymer
chains55.
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As in the case of the complex viscosities, the values of G′ and G′′ of all samples
increased with increasing graphene content (Figure 3.22 and Figure 3.23). A
remarkable increase in the storage and loss moduli was observed when the graphene
content is increased to 5%, indicating a stiffer composite. PCl chains are relaxed at
low frequencies and follow a typical terminal behaviour, however by increasing the
filler contents the terminal behaviour gradually weakens and tends to a pseudoplateau56, 57.
In all composites, by increasing the reinforcement content the storage and loss
modulus becomes less dependent of frequency, that indicates a transition from a
Newtonian liquid to an ideal Hookean solid, along with formation of a network
structure that is mechanically stable53,55.
Frequency is also effective on the complex viscosity as the viscosity decreases by
increasing the frequency, indicating non-newtonian behaviour and pseudo-plastic
characteristics of PCl-CCG composites52, 56.
Compared to mixPCl-CCG samples, the shear thinning behaviour in covalently
linked composites takes place at a slower rate with less frequency dependence and
exhibits pseudo-plateau behaviour at higher frequencies. This behaviour can be due
to existence of covalent attachments between graphene and polymer chains and good
alignment of the graphene sheets in the matrix, that makes the composites more
resistant to the breakage of the links under the shear force52. Furthermore, mixPClCCG composites show higher viscosities at the same apparent graphene content that
can make the processing more difficult. The higher viscosities of the mix samples
can be attributed to the higher actual graphene contents in the composites after
processing, that is in agreement with TGA results, attributed to poor attachments
between graphene of the polymer.
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(a)

(b)

Figure 3.21. The frequency dependence of the complex viscosity for (a) cPCl-CCG
and (b) mixPCl-CCG composites.
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(a)

(b)

Figure 3.22. The frequency dependence of storage modulus for (a) cPCl-CCG and
(b) mixPCl-CCG composites.
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(a)

(b)

Figure 3.23. The frequency dependence of loss modulus for (a) PCl-CCG and (b)
mixPCl-CCG composites
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3.4. Microwave-assisted Preparation and Characterization of Graphene/PCl
Composites
3.4.1. Discussion of Composite Preparation
In the previous section, graphene/PCl composites were developed through simple
mixing or covalent attachment methods. A stable DMF dispersed graphene
dispersion was used as filler. Traditionally, graphene oxide (GO) solutions are the
most commonly used fillers for preparation of graphene/polymer composites.
However, due to different oxygen containing functional groups attached in the basal
plane, GO is electrically insulating or, at best, a semi-conductor. Chemical and
thermal reductions are the most routine methods used to reduce the graphene oxide
sheets into conducting graphene nanosheets before incorporating them into polymers.
However, those methods have always been criticised as hazardous in terms of
toxicity, low-yield and energy-intensive procedures. Recently, it has been shown that
microwave irradiation is a quick and convenient alternative to flash heating
methods58-59 and can be adopted to reduce graphene oxide to graphene. In this
section, the feasibility of developing microwave-assisted graphene/PCl (mPCl-rGO)
composites through in situ polymerization with simultaneously thermal reduction of
graphene oxide was investigated. Microwave-assisted synthesis of the samples
carried out in a CEM Discover 2.45-GHz microwave oven. To prepare PCl,
appropriate amount of ε-caprolactone and tin 2-ethylhexanoate were reacted using
microwave irradiation (100 W max) at a constant temperature of 140 °C.This
microwave synthesised PCl is labelled as mPCl. Microwave-assisted graphene/PCl
composites (mPCl-rGO) with 0.1 and 1 wt. % graphene contents were developed
through sonication an appropriate volume of aqueous graphene oxide in εcaprolactone until well dispersed. Following the addition of tin 2-ethylhexanoate, the
mixture was heated slowly using microwave irradiation (100 W max) and then kept
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at a constant temperature of 140 °C for 1 hour. The schematic diagram of the
microwave-assisted preparation of mPCl-rGO composites is shown in Figure 3.24.
The mPCl-rGO composites with more than 1 wt.% graphene concentrations were so
brittle to handle. A graphene/PCl composite with 1 wt.% graphene content (mPClCCG) was also developed as control. The mPCl-CCG composite was prepared by
mixing the mPCl in an appropriate amount of a 0.5 mg ml-1 stable solution of DMFdispersed graphene.

Figure 3.24. Microwave-assisted preparation of graphene/PCl composites.

3.4.2. Characterization

of

Microwave-assisted

Prepared

Graphene/PCl

Composites
3.4.2.1. Raman Spectra
Raman spectra of graphene oxide (GO), chemically converted reduced graphene
(CCG) and the microwave reduced graphene polycaprolactone composite (mPClrGO) in this case with 1 wt.% graphene were obtained (Figure 3.25). The test was
carried out on dried GO and CCG flakes and fractured composite film with 1 mm
thickness using a 632 nm laser line and a 300-line grating. The Raman spectrum of
CCG is presented for comparison purposes.
As expected all three spectra are dominated by the D (1250-1450 cm-1) and G (15301670 cm-1) bands60-62. In the Raman spectrum of GO, the D and G bands are located
at 1343 and 1606 cm-1 respectively while in the microwave synthesised mPCl-rGO
composite, the D and G bands shift to1327 and 1599 cm-1, indicating restoration of
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the pi-electron structure and is very similar to that observed for chemically converted
graphene (CCG). This result demonstrated that GO is successfuly reduced during the
microwave-assisted polymerisation of caprolactone.
The intensity ratio of the D and G bands changes from 1.13 for GO to 1.47 for mPClrGO close to the 1.61 observed for CCG. This increase in ID/IG ratio can be because
of a decrease in the average size of the sp2 domains during the reduction of GO,
along with the formation of new graphitic domains that are smaller in size but greater
in number compared to those in GO29, 63. Minor peaks due to the polymer are also
observable in the mPCl-rGO spectrum.

Figure 3.25. Raman spectra of powder samples of graphene oxide (GO), chemically
reduced graphene (CCG) and a graphene-polycaprolactone composite with 1 wt.%
graphene oxide (mPCl-rGO), showing the shift in positions and relative intensities of
the D and G bands.

3.4.2.2. X-ray Diffraction
X-ray diffraction (XRD) is an important technique for determining whether graphene
oxide sheets are reduced and to see if they present as individual exfoliated sheets in
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the nanocomposites. Figure 3.26 is a comparison between XRD patterns of GO, PClCCG 1% and mPCl-rGO 1%. GO sample was prepared through depositing 500µl of
GO dispersion on a quartz substrate followed by evaporating the solvent at room
temperature. Composites films with around 1 mm thicknesses were frozen in liquid
nitrogen, fractured and mounted on a XRD sample holder for the test.
The XRD spectrum of graphene oxide is dominated by an intense, sharp peak at 2θ =
10.5° (d-spacing ~ 8.37 Å) indicating a large interlayer distance due to surface
impurities such as hydroxides and epoxides. In the spectrum of the polymer
composite mPCl-rGO, the peaks at 2θ = 21 and 24° can be assigned to
polycaprolactone which mask the broad weak band due to pristine reduced exfoliated
graphene sheets. The removal of the peak at 10.5° indicates exfoliation and reduction
of GO to single or few-sheet graphene with a much reduced inter-sheet spacing59, 64.
This result also indicates that the graphene sheets are uniformly dispersed inside the
polymer matrix. This is also observed in the spectra of the polymer composite
produced using chemically converted and exfoliated graphene, PCl-CCG.

Figure 3.26. X-ray diffraction patterns of GO and graphene/PCl composites
synthesised using graphene oxide (mPCl-rGO) and chemically converted graphene
(mPCl-CCG).
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3.4.2.3. Fourier Transform Infrared Spectroscopy
FTIR spectrum of GO, mPCl, mPCl-CCG 1% and mPCl-rGO 1% are shown in
Figure 3.27. To prepare the FTIR samples, dried GO flakes were mixed with KBr
powder with 1:10 ratio and the blend was pressed into the FTIR sample holder. The
FTIR test on the composites was run on 1 × 1 cm hotpressed films using ATR
attachment.
The FTIR pattern of mPCl is typical of PCl and is similar to the commercial PCl
used in Section 3.3, indicating successful synthesis of PCl through microwaveassisted polymerization. In the infrared spectrum of GO, the C=O stretching and
deformation peaks appear at 1730 cm−1 and 1400 cm−1 respectively. The strong peak
at 3410 cm−1 is attributed to O–H stretching. In mPCl and mPCl composites, similar
to what was observed in Figure 3.16, a carbonyl stretching mode can be identified at
1724 cm−1, the band at 1292 cm−1 is assigned to the backbone C-C and C-O
stretching modes in crystalline PCl and peaks at 2943 and 2866 cm-1 are attributed to
asymmetric CH2 stretching and symmetric CH2 stretching respectively. After
reduction by both microwave and chemical methods, the intensity of the graphenebased oxygen peaks are decreased significantly confirming the reduction of graphene
oxide. The OH stretch peak is also not present showing good exfoliation of the
graphene sheets.
Comparing the FTIR spectra of mPCl and the mPCl 1% composite, all the bands
relative to the carbonyl stretch at 1724 cm−1 have increased in intensity, with the
band at ~2900 cm-1, attributed to CH2 stretching, being the most significant. It could
be argued that the presence of the Sn catalyst (see Figure 3.24) containing a number
of CH3/CH2 groups could contribute to this intensity increase at higher wavenumber.
However, the appearance of a new carboxylate band around 1710 cm-1 should also be
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evident. While there is no distinct second band at 1710 cm-1, the broadening of the
1724 cm−1 polymer carbonyl band may result from the presence of catalyst. Given
that the structure of the catalyst anion is similar to the PCl unit structure, the intensity
increase in the rest of the spectra might also be expected.

Figure 3.27.Infrared spectra of GO, mPCl and two composites made with GO (mPClrGO) and CCG (mPCl-CCG).
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3.4.2.4. Thermogravimetric Analysis
The thermal degradation of the polymer composites was measured using thermal
gravimetery. 10mg of each sample was heated to above 900 °C under nitrogen at a
rate of 5 °C min−1.
Figure 3.28 represents the thermal behaviour of GO, mPCl, mPCl-rGO with 0.1 and
1 wt.% graphene content and mPCl-CCG with 1wt.% graphene content. As GO is
thermally unstable, it starts losing mass upon heating29. GO loses around 10% of its
weight below 100 oC and continues losing mass due to evaporation of trapped
moisture. The major weight loss of GO takes place between 120 to 250 oC that is
assigned to the reduction of and removal of surface epoxide and hydroxide defects.
The thermal degradation of polycaprolactone is very dependent on chain length
(from 300 to 500 °C for average chain lengths of 10000 to 80000) so direct
comparison of the composites behaviour with a pristine polymer is difficult as the
length of the graphene-anchored PCl chain is unknown. However, increasing levels
of graphene (either graphene oxide or reduced graphene) in the composites result in
an increase in the thermal stability of the composite.
The degradation of the composite also appears to be two-staged; an initial minor loss
from 200-250 °C and the full degradation of the polymer. This initial loss was
originally interpreted to either loss of basal defects as in GO or of short PCl chains
attached to basal defects. However, a similar two-staged degradation profile was
obtained for PCl-CCG which is produced with graphene that does not have these
basal defects so the initial weight loss can be assigned to shorter polymer chain
lengths or very short polymer chains joining two graphene molecules as a
crosslinker.
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The decomposition temperature of the microwave synthesised PCl was found to be
around 150oC lower than the commercially obtained polymer as used in section 3.3,
which is ascribed to the difference between the average chain length and molecular
weight of the polymers. The microwave synthesised composites exhibited around
100 °C increase in thermal stability while no significant change was observed in
decomposition temperatures of cPCl-CCG and mixPCl-CCG composites, indicating
that addition of graphene does not have a profound effect on improving the thermal
stability of a PCl with high molecular weight.

Figure 3.28.Thermogravimetric analysis of GO, mPCl, mPCl-CCG 1% and mPClrGO composites with 0.1 wt.% and 1 wt.% graphene content.

3.4.2.5. Differential Scanning Calorimetry
DSC curves of mPCl and mPCl-rGO 1% composite are shown in Figure 3.29. 5–8
mg of dried samples were presealed into aluminum pans for the tests.
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Microwave synthesised samples show a melting point that is very similar to what
was observed on PCl samples in our previous experiments in Section 3.3. DSC
shows that the melt point of the composite remains constant at around 58 °C. This
allows easy melt processing of the composite. However, the crystallisation
temperature changes dramatically from 26 °C for polycaprolactone to 39 °C for a
composite with 1 wt.% of graphene. This indicates that the incorporation of graphene
nanosheets affect the polymer microstructure by acting as multiple nucleation centres
for crystallisation.
Microwave synthesised PCl shows similar melting point but higher crystallization
temperature compared to the commercial PCl used in Section 3.3, that can be due to
its lower molecular weight and consequently lower viscosity that induces
crystallization at higher temperatures.

Figure 3.29.Differential scanning calorimetry results for mPCl and mPCl-rGO 1%
(dashed).
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The nucleating effect of the exfoliated GO nanosheets on the crystallization of PCl is
also confirmed by polarised optical microscopy. This test was carried out by Dr. Eoin
Murray (IPRI). Figure 3.30 shows polarised optical microscopy images of mPCl and
mPCl-rGO 1% after the samples were heated to 100 °C for 30 seconds and allowed
to cool below the respective crystallisation temperature. The effect of rGO on the
crystallization of PCl is similar to what is discussed in detail in section 3.3.2.2 .
As discussed with Dr. Murray, the spherulites of pure mPCl are much larger in size
and less densely packed than the graphene doped material showing the large increase
in nucleation density in the composite material. The result is in agreement with
similar studies on GO/PCl composites in the literature65.
(a)

(b)

Figure 3.30. Polarised optical microscopy images taken below the crystallisation
temperature showing the initial nucleation and differences in spherulite size and
density of (a) mPCl and (b) mPCl-rGO 1%.

3.5. Enzymatic Degradation of Graphene/PCl Composites
3.5.1. Discussion
Hydrolytic degradation of PCl in aqueous medium takes place through hydrolysis of
ester bonds and subsequent scission of the polymer chains into shorter chains,
oligomers and caproic acid. Due to its semi crystalline and hydrophobic structure,
PCl has a low rate of hydration and hydrolytic cleavage; therefore its full degradation
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can take several years66. On the other hand, enzymatic degradation of PCl occurs at
faster rate as the enzymes (e.g. lipases and esterases) attach to the polymer surface
and hydrolyse the surface ester bonds in a much shorter time frame forming shorter
chain polymers and oligomers. In this section the enzymatic degradation of pristine
polycaprolactone and PCl-CCG composites were compared and the physical results
of this degradation were examined. The Enzymatic degradation tests were carried out
by Dr. Brianna Thompson and Dr. Eoin Murray (in the IPRI, UOW laboratories). Dr.
Murray also ran the TGA experiment. Pristine PCl and PCl-CCG composites with
0.1,1 and 5 wt.% graphene content were cut into 5mm discs and were enzymatically
degraded through incubating them in a pseudomonas lipase solution. The samples
were withdrawn and rinsed with DI water at regular time points over 72 hours.
3.5.2. Enzymatic Degradation
Figure 3.31a, prepared by Dr. Brianna Thompson, shows the absolute mass loss of
PCl and PCl-CCG composite discs over 96 hours in the presence of pseudomonas
lipase.
Pristine PCl, cPCl-CCG0.1%, cPCl-CCG1% and mixPCl-CCG5% composites lost
most of their mass in the first 24 hours with absolute losses of 1.2-1.5 g per disc,
corresponding to 50-60% of the starting weights of the samples. The degradation rate
was found to be much slower in cPCl-CCG 5% compared to the other samples. On
the other hand, the mass loss of the mixed blended sample (mixPCl-CCG 5%) is
close to the pure PCl after 4 days.
As discussed with Dr. Eoin Murray, this result can indicate the presence of strong
covalent links in the covalently linked graphene/PCl composites, resulting in a
decrease in the mass loss at higher graphene content. The higher mass loss in the
mixed sample compared to covalently linked sample with the same graphene content
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can also be due to non-homogeneous dispersion of the graphene sheets throughout
the polymer matrix in the mixed samples along with poor attachments between the
polymer chains and graphene sheets inside the polymer matrix.
Figure 3.31 b shows the effect of the enzyme concentration on the degradation of the
samples. By increasing the enzyme concentration from 8 U m-1 to 16 U ml-1, the PCl
weight loss has been doubled; however, increasing the enzyme concentration to 16 U
ml-1 has not caused any significant effect on the degradation of the composites.

(a)

(b)

Figure 3.31. (a) Degradation patterns and (b) the effect of enzyme concentration on
the degradation rate of PCl and PCl-CCG composites.
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3.5.3. Characterization of Enzymatically Degraded PCl Samples
3.5.3.1. Differential Scanning Calorimetry
Enzymatic degraded PCl, cPCl-CCG composites with 0.1 and 5 wt.% graphene and
mixPCl-CCG cimposite with 1 wt.% graphene were characterized using DSC. Figure
3.32 shows the DSC curves of the samples after 16 hours of degradation. The DSC
test was also done on samples degraded for 72 hours but the results were similar to
the 16 hours degraded samples.
There is not any significant difference in melting points of the samples before and
after degradation, which remains at 55-60 °C, suggesting a surface erosion
mechanism. However, there are some variations in the crystallization temperatures of
the samples .The crystallization temperature of the pure PCl is 19 oC before the
degradation while it’s been increased to 30 oC in the degraded sample. For the
graphene/PCl composites, the crystallization temperature increased slightly (between
2 to 5 oC) after degradation. Higher crystallization temperature in the degraded
samples can be attributed to the overall reduction in the molecular weight of the
samples after degradation.
A comparison between the integrated peak areas of PCl samples before and after
degradation shows that the crystallinity of the samples is decreased after degradation.
Although the crystalline part is more resistant to enzymes attacks compared to the
amorphous region67, the previous studies68,

69

have shown that the enzymatic

degradation of PCl took place not only in the amorphous phase, but also in the
crystalline phase that justifies the decrease in the crystallinity of the degraded
samples.
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Due to higher degradation rate in the mixPCl-CCG composite, the remaining amount
of the degraded samples were quite low, therefore lower mixPCl-CCG samples (
0.5 mg) for were used for DSC compared to the other samples, which might be
reason of much shorter DSC peaks in the mixPCl-CCG samples.

Figure 3.32. Differential scanning calorimetry curves of the degraded PCl samples.

3.5.3.2. Scanning Electron Microscopy
The surface morphology of the PCl samples was studied after 24 hours of
degradation. The 5mm discs of the samples were coated with a thin layer of platinum
(~ 3 nm thickness) and were mounted on a SEM sample holder for the microscopy.
Figure 3.33 shows the SEM surface images of undegraded and degraded PCl as well
as cPCl-CCG 1%, cPCl-CCG 5% and mixPCl-CCG 1% composites.
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As it can be seen, the surface morphology is similar in all samples before
degradation. On degradation, the amorphous regions of the polymer are degraded
first as they offer easier access for hydrolysis and the surfaces of all materials show
deep pitting and porosity after 24 hours of degradation. However, PCl composites
exhibit a more fibrillated morphology specially at higher graphene contents, that can
be due to their morphological differences caused by addition of graphene. In the PClCCG composites, graphene nanosheets appear to be exposed following the removal
of the covering amorphous polymer. The exposure of graphene sheets is more visible
in composite with higher graphene content (Figure 3.33h).
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(a)

(e)

(b)

(f)

(d)

(d)

(c)

(g)

(d)

(d)

(d)

(h)

(d)

(d)

Figure 3.33. SEM surface images of (a-d) undegraded and (e-h) degraded (a,e) PCl,
(b,f) mixPCl-CCG 1%, (c,g) cPCl-CCG 1% and (d,h) and cPCl-CCG 5%
samples.The scale bar represents 1 µm.

(d)

(d)
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3.5.3.3. Raman Spectra
Raman spectra of PCl and PCl-CCG composites with 0.1, 1 and 5 wt.% graphene
content are shown in Figure 3.34 before degradation and after enzymatic degradation
for 16 hours. The test was run on 5mm discs used for degradation tests using a 632
nm laser line and a 300-line grating.
The Raman spectrum of PCl shows the characteristic peaks of the polymer as
discussed in Section 3.3.2.5. Two distinguished peaks at 1328 and 1598 cm−1 in PClCCG composites correspond to D and G band of graphene sheets that get more
dominant on increasing the graphene content. As it can be seen there is not any
significant difference in Raman spectra of PCl samples before and after degradation,
indicating that degradation has no detectable effect on the chemical composition of
the material and on the reduction state of the graphene.

(a)

(b)
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(c)

(d)

(e)

Figure 3.34. Raman spectra of (a)PCl and (b-e) PCl-CCG composites before and
after 16 hours enzymatic degradation.

3.5.3.4. Thermogravimetric Analysis
TGA was performed on the remaining discs of PCl, cPCl-CCG and mPCl-CCG
composites with 5 wt.% graphene content at different time points along the
degradation process. As it can be seen in Figure 3.35 all samples show a sharp

148

monotonic weight loss between 340 and 420 °C, which can be assigned to the
decomposition of the original polymer chain length, indicating that any shorter
chains are removed from the degraded material. In addition, as CCG weight losses
are minimal in this temperature range, the residual weight after full decomposition of
the polymer can be assigned to the graphene content. The graphene percentages
calculated from TGA analysis of the cPCl-CCG composite are very consistent across
the degradation time indicating a consistent rate of graphene removal. The
percentage of residues was found to be 7.7, 8.2, 8.8 and 9.8% after 0, 6, 24 and 72
hrs degradation respectively. However, the graphene percentage in the blended
mixtures (mixPCl-CCG) increases substantially from 5.4% to almost 12.9, 18.3 and
19.7% after 6, 24 and 72 hrs respectively, indicative of a non-consistent rate of
graphene/polymer removal and hence a poorly dispersed material.

(a)
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(b)

Figure 3.35. Thermogravimetric analysis of (a) cPCl-CCG and (b) mixPCl-CCG at
different degradation times. The residual weight after full decomposition of the
polymer can be attributed to graphene content.

3.6. Preparation and Characterization of Extrusion Printed Graphene/PCl
Structures
3.6.1. Discussion

Development of scaffolds for tissue engineering is one of the most important
applications

of

biomaterials.

In

the

previous

sections,

preparation

and

characterization of graphene/PCl composites through mixing, covalent attachment
and microwave-assisted methods were described.

The synthesised cPCl-CCG composites showed large improvements in the
conductivity and mechanical properties of the polymer. Initial in vitro cytotoxicity
testing also showed good biocompatibility and analysis of the degradation rates
showed consistent, non-toxic biodegradation of the composite material. Importantly,
the melt properties of the polymer were also retained on the addition of graphene in
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both cPCl-CCG and mPCl-rGO composites, resulting in an easily processable
material ideal for fabrication into tissue engineering scaffolds using fused deposition
modelling (FDM).

In this work, the feasibility of extruding and printing fibres and complex threedimensional scaffolds of cPCl-CCG and mPCl-rGO composites was investigated.
mPCl-rGO composite with 1% graphene content was printed into scaffold using a
3D-Bioplotter from Envisiontec (Germany) and the biocompatibility of the printed
structure was investigated. cPCl-CCG composites with 1, 2.5 and 5 wt.% graphene
content were printed into fibres with varying diameters and their mechanical
properties and cytotoxicity was studied. Complex scaffolds were also fabricated from
a composite with 1% graphene content. A KIMM SPS1000 bioplotter extrusion
printing system was used to fabricate structures from cPCl-CCG composites.
3.6.2. Characterization of Extrusion Printed cPCl-CCG Structures
3.6.2.1. Melt Behaviour
Melt extrusion printing is very dependent on a number of material parameters,
especially the melt temperature and viscosity. Figure. 3.36 shows the change in the
melting point and viscosity of the composites with increasing graphene content. The
melting point and complex viscosity were measured following the procedure
discussed in Section 3.3.2.2 and 3.3.2.10 and respectively
Differential scanning calorimetry showed that the addition of graphene to
polycaprolactone did not significantly affect the melting point of the composites,
which remains between 55-60 °C. Graphene however, has an increasing effect on
complex viscosity (η*) of the polymer composites. Graphene contents above 5 wt.%
show an increase in the viscosity indicating the strengthening effect of graphene on
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PCl. However, the maximum viscosity of the synthesised composites was found to
be 33560 Pa.s (5 wt.% graphene), which is well within the capabilities of the printer.

Figure. 3.36. Melting point and viscosity of PCl and cPCl-CCG composites at
different graphene contents.

3.6.2.2. Extrusion Printing
cPCl-CCG composites were printed/extruded successfully in the form of scaffolds
and fibres with easily controllable diameters and fibre morphologies. The extrusion
printing was carried out by Mr. Rhys Cornock (in the IPRI, UOW laboratories). The
diameter of the extruded fibres could be controlled by either changing nozzle
diameter or temperature. Applied pressure and/or head speed were varied between
100 and 500 µm while retaining fibre shape (Figure.3.37). Fibres with rounded crosssections were produced without using a substrate, instead extruded into free space
and collected. In the preliminary tests it was found that the cross sections of the
fibres were not round as they were printed on a glass substrate. To make fibres with
regular cross sections, the fibres were produced without using a substrate, instead the
material was guided out of the print tip using tweezers, so the fibers could be printed
successfully with circular cross section.
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Complex three-dimensional scaffolds were printed onto a glass substrate.
Figure.3.37c shows a multi-layer lattice with a fibre thickness of 220 µm and a poresize of 130 µm, which is intended as a 3-dimensional cell scaffold. Figure.3.37d
shows a similarly sized scaffold with alternating conducting graphene containing and
insulating non-graphene containing matched concentric circles, which can be used to
examine the effects of cell growth in regions under electrical stimulation.

Figure.3.37. (a) Printed cPCl-CCG fibres with different diameters, (b) cross-section
of extruded PCl-CCG fibres, (c) cPCl-CCG composite printed in the form of a
scaffold and cPCl-CCG composite and pristine PCl printed in the form of combined
scaffold (d).

3.6.2.3. Raman Spectra
Figure 3.38 shows the Raman spectra of PCl and printed fibres with 1, 2.5 and 5
wt.% graphene content. The Raman test was carried out on the surface of the fibres
using a 632 nm laser line and a 300-line grating. The Raman spectrum of PCl shows
the characteristic peaks at 1726 cm−1 (ν C=O), 1060 cm−1 and 1106 cm−1 (skeletal
vibration) and 1281–1305 cm−1 attributable to CH2 groups. There are two
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distinguished peaks at 1328 and 1598 cm−1 corresponding to D and G band of
graphene sheets in PCl/graphene fibres. By addition of graphene, the intensity of the
PCl peaks decreases as the intensity of graphene peaks is higher than that of PCl.

Figure 3.38. Raman Spectra of the printed PCl fibres at different graphene contents.

3.6.2.4. Mechanical Properties
Figure. 3.39 shows the mechanical properties of the printed PCl and cPCl-CCG
fibres with 1, 2.5 and 5 wt.% graphene content, and the detailed data of the
mechanical properties are listed in Table 3.3. To prepare samples for mechanical
properties tests, the fibres were cut to the length of 10 mm and the thickness of the
samples was measured using SEM.
Generally, addition of graphene increases the tensile strength and Young’s modulus
of the fibers. Graphene/PCl composite fibres exhibited an increase of up to 50% in
tensile strength from 33 MPa to 50 MPa and a more than 160% improvement in
tensile yield strength with less than 5 wt.% graphene content. The Young’s modulus
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of the fibres was also increased by more than 140% on addition of 5 wt.% graphene.
These results indicate a significant contribution of graphene to strength
improvement, deformation resistance and stiffness of the fibres. Although the
addition of graphene up to 5 wt.% reduced the elongation at break of the composite,
the printed composites still exhibit high elongation at break of 750%, indicating a
good flexible, strong fiber.

Figure. 3.39. Mechanical properties of extruded cPCl-CCG fibres (300 – 365 µm) at
different graphene contents.

Table 3.3.Mechanical properties of extruded cPCl-CCG fibres [300 – 365 µm] at
different graphene contents.
Graphene
Content
(wt.%)
0

Tensile
Strength
(MPa)
33 ± 0.7

Young’s
Modulus
(MPa)
232.8 ± 18

Elongation at
Break (%)

1

48 ± 1

409 ± 26

1326 ± 76

2.5

48 ± 1

474 ± 28

773 ± 54

5

50 ± 1

557 ± 26

1295 ± 81

155

2251 ± 91

3.6.2.5. Cell Study
The cytotoxicity of the extruded fibres was tested by Dr. Brianna Thompson and Dr.
Eoin Murray (in the IPRI, UOW laboratories) through seeding electroactive PC12
cells onto the fibres. As discussed with Dr. Thompson, Figure 3.40a shows
differentiated PC12 cells exhibiting a neural morphology growing on the printed
scaffolds. The green phalloidin stain shows that the actin cytoskeleton of the cells
was typical of PC12 cells which have differentiated towards a neuronal phenotype.
Figure 3.40b shows cells adhered to adjacent fibres, with the bed of cells growing on
the underlying microscope slide, demonstrating that the nerve cells preferentially
adhered to and differentiated on the extruded fibres over the uncoated glass.

Figure 3.40. Differentiated PC12 cells showing good adherence and morphology on a
(a) single fibre and on (b) two fibres and the glass substrate.

3.6.3. Extrusion Printed mPCl-rGO Scaffold
3.6.3.1. Extrusion Printing
The processability of the mPCl-rGO 1% composites was investigated through
printing them into scaffold using a 3D-Bioplotter (Envisiontec). The printing of the
scaffold was carried out by Dr. Robin Gorkin in the IPRI, UOW laboratories. Results
from the 3D-Bioplotter showed the mPCl-rGO composite material was easily and
controllably melt processable. In Section 3.6.2.1 it was shown that cPCl-CCG
composites retain the melt temperature and rheological properties (complex
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viscosity) of the pristine polymer on addition of graphene (Figure. 3.36). Following
the incremental adjustment of various printing parameters to find the optimal
settings, the composites were printed/extruded successfully in the form of scaffolds
and fibres with easily controllable diameters and fibre morphologies. As a pilot
three-dimensional structure for cell growth and tissue engineering, a porous mesh
design was created using Envisiontec software and printed with several crisscrossing
layers (with a 90 degree shift between layers) extruded from a 0.4mm nozzle (as seen
in Figure 3.41). The resulting multi-layer scaffold structure has pore sizes of
approximately 1mm.

Figure 3.41. Melt extrusion printed three-dimensional porous mesh scaffold

3.6.3.2. Cell Study
Biocompatibility of the PCl-rGO composite was assessed by Dr. Brianna Thompson
and Dr. Eoin Murray (in the IPRI, UOW laboratories) via geowing L-929 cells on the
film and printed scaffold made from the material. As discussed with Dr. Thompson,
the materials were found to allow attachment and proliferation of L-929 fibroblasts,
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albeit at lower rates than tissue culture plastic alone. The results of a Pico Green
assay showed that although the rate of growth was slower on the mPCl-rGO or mPCl
films, the cell population underwent 2-3 doublings on the synthesised materials,
compared to 3-4 doublings on tissue culture plastic. The cell densities measured after
4 days of culture were 5400±300 cells cm-2 on PCl, 10000±2000 cells cm-2 on mPClrGO and 19200±700 cells cm-2 on tissue culture plastic (a cell density representing
greater than 100% confluence of cells) (Figure 3.42).

Figure 3.42. Cell density of L929 fibroblasts after 4 days of growth on several
surfaces. Cell density increased from a seeding density of 1500 cells cm-2 on tissue
culture-treated polystyrene (control), and on unmodified PCl and mPCl-rGO films.

Microscopy confirmed that cells adhered to and proliferated on the surfaces, forming
good focal adhesions (Figure 3.43) and covering all surfaces of the printed scaffolds
(Figure 3.43a), except those contacting the plate bottom. The cells grew with normal
fibroblast morphology (Figure 3.43b) and the density of the cells increased over the 4
days of culture. A confluent layer of cells was observed to form on the tissue culture
plastic underneath the scaffolds, suggesting that any differences experienced by the
growing fibroblast cells was surface-confined, and not related to any soluble factors
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released into the growth media. As with the mPCl-rGO films assessed by Pico Green
Assay, the rate of L-929 cell growth was somewhat slower than that expected on
tissue culture plastic alone, but the cells attached firmly and migrated and
proliferated to cover the entire scaffold.

(b)

(a)

(c)

(d)

Figure 3.43. Images of L-929 cells growing on printed mPCl-rGO scaffolds. The
cytoskeleton is labelled with Alexa488-phallioin (green) and the nuclei are DAPI
stained (blue) (a,b). Isosurfrace images of cells growing on the scaffolds, illustrating
their adhesion to the side walls of the scaffolds, not merely the top surfaces (c,d).

3.7. Further Studies on Processability of the cPCl-CCG Composites
The processability of the synthesised cPCl-CCG composites were further studied
through other techniques such as wet-spinning, spray coating and filtering. These
experiments were carried out to investigate the feasibility of processing the
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composites using different techniques. The products were not fully characterized
because of time constraints and also because they were not the focus of this project.
The methodology of the experiments is defined in experimental chapter. In wetspinning test, cPCl-CCG composites with 0.5 and 1 wt.% graphene content
coagulated well in the coagulation bath and homogenous and flexible fibres were
produced. In spray coating experiment, composite with higher graphene contents (1
and 5 wt.%) resulted in an inhomogeneous coating while films with fewer amounts
of graphene contents (0.1 and 0.5 wt.%) seemed more homogenous. The product of
the filtering was a homogenous and flexible cPCl-CCG film with a resistivity of 2.03
kΩ.sq-1. The good processability of the cPCl-CCG composites in the mentioned
fabrication techniques offers new opportunities for future researches.
3.8. Conclusion
Developing a processable biomaterial with improved mechanical properties and
conductivity was the main aim of this work. As the first step, PCl and graphene were
chosen as matrix and filler respectively.
Previous work on PCl had adopted a mixing method for developing graphene oxide
polymer composites43,

70

. Adapting this method using reduced, well dispersed

graphene resulted in PCl-CCG composites with improved mechanical and
conducting properties compared to the pristine PCl. However, the graphene
nanosheets were not homogenously dispersed inside the polymer matrix that led to
composites with significant decrease in their elongation at break and minor increase
in their tensile strength.
Covalently linking the polymer chains to graphene resulted in improved mechanical
properties and conductivity compared to pristine PCl as well as very homogeneously
dispersed graphene nanosheets inside the composite matrix. Addition of graphene
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had a significant increase of 12 orders of magnitude on conductivity of the polymer.
In terms of mechanical properties, addition of just 0.5 wt.% graphene increased
tensile yield stress by almost 50% and doubled it on addition of 5 wt.%. Young’s
modulus also increased by more than 100% (0.5 wt.%) and 170% (5 wt.%) across the
same range.
Microwave irradiation was also successfully used as a quick, efficient, green
synthesis route to produce graphene/PCl composites. During the polymerisation, the
graphene oxide was reduced resulting in dispersion of graphene sheets in the
polymer matrix that were comparable to graphene produced using thermal and
chemical processing. However, the mPCl-CCG composites were not comparable to
the cPCl-CCG and mixPCl-CCG in terms of mechanical properties as the synthesised
composites were not strong enough for mechanical testing after the hotpressing.
Further optimisation on the synthesis procedure might improve the resultant
composite.
Enzymatic degradation of PCl-CCG composites was examined in a pseudomonas
lipase solution. As opposed to the mixed samples, covalently linked composites were
found to degrade with a slower rate at higher graphene concentration. TGA results
also confirmed a consistent rate of graphene removal in the covalently linked
composites. These results further support the homogenous dispersion of graphene
sheets in the polymer matrix along with strong linkages in cPCl-CCG composites.
Characterization of the composites showed that the addition of graphene to PCl did
not affect the melting point or viscosity of the composites considerably, so the
processability of the composites was investigated by printing them into a variety of 2
and 3-dimensional structures using an additive fabrication approach. cPCl-CCG
composites were plotted in the form of fibres and scaffolds and were characterised.
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The mechanical properties of composite fibres were greatly improved with more than
50% increase in tensile strength and up to 144% improvement in Young’s modulus
on the addition of less than 5 wt.% graphene content. Biocompatibility of the
composites was also confirmed by the preferred proliferation of PC12 cells on the
extruded fibres. mPCl-rGO composite also retained the biocompatibility of the
polymer resulting in very promising tissue engineering scaffold materials.
Processability and biocompatibility of the mPCl-rGO was confirmed by printing the
composites into scaffolds and by culture of a rat fibroblast cell line (L-929) on films
and printed scaffolds made from the material.
Table 3.4. compares the PCl composites prepared in this work with the similar works
reported in the literature in terms of mechanical properties and conductivity. The
previous work showed that the addition of GO improves the strength and Young’s
modulus of PCl, but results in a decrease in the elongation at break of the polymer.
The prepared GO/PCl composites also lack electrical conductivity. Apart from the
added value of conductivity, the graphene/PCl composites prepared in this work (e.g.
mixPCl-CCG) show better improvement in their tensile strength and Young’s
modulus compared to the GO/PCl composites from the literature; however, it is hard
to compare the samples as the PCl molecular weight and the filler content varies in
different work.
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Table 3.4. The mechanical properties and electrical conductivity of the PCl
composites with GO and CCG as filler.
Mechanical properties
(improvement
Number of
Average
Molecular
Weight

relative

to

the

neat
Conductivity

polymer)

(S m-1)

Filler

Composite

Tensile

(content)

type

yield (TY)

Young’s

or

modulus

(Mn)

tensile

strength

(MPa)

(improvement
Elongation

relative

to

at break (%)

neat polymer)

12%

NA

548%

NA

Reference
the

(TS) (MPa)

174000

70 000–
90000

GO (10%)

Film

GO (2%)

Film

by

mixing

Film

(5%)

Covalently
80,000

linked CCG

Film

(5%)

Covalently
80,000

1000

26 (70%)

(205%)

TS:

CCG
80,000

TY:

linked CCG
(5%)

Fibres

27.5 (94%)

440
(112%)

Kai et al.43

Wan

and

Chen70

9E-1

TY:

360

20 (100%)

(283%)

TY:

259

17 (70%)

(177%)

TS:50.6

557

(50%)

(140%)

48%

(12 orders of

This thesis

magnitude)

166%

3E-3
(10 orders of

This thesis

magnitude)

1295%

NA

This thesis

NA: Not available

Although mixPCl-CCG composites show slightly better tensile strength, Young’s
modulus

and

conductivity compared

to

the

cPCl-CCG

composites,

the

characterization of the samples confirmed homogenous dispersion of CCG inside the
PCl matrix and better attachment between the polymer chains and CCG sheets in
cPCl-CCG samples, resulting in higher elongation at break in them.
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Generally, it was shown that addition of graphene can significantly enhance the
mechanical and conductivity of PCl without affecting the polymer biocompatibility.
The composites showed excellent processability and solubility that makes them good
candidates for use in a number of applications including conducting biodegradable
systems for tissue engineering.
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4. Preparation

and

Characterization

of

Graphene/Chitosan Composites
4.1. Introduction
The development of tissue engineering was a real breakthrough in overcoming the
limitations of traditional treatments of conditions that require the repair or
replacement of tissues1-3. Using this technique, cells can adhere to three dimensional
scaffolds, which then provide structural support while the tissue regenerates to repair
the damaged tissue and organs. One of the major limitations in tissue engineering is
the development of suitable materials for these scaffolds. Processability, appropriate
physical properties and biocompatibility are the major factors that determine the
suitability of these materials4. Traditional polymeric materials possess some but not
all of these properties. However, fillers can be utilized to change or improve their
properties. For example, the introduction of an electrically conducting filler to a
polymeric matrix would produce conducting scaffolds, which can be beneficial as
electrical stimulation has been shown to improve the growth of electro-responsive
cells such as nerve and muscle cells.
Both natural and synthetic polymers have been widely investigated as polymeric
matrices and both of them have their own merits and shortcomings for biomedical
applications. Natural polymers were the first biodegradable materials used in clinical
research5. The Inherent advantages of natural polymers such as good cell adhesion
and proliferation, in vivo degradation, bioactivity and natural remodelling make them
appropriate candidates for biomedical applications, particularly in the tissue
engineering field5.
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Chitosan (Figure 4.1) is a semi-crystalline natural polymer that is a derivative of
chitin. This natural polymer can be obtained by the partial deacetylation of chitin
under alkaline conditions or by enzymatic hydrolysis in the presence of a chitin
deacetylase. Due to its good biocompatibility and biodegradability, chitosan has been
used in a large number of applications such as artificial skin, tissue engineering and
drug delivery. Furthermore, the good swelling behaviour of chitosan makes it an
appropriate candidate to form hydrogels for tissue engineering scaffolds. The
structural similarities of hydrogels to tissues as well as the small likelihood of
receiving negative reactions from the immune system of the host make hydrogels
suitable materials for developing scaffolds for tissue engineering field6, 7.

Figure 4.1. Structure of chitin and chitosan8.
Despite its excellent biocompatibility, chitosan is difficult to process. Chitosan is
insoluble in pure water or organic solvents, but soluble in an acidic medium. The
solubilisation of chitosan in acid is followed by formation of weak bonds between
the polymer chains and acid that lead to the development of an entangled hydrogel9.
The acid type and chitosan concentration play an important role in determining the
properties of the resultant chitosan film10,

11

. Choosing the correct acid type and

chitosan concentration becomes even more crucial when producing composites with
chitosan and a filler. Although acetic acid is the most commonly used solubilizing
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crosslinking acid in the preparation of chitosan films, it needs to be used with great
care as it can cause adverse effects on cell growth12. In contrast, lactic acid is a
chemical compound with pivotal role in energy metabolism of living organism and in
many biochemical reactions. This material is the simplest 2-hydroxycarboxylic acid
with a chiral carbon atom and exists in two enantiomeric forms. Lactic acid has a
hydroxyl and an acid functional group that makes it a suitable material for
esterification reactions13 and to be used as crosslinker. It has been shown that the
chitosan films made using lactic acid exhibit much better elongation at break14-16,
which makes them better candidates for fabricating scaffolds for tissue engineering.
Chitosan is an ideal polymer for the composite synthesis as the presence of multiple
functional groups (Figure 4.1) on the chitosan backbone results in easy covalent or
physisorbed attachment of filler materials into the polymer matrix. However, poor
mechanical properties restrict its application in some fields. The incorporation of
carbonaceous nanofillers and the synthesis of composites provide effective routes to
improved physico/chemical properties of such biopolymers.
Most work on composites of natural polymers and carbonaceous materials has been
carried out with non-conducting graphene oxide (GO). It has been shown that the
addition of GO can improve the mechanical properties of the polymer while retaining
its processability. For example, alginate/GO fibers containing 4 wt.% GO prepared
by wet-spinning show significant improvement in their tensile strengths and Young’s
modulus compared to pristine alginate fibres17. A number of authors have also shown
that the addition of GO can improve the mechanical properties of chitosan films
significantly18, 19.
Addition of a conducting filler can not only improve the mechanical properties of the
polymer but also makes it conducting, which is likely to be beneficial for developing
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conducting substrates for cell stimulation. Some researchers have used carbon
nanotubes (CNTs) as filler to develop composites using natural polymers20-26.
Although the addition of CNTs can improve the mechanical properties and
conductivity of the natural polymers, they are not appropriate fillers for biomedical
applications because of their toxic nature27,

28

, poor dispersibility and tendency to

aggregation29.
Among the carbonaceous nanofillers, graphene is regarded as an ideal reinforcing
filler in the preparation of polymer composites due to its high aspect ratio and
excellent mechanical, electrical, optical, thermal and magnetic properties30,

31

. In

contrast to other widely used nanomaterial fillers such as CNTs, the synthesis of
graphene is facile, inexpensive and can easily be scaled up. However, not much work
has been done on developing graphene composites using natural polymers and, in
particular, very little work has been done to study the effect of the addition of well
dispersed, electrically conductive graphene nanosheets on the chitosan matrix.
In the previous chapter, DMF dispersed graphene was used as a filler to prepare
graphene/PCl composites. The resultant graphene/PCl composites exhibited
enhanced mechanical properties and conductivity while retaining their processability
and biodegradability. Chitosan is soluble in weakly acidic solutions so it is possible
to use aqueous chemically converted graphene (CCG) dispersion to prepare chitosan
composites. As mentioned earlier, the first aqueous graphene dispersion was, in fact,
synthesised in our group in 2008 by Prof. Dan Li32. Ever since, this processable
aqueous dispersion of graphene nanosheets has become one of the major components
in the preparation of many graphene composites.
The formation of covalent attachments between the carboxylic groups of graphene
sheets and the functional groups of chitosan has the potential to further enhance the
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electrical and mechanical properties of the polymer. In the previous chapter, we
showed that covalently linking the PCl and graphene sheets led to the development
of a processable conducting composite with improved mechanical properties. The
presences of amine groups in chitosan and carboxyl groups in graphene sheets allows
for the potential for covalent attachment between matrix and filler. Following a
similar method used for preparation of cPCl-CCG composites, covalently linked
graphene/chitosan composites can be developed and characterised.
Natural polymers reinforced with carbonaceous materials are good candidates for
developing biomedical devices and, particularly, scaffolds for tissue engineering.
Lyophilisation is the most commonly used conventional method for fabrication of
scaffolds from natural polymers. There are reports in the literature on the preparation
of scaffolds using natural polymers, namely chitosan and collagen, reinforced with
GO33, CNT34-36, carbon37 and collagen-nanotube biocomposites38. However,
conventional methods of developing scaffolds have several drawbacks including an
inability to have precise control over the geometry and pore size of the scaffolds39.
3D printing is a relatively new technique with the capability of overcoming the
limitations of conventional methods. This fast and facile technique has been utilised
for the fabrication of scaffolds with a high degree of control over the size and shape
of the printed structure. The availability of 3D printing systems in our group
presented us with the opportunity to investigate the extrusion printing of a
graphene/natural polymer composite for the first time. To the best of our knowledge,
this is the first extrusion printed graphene/chitosan scaffold developed using a 3D
printing technique.
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4.2.Preparation of Graphene/Chitosan Composites using a Mixing Method
4.2.1. Discussion of Composite Preparation
The development of graphene/chitosan composites using lactic acid and an aqueous
graphene dispersion is described in this section. The graphene dispersion used in this
work was aqueous graphene dispersion synthesized following Dan Li’s method32.
The dispersion was prepared via reduction of GO in water using hydrazine to make
0.5 mg ml-1 graphene dispersion. As mentioned earlier, chitosan does not dissolve in
water but can be dissolved in an acidic media. Acetic acid is the most commonly
used acid in preparation of chitosan films18, 40-42, therefore we first used acetic acid to
explore the development of graphene chitosan composites.
The samples with 0, 1.5 and 3 wt.% graphene content were prepared by addition of
chitosan powder to water or an appropriate amount of aqueous CCG dispersion
followed by addition of acetic acid. After stirring and sonication, the solution was
cast onto a petri dish and dried at 50 °C. However, the resulting composite films
were very brittle particularly at graphene contents above 1.5 wt.%. Furthermore,
acetic acid did not go well with graphene dispersion and crashed the dispersion
quickly. As a result, we shifted to lactic acid that is less cytotoxic than acetic acid
and it was found to be much less disturbing to graphene dispersion. Moreover,
chitosan films developed using lactic acid possess higher strains14-16, that can tackle
the fragility problem of the chitosan composites made by using acetic acid.
Preliminary experiments were carried out to determine the optimum chitosan:lactic
acid ratio for composite preparation. Chitosan powder and lactic acid with ratios
ranging from 1:0.5 to 1:3 were added to water. After stirring and sonication, the
mixture was cast onto a petri dish and dried at 50 °C. After evaporation of the
solvent, the excess acid was removed by washing the samples in several steps with
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ethanol/phosphate buffered saline (PBS) solutions. The resulting films were cut into
strips with a width of 3 mm and a length of 20 mm for mechanical properties test.
The tensile properties of the samples were measured using a tensile tester at a
constant rate of 5 mm min-1. Table 4.1 demonstrates the effect of chitosan:lactic acid
ratio on the mechanical properties of the films. Films with less lactic acid were found
to display worse mechanical properties and based on the mechanical properties
results, 1:2 was found to be the optimum chitosan:lactic acid ratio for the process.

Table 4.1. Mechanical properties of chitosan composites at different chitosan/lactic
acid ratios.
Chitosan/Lactic

Tensile Strength

Elongation at

Acid Ratio

(MPa)

Break (%)

1:0.5

18.2±0.9

3.5±0.7

1:1

18.0±1.1

4.4±0.5

1:1.5

17.4±1

8.9±0.4

1:2

21.1±1.5

12±0.3

1:3

20.1±1.2

11.2±0.5

To prepare the composites, chitosan powder was added to an appropriate amount of
the aqueous graphene dispersion followed by slow addition of acid. After stirring and
sonication, the solution was cast onto a petri dish and dried at 50 °C. The excess acid
was removed by washing the samples in several steps with ethanol/PBS solutions.
Graphene/chitosan composites were labelled as CSG-0, CSG-0.1, CSG-0.5, CSG-1.5
and CSG-3, according to the weight percentage of the graphene content per chitosan,
with CSG-0 containing no graphene and CSG-3 containing 3 wt.%. In order to
determine the effect of the acid on material properties, materials with acetic acid
instead of lactic acid were also prepared in a similar fashion and are labelled CSG-
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(AA). All prepared samples are listed in Table 4.2 and the schematic of the reaction
is presented in Figure 4.2.
Table 4.2. CSG samples prepared using lactic acid or acetic acid at different
graphene contents.
Acid type

Graphene contents

Sample label

(wt.%)
Lactic acid
Lactic acid
Lactic acid
Lactic acid
Lactic acid
Acetic acid
Acetic acid
Acetic acid
Acetic acid
Acetic acid

0
0.1
0.5
1.5
3
0
0.1
0.5
1.5
3

CSG-0
CSG-0.1
CSG-0.5
CSG-1.5
CSG-3
CSG-0 (AA)
CSG-0.1 (AA)
CSG-0.5 (AA)
CSG-1.5 (AA)
CSG-3 (AA)

Figure 4.2. Preparation of graphene/chitosan composites through mixing method.
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It is important how to mix the composite ingredients to avoid crashing of the
graphene dispersion as graphene dispersion can crash in acidic media. Our first
attempts on developing homogeneous chitosan graphene dispersion failed as the
graphene dispersion crashed on addition of chitosan and acid. To tackle this problem,
chitosan and graphene dispersion were stirred well for 15 min and then the acid was
added dropwise under stirring. At higher graphene concentrations, addition of acid
under mild sonication helps the homogeneity of the dispersion. After stirring for 2
hours, the dispersion should be sonicated to exfoliate agglomerate graphene and to
remove the air bubbles formed during the stirring.
It is crucial to remove excess amount of lactic acid after formation of the CSG films.
Unreacted acid makes the sample media acidic that is not desirable for swelling and
biocompatibility test.
Figure 4.3 shows CSG samples with 0, 1.5 and 3 wt.% CCG in deionised (DI) water
before removing the excess acid. CSG-0 dissolves quickly in water in less than 30
minutes; however, hydrophobicity of graphene significantly decreases the solubility
of graphene/chitosan composites and these samples remained undissolved after 2
hours immersed. To remove the unreacted acid, the samples were washed with a 0.1
M NaOH solution followed by water. However, preliminary cell studies carried out
by Dr. Brianna Thompson showed that NaOH remaining is still enough to make the
culture media basic, that is not suitable for cell growth. Following a washing protocol
proposed by Dr. Johnson Chung, the samples were washed in several steps with
ethanol/phosphate buffered saline (PBS) solutions by decreasing the ethanol/PBS
ratio stepwise until the films were in PBS alone. This washing method resulted in
complete removal of excess acid and preparation of samples with good swellability
and biocompatibility.
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(a)

(a)

(b)

(b)

(c)

(c)

(a)

(b)

(c)

Figure 4.3. CSG samples in DI water with (a) 0, (b) 1.5 and (c) 3 wt.% CCG content
before removing the excess acid.

4.2.2. Characterization
4.2.2.1.Thermogravimetric Analysis
Thermal properties of CCG, Chitosan, lactic acid (LA), CSG-0 and CSG-3 are shown
in Figure 4.4. It is possible to study thermal behavior of the individual components of
the chitosan/acid/graphene system using thermogravimetric analysis (TGA). TGA
was performed on 10mg of samples with a heating rate of 5 oC min-1 under a nitrogen
atmosphere.
CCG exhibits a high thermal stability and very slight weight loss over the
temperature range of 30-900 °C. This high stability is attributed to good reduction
and deoxygenation of GO with improved van der Waals forces between layers43.
Lactic acid shows relatively low thermal stability with two regions of weight loss
between 24 to 100 oC and 100 to 200 oC that can be due to moisture evaporation and
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structural decomposition of lactic acid, respectively. TGA curve of chitosan exhibits
around 5% weight loss between 30-100 oC that is attributed to evaporation of trapped
moisture, followed by decomposition of the polymer that occurs at around 250 oC.
In the TGA curves of the composites, three regions of weight loss can be observed,
90-250 °C attributed to water and lactic acid loss, a major weight loss at 250-330 °C
and a slow weight loss to 900 °C showing chitosan decomposition and a slow weight
loss from 330-900 °C that is attributed to partial graphene decomposition and
remaining of carbon materials.
Although the decomposition temperature of lactic acid is as low as 100 °C, the
composites show good thermal stability up to 250 °C, indicating successful removal
of the excess lactic acid. Composite with 3 wt.% graphene content (CSG-3) shows
slight increase in the decomposition temperature and slower degradation profile
compared to that of chitosan/lactic acid materials (CSG-0), that is due to presence of
graphene nanosheets in improving thermal stability of the composite. There is around
4.1% difference between the material residues of CSG-0 and CSG-3 at 900 oC that
can be correlated to graphene content in the CSG-3 samples.
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Figure 4.4. Thermogravimetric curves of CCG, pristine chitosan, LA, CSG-0 and
CSG-3 samples.

4.2.2.2. Scanning Electron Microscopy
Scanning electron microscopy (SEM) was used to determine the quality of the
dispersion of nanosheets in the polymer matrix. To obtain SEM images from the film
surfaces, samples were cut into 0.5 × 0.5 mm pieces and were mounted on a SEM
sample holder followed by coating with a thin layer of gold. To prepare samples for
cross-sectional images, samples were frozen in liquid nitrogen and were fractured
before coating.
Figure 4.5 shows surface (a,b,c,d) and cross-sectional (e,f,g,h) SEM images of
chitosan films with different graphene loadings. The surface images of the samples
with different graphene loadings show a smooth morphology and no obvious change
could be observed in the film surfaces, indicating homogenous dispersion of
graphene sheets in the chitosan matrix without any agglomeration. Comparing the
cross-sectional images of graphene-containing composites to the CSG-0 film, the
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inner structure of CSG-0.5, CSG-1.5, and CSG-3 are much denser and stratified than
that of CSG-0, indicating the strong interaction between chitosan and graphene. This
strong interaction resulted in enhancement of the tensile strength by increasing the
graphene content as observed in mechanical properties test.
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Figure 4.5. SEM images of surface (a,b,c,d) and cross section (e,f,g,h) of CSG-0
(a,e), CSG-0.5 (b,f), CSG-1.5 (c,g) and CSG-3 (d,h) films. The scale bar represents
200 µm.
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4.2.2.3. X-ray Diffraction
X-ray diffraction (XRD) was utilised to study the effect of graphene and lactic acid
addition on the crystallinity and structural properties of chitosan. XRD was carried
out on CSG-0, CSG-0.5 and CSG-1.5 samples as well as on chitosan powder
mounted on a quartz substrate. . Figure 4.6 shows the XRD patterns of chitosan and
CSG films with 0, 0.5 and 3 wt.% graphene content.
Pure chitosan shows two major peaks at 2θ = 10.7° and 2θ = 21.2° that correspond to
the crystalline structure of the chitosan, based on what is reported by Jaworska et al.
and Yuan et al.44, 45. In the XRD patterns of CSG-0, CSG-0.5 and CSG-3, the second
peak is broadened and the first peak is suppressed. The crystalline diffraction peak at
2θ = 10.7° is stronger in chitosan powder compared to chitosan composites implying
a slightly higher crystallinity in chitosan powder. The reduction in diffraction
intensity at 2θ = 10.7° and the broadening of the peak at 21.2° indicates a decrease in
the degree of crystallinity of the chitosan on addition of lactic acid and graphene.
However, as is evident from the XRD patterns, the addition of graphene did not
cause any significant change in the chemical structure of the chitosan in the
composite films, indicating that the interaction between chitosan, lactic acid and
graphene is mainly a physical one.
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2𝜃 (Degree)

Figure 4.6. XRD spectra of chitosan and CSG films.

4.2.2.4. Raman Spectra
Figure 4.7 illustrates the Raman spectra of CCG, chitosan and CSG composites with
0.5 and 3 wt.% graphene content. Raman spectra were collected on samples from
400 to 2500 cm-1 on 10 mg chitosan and CSG powder and on CSG films.
In chitosan, the peaks at around 898 are attributed to NH2 wagging48. Peaks at 1377
cm-1 can be attributed to different vibrational modes of CH, CH2 and CH3 groups and
the multiple peaks around 1099 cm-1 can be attributed to ether bonds and the
stretching of glycosidic bonds48. In the spectra of the graphene composites there are
two significant peaks at 1328 and 1598 cm−1 corresponding to thr D and G bands of
the graphene sheets. The graphene peaks are also visible in the Raman spectra of
chitosan composites. On increasing graphene content, the peaks due to chitosan films
are less visible as the intensity of the characteristic D and G bands of graphene are
greater than that of chitosan films. In samples with highest graphene content, only
the D and G band graphene peaks are visible. The D and G bands show no shift and
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the ID/IG ratio is virtually unchanged from the pristine graphene to the graphene
composites, indicating little or no change in the sp2 nature of the graphene
nanosheets.

Figure 4.7. Raman spectra of pristine chitosan, CCG and CSG samples containing
0.5 and 3 wt.% CCG.

4.2.2.5. Fourier Transform Infrared Spectroscopy
Fourier transform infrared (FTIR) spectroscopy was used to investigate the possible
interactions between chitosan, lactic acid and graphene. The FTIR spectra of CSG
films were obtained using 1 cm × 1 cm films on an ATR attachment. In terms of the
chitosan, the chitosan powder was mixed with KBr powder with 1:10 ratio and the
blend was pressed into the FTIR sample holder before putting into the FTIR test
chamber. FTIR spectra were measured between 400 and 4000 cm−1 and Figure 4.8
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shows the spectra of chitosan and CSG composites with 0, 0.5 and 3 wt.% graphene
content.
In the FTIR spectrum of chitosan, based on what is reported by Yang et al. 41 and
Pawlak and Mucha49, the absorbance band at 1658 corresponds to the C=O stretching
vibration of −NHCO- of chitosan. The peak at 1573 cm−1 attributes to the NH
bending in –NHCO- although reported by Pawlak and Mucha as 1560 cm−1, maybe
due to overlap of 1560 and 1593 cm−1 (NH of NH2) . The broad band around 3400
cm−1 corresponds to N–H stretching vibration of amino group in the spectrum. The
absorption peaks at 1037 to 1153 cm−1 have been attributed to primary and secondary
alcoholic groups41, 49. The bands around 2800-3000 cm−1 correspond to characteristic
C–H stretches.
The FTIR spectra of CSG-0, CSG-0.5 and CSG-3 are very similar. The peak at 1720
cm-1 in the spectra of the composites is assigned to the C=O of the COOH groups
from lactic acid and CCG. In all three CSG samples, the bands corresponding to the
C=O characteristic stretching band of the amide group (1658 cm−1), N−H bending of
−NH2 (1573 cm−1) and N–H stretching vibration of amino group (3464 cm−1) in
chitosan shift to lower wavenumbers that are 1639 cm-1, 1558-1566 cm-1 and 34443448 cm-1, respectively. These shifts indicate likely hydrogen bond interactions
between amine group of chitosan and hydroxyl and carboxyl groups of lactic acid
and graphene.
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Figure 4.8. FTIR spectra of chitosan and CSG samples with 0, 0.5 and 3 wt.% CCG
content.

4.2.2.6. Conductivity
The electrical conductivity of the composite films was measured using a four-point
probe resistivity measurement system (JG 293015 Jandel) as described in Chapter 2.
The conductivity of CSG and CSG-(AA) samples with 0.1, 0.5, 1.5 and 3 wt.%
graphene content is shown in Figure 4.9 .
Chitosan is generally insulating in nature with a conductivity less than 1E-8 S m-1 50.
As expected, the conductivity of the composites increases with increasing graphene
content. The CSG composites exhibit a low percolation threshold of 0.1 wt.%
graphene, resulting in a conductivity of 6.7E-4 S m-1 that is orders of magnitude
higher than the pristine polymer. By increasing the graphene content to 0.5 and 1.5
wt.% the conductivity keeps increasing to 2E-3 and 6.7E-2 S m-1, respectively. The
highest conductivity was 1.33E-1 S m-1 achieved in the composite with 3 wt.%
graphene content.
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The control films initially developed using acetic acid instead of lactic acid show
conductivities consistently one order of magnitude less than those made with lactic
acid. The conductivity of CSG-(AA) samples with 0.1 wt.% graphene content was
found to be around 1E-4 S m-1, that increases to 1.33E-02 S m-1 as the graphene
content increases to 3 wt.%.
The greater conductivity in composites crosslinked by lactic acid is probably due to
the formation of a greater number of hydrogen bonds among the hydroxyl and
carboxylic groups of the composite components that resulted in better interaction
between CCG sheets that prevention in forcing the sheets apart.

Figure 4.9. Conductivity measurements of CSG composites produced using ()
lactic acid and () acetic acid. The conductivity of pristine chitosan is taken to be
approximately 1E-8 S m-1 50.

4.2.2.7. Swelling Studies
The swelling characteristics of the chitosan composites were determined by swelling
a known weight (50-100 mg) of sample in DI water at room temperature with the
swelling %, Esr, calculated using the following equation51, 52:
Esr = [(Ws - Wd)/ Wd] × 100
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where Esr is the percent swelling of the sample (%), Ws denotes the weight of the
sample in swollen state and Wd is the initial weight of the sample.
Due to its excellent swelling behavior, chitosan it an ideal candidate for developing
hydrogels for biomedical applications. Water penetrates inside the hydrogel networks
and causes them to swell and get their form6,

53-55

. The swelling behaviors of the

CSGs with 0, 0.5, 1.5 and 3 wt.% CCG and CSG-(AA) samples with 0 and 3 wt.%
CCG are illustrated in Figure 4.10. All samples swell relatively fast in the first 30
min followed by a decrease in their swelling rate in subsequent hours. CSG-0 film
swells in DI water up to 400% in the first 10 min and up to 500% within 6 hours. The
changes in swelling rate are insignificant between 6 to 48 hours. As is clearly
apparent, the swelling of the chitosan composites could be controlled by the addition
of CCG with swelling decreasing with increasing the CCG content. On addition of
CCG and after 6 hours, the swelling rate of composites decreases from 500% in
CSG-0 to around 250, 200 and 140% in composites with 0.1, 1.5 and 3 wt.% CCG,
respectively. This inverse relationship between the swelling rate and graphene
content can be attributed to the decrease in the number of available hydrophilic
groups (e.g. OH and NH2) in the polymer due to hydrogen binding with hydrophobic
graphene nanosheets, which decreases the water absorption56,
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. The mechanical

reinforcing effect of graphene also restricts the swelling.
The swelling rate of CSG (AA) samples is lower than that of the CSG samples. The
maximum swelling rate of CSG-0(AA) film is around 150% that is significantly
lower than what was achieved with CSG-0 sample. The higher swelling rate in CSG
samples can be attributed to the increased hydrophilicity of lactic acid with an
additional OH group for hydrogen binding. This may result in more lactic acid
remaining in the composite after the washing step which would enhance the swelling.
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However, the difference in swelling rate decreases at higher graphene contents where
CSG-3 swells just 35% more than CSG-3(AA) after hrs, reflecting the overriding
effect of the hydrophobic additive on swelling.
(a)

(b)

Figure 4.10. (a) Swelling characteristics of CSG and CSG(AA) in DI water over 48
hours and (b) the CSG composite swelling rates in the first five minutes.
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4.2.2.8. Mechanical Properties
To prepare samples for mechanical property tests, the samples were cut into strips
with a width of 3 mm and a length of 20 mm. The tensile properties of the samples
were measured at a constant rate of 5 mm min-1 as described in Chapter 2.
Typical stress-strain curves for chitosan films with different graphene loadings are
shown in Figure 4.11 and Table 4.3. The tensile properties of the composites
significantly increase with increasing the graphene content, followed by only a small
decrease in elongation at break. By incorporation of only 0.5 wt.% graphene, the
yield strength is improved by more than 58%. The stiffness of the composites also
improves on addition of 0.1, 0.5 and 1.5 wt.% graphene by more than 26, 36 and
70% respectively. The addition of 3 wt.% graphene greatly improved the tensile
strength by more than 217% while the Young’s modulus is also improved
significantly to more than 135%.
The excellent improvement in mechanical properties of the composites indicates a
good dispersion of the graphene sheets in the composite matrix and a strong
interaction between graphene and the other components of the composite.
As expected, the tensile strength of the samples drops at their swollen state as water
molecules interact strongly with the hydroxyl groups of chitosan, resulting in
swelling and weakening of intermolecular H-bonds. The tensile strength of the CSG0 swollen film is around 230 kPa. The addition of graphene increases the tensile
strength and stiffness of the composites in their swollen state. By increasing the
graphene content to 0.1, 0.5 and 1.5 wt.%, the tensile strength of the polymer
increases to 272, 276 and 284 kPa, respectively. Addition of 3 wt.% graphene
increased the tensile strength to more than 370 kPa. The stiffness of the swollen
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samples is also improved on addition of 3 wt.% graphene and reached more than 520
kPa ,corresponding to an increase of 60% compared to the swollen CSG-0.
On the other hand, swollen samples show much better elongation at break compared
to dried samples that could be due to presence of water molecules inside the polymer
matrix that gives some flexibility to the samples. Elongation at break of the swollen
CSG-0 is around 50%, more than four times higher than when it is dried, and swollen
CSG-3 is almost 7 times higher than dried films.
(a)

(b)

Figure 4.11. Stress-strain curves of CSG samples in (a) the dry state and (b) the
swollen wet state
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Table 4.3. Mechanical properties of CSG samples with different graphene contents in
the wet and dry state.
Dry State

Wet State

Tensile

Elongation

Young’s

Tensile

Strength

at Break

Modulus

Strength

at Break

Modulus

(MPa)

(%)

(MPa)

(kPa)

(%)

(kPa)

CSG-0

21.1±1.5

11.2±0.3

578±25

230±4

51±6

319±12

CSG-0.1

28.5±2.3

10.3±0.5

733±30

272±11

54±4

328±18

CSG-0.5

33.5±1.3

10.0±0.6

787±48

276±7

48±4

433±27

CSG-1.5

55.8±1.8

9.8±0.9

987±90

284±11

55±6

462±22

CSG-3

68.3±1.3

5.6±0.8

1359±75

372±11

52±6

529±31

Sample

Elongation Young’s

4.2.2.9. Scaffold Printing
Developing scaffolds for tissue engineering is one of the most important applications
of the biocomposites. Cells are cultured on scaffolds to grow and regenerate
damaged tissues in three dimensions. By forming the new tissue, the biodegradable
scaffold degrades and is absorbed or discharged by the body. Freeze drying is a
conventional and commonly used method for the preparation of biomedical scaffolds
particularly from natural polymers58-61. A three dimensional structure was easily
produced by freeze drying the CSG solutions with 0.5 wt.% graphene content. Figure
4.12b shows the resulting highly porous, material exhibiting very high surface area
and extremely low density. However, in conventional methods like freeze drying, it
is not possible to accurately control some critical parameters such as morphology,
shape and dimensions of the fabricated scaffolds62, 63. By utilizing new fabrication
methods such as extrusion printing, it would be possible to fabricate the required
structures with high precision.
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(c)

(d)

Figure 4.12. (a-c) SEMs of highly porous freeze dried CSG-0.5 composite at
different magnifications. Note that the visible bright lines in (c) are the edges of the
graphene sheets dispersed inside the structure. (d) A 1 cm thick block of CSG-0.5
composite.

Graphene/chitosan composites were successfully extrusion printed into fibres of
varying diameters and scaffolds of 1.5 × 1.5 cm in dimension and a pore size of 500
× 500 µm by Dr. Johnson Chung in the IPRI laboratories. Figure 4.13a,b shows a
scaffold containing 0.5 wt.% CCG content printed to thirty layers and Figure 4.13c
represents printed fibres with diameters varying between 50 µm to 1 mm. The
dimensions of the scaffold, including the number of layers and the pore size can be
easily varied based on the final application of the product.
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(a)

(b)

(c)

Figure 4.13. Optical images of 0.5 wt.% graphene/chitosan (CSG-0.5) scaffolds
fabricated by extrusion printing at (a) high and (b) low resolution, and (c) 0.5 wt.%
graphene/chitosan (CSG-0.5) fibres extrusion printed with diameters varying
between 50 µm to 1 mm (the scale bars represent 500 µm).

4.2.2.10. Biocompatibility
The biocompatibility of the developed chitosan materials was investigated by Dr.
Brianna Thompson and Dr. Eoin Murray in the IPRI laboratories through growing
mammalian cells in diluted CSG dispersions and culturing cells on CSG films and
scaffolds. Before growing cells on the films, fibroblast cells were exposed to
graphene/chitosan solution using flow cytometry. It was done to accurately evaluate
the effect of the composite components on the cells, as the toxic effect of the
components can decrease when they are incorporated in the polymer matrix. Figure
4.14 shows cell density and dead cells percentage after 5 days of exposure to CSG
dispersions stabilised with either lactic acid or acetic acid.
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As discussed with Dr. Thompson, all cultures were observed to have less than 5%
dead cells, which our lab has found to be typical of L-929 cells grown at high cell
density. The results confirm the lack of toxicity in the composite dispersions.
(a)

(b)

Figure 4.14. Flow cytometric analysis of L-929 cells showing (a) cell density and (b)
% dead cells after 5 days of exposure to CSG dispersions stabilised with either lactic
acid or acetic acid.

To investigate the biocompatibility of the composite films, L-929 cells were grown
by Dr. Brianna Thompson on CSG-0 and CSG 1.5 films for 48 hours followed by
staining with a live-dead cell stain. Figure 4.15 shows the L-929 fibroblast cells
growing on a CSG film (a) and tissue culture plastic (b). The images show that cells
adhered well to the film surfaces and exhibited a morphology that is typical of
fibroblasts. The proportion of dead cells was found to be less than 0.1%, and the
density of the cells was increased over the seeding density. Cells show similar
adhesion and morphology on both CSG-1.5 and graphene-free (CSG-0) films,
indicating that the addition of graphene did not affect the attachment or proliferation
of cells.
In Figure 4.15, the migratory capabilities of fibroblast cells seeded at a higher density
on chitosan (d) and CSG-1.5 (e) films were also compared to the migration on tissue
culture plastic (c). The migrate distance on CSG films and tissue culture optimised
control surface was found to be relatively similar, indicating that addition of
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graphene or lactic acid has not significantly affected the adhesion and metabolism of
the fibroblast cells. Absence of toxicity and lack of changes in proliferation or
migration ability compared to tissue culture controls over 48 hours confirms
biocompatibility of the synthesised chitosan material.
L-929 fibroblast cells were also grown on a 30 layer printed scaffold extruded from
CSG-0.5, with a fibre diameter of 100 µm and a pore size of 500 µm. The scaffold
was printed by Dr. Johnson Chung in the IPRI, UOW laboratories. As shown in
Figure 4.16, cells adhered to and proliferated on the scaffolds, and cells can be
observed on the scaffold surface through all 30 layers.

(a)

(c)

(b)

(e)

(d)

Figure 4.15. Fluorescence microscope images of L-929 fibroblast cells growing on a
(a) CSG film and (b) tissue culture plastic stained with a live/dead stain. Microscope
images in (c), (d) and (e) show fibroblast migration under a barrier over 24 hours on
(c) tissue culture plastic, (d) a chitosan film and (e) CSG film and the scale bars
represent 100 µm.
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Figure 4.16. Z-projected confocal microscope images of L-929 fibroblast cells
growing on several layers of an extrusion-printed CSG-05 scaffold.

4.3. Preparation of Graphene/Chitosan Composites using Covalent Attachment
4.3.1. Discussion of Composite Preparation
As was shown in the previous chapter, covalent linkages between the polymer chains
and the filler have the potential to improve the properties of the resultant composite.
Covalently linked graphene/PCl composites exhibited good mechanical properties
while retaining their processability and biocompatibility. The feasibility of
developing covalently linked graphene/chitosan composites was investigated in this
section. Chitosan composites prepared by lactic acid (CSG) showed good
processability, biocompatibility, conductivity and mechanical properties, so the same
sample preparation method was adopted for the preparation of covalently linked
chitosan graphene composites (cCSG) with the addition of coupling agents.
The presence of carboxyl groups in graphene and amine groups in chitosan provides
the opportunity for covalently linking these components using an appropriate
coupling agent; 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide (EDC) and Nhydroxysuccinimide (NHS) were used as crosslinking agents. The first series of

196

composites were developed using only EDC as coupling agent and that resulted in
composites with average, inconsistent mechanical properties and conductivity.
Therefore, NHS was also involved into the reaction as EDC and NHS usually act as
catalysts together in crosslinking reaction to form covalent links between –COOH
and −NH2 groups64 as shown in the following equation:

where R represents CCG or lactic acid and R’ represents the chitosan backbone.
To prepare the composites as shown in Figure 4.17, chitosan was dissolved in an
appropriate amount of 0.5mg ml-1 dispersion of aqueous CCG by slow addition of
lactic acid under stirring until a homogeneous dispersion was obtained. NHS was
added and allowed to stir for 30 minutes. Then, EDC was added and stirred
overnight. The mixture was cast into petri dishes and dried at 50 oC to form solid
films.

Figure 4.17. Preparation of graphene/chitosan composites through covalent
attachment method.
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The covalently linked graphene chitosan composites were labelled as cCSG-0,
cCSG-0.1, cCSG-0.5, cCSG-1.5 and cCSG-3, according to the weight percentage of
the graphene content per chitosan, with cCSG-0 containing no graphene and cCSG-3
containing 3 wt.%.
4.3.2. Characterization
4.3.2.1. Fourier Transform Infrared Spectroscopy
In order to confirm the presence of covalent linkages, the FTIR spectra of the
composites were obtained. FTIR spectroscopy has the potential to identify the new
amide linkages formed between the lactic acid, graphene and the chitosan
(Figure 4.17).
Figure 4.18 represents the FTIR spectra of chitosan and cCSG composites with 0, 0.5
and 3 wt.% graphene content. The FTIR test was carried out on 1 × 1 cm films using
ATR attachment as described previously in Section 4.2.2.5.
FTIR spectrum of chitosan shows the chitosan characteristic peaks as discussed in
Section 4.2.2.5. FTIR spectra of cCSG samples are different from what was observed
in CSG samples (Figure 4.8). A new peak has appeared at 1630 cm−1 that can be
attributed to the amide groups formed after formation of covalent linkages between
amine groups of chitosan and carboxyl groups of lactic acid and graphene. Another
new peak can be observed in cCSG samples at 1531 cm−1 that can be corresponded to
the amide groups formed due to covalent linkages between chitosan and lactic acid.
The intensity of the peak decreases by increasing the CCG content, which can be due
to a decrease in the number of covalent attachments between lactic acid and chitosan
because of attachment of CCG to the polymer backbone. A decrease in the intensity
of NH2 absorbance peak can be observed in cCSG samples that may also be due to
covalent attachment between some NH2 groups on the chitosan chains and COOH
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groups of graphene and lactic acid that resulted in formation of NHCO groups65. The
peak at 1709 cm−1 is belonging to the COOH groups from lactic acid and CCG. Due
to presence of amide groups in the chitosan and the likelihood of overlapping of the
new amide peaks after covalent attachment, it is hard rely on the FTIR results as a
conclusive proof of covalent attachment between chitosan and CCG.

Figure 4.18. FTIR spectra of chitosan and cCSG samples with 0, 0.5and 3 wt.% CCG
content.
4.3.2.2. Thermogravimetric Analysis
TGA was used to study the effect of the covalent attachment of the graphene on
thermal behavior and stability of the synthesized samples. TGA was performed on 10
mg of samples with a heating rate of 5 oC min-1 under a nitrogen atmosphere. Figure
4.19 compares the thermal properties of chitosan, lactic acid, and the covalently
linked chitosan composites with 0, 0.5 and 3 wt.% graphene contents.
Similar to what was observed in CSG composites in section 4.2.2.1, cCSG samples
show three weight loss regions. A slow weight loss between 90 to 250 oC that is
attributed to water and lactic acid loss, a major loss at 250 to 340 oC due to chitosan
decomposition and a slow weight loss from 340 to 900 oC that is attributed to partial
graphene decomposition. The covalent attachment of graphene appears to have
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improved the thermal stability of the samples from around 250 oC in the cCSG-0 to
more than 270 oC in cCSG-3 composite, presumably as a result of covalent
attachments between the polymer chains and graphene sheets. The decomposition
temperature of the CSG-0 sample is around 240 oC that is increased to around 250 oC
in cCSG-0 film. The cCSG-3 also exhibits better thermal stability than the CSG-3
composite that decomposes at around 250 oC, around 20 oC lower than the cCSG-3
sample.
The graphene percentage of cCSG-3, calculated from TGA analysis, was found to be
around 3%, is consistent with the percentage of graphene added to the reaction
initially. This result indicates formation of strong attachments between polymer
chains and graphene sheets via covalent linkages. Generally, it can be said that
formation of covalent attachments has improved the thermal properties of chitosan
samples at the same CCG content.
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Figure 4.19. Thermogravimetric curves of pristine chitosan, lactic acid (LA) and
cCSG samples prepared with 0, 0.5 and 3 wt.% graphene respectively.

4.3.2.3. Scanning Electron Microscopy
Figure 4.20 shows SEM images of covalently linked chitosan films with 0. 0.5 and 3
wt.% graphene loadings. The samples were prepared for SEM following the method
explained in 4.2.2.2.
The surface roughness of the films increases by increasing the graphene contents and
cCSG composite with 3 wt.% graphene has a rougher surface compared to non
covalent chitosan/CCG composites. This surface roughness can be the effect of
covalent attachment between the polymer chains and graphene sheets. In the crosssectional images, it can be clearly seen that the addition of graphene has changed the
morphology of the samples and sample with 3 wt.% graphene is more stratified than
that of cCSG-0. Compared to CSG-3 film, cCSG-3 composite shows more stratified
and compact morphology that can be because of the formation of covalent
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attachments in the polymer matrix and disruption of the hydrogen bonds. No
aggregation can be observed on the surface and cross section of the films confirming
that graphene sheets dispersed well in the chitosan matrix and there is good adhesion
between the polymer and graphene sheets.
The fractures on the cross section images of the films are induced by SEM beam of
electrons, probably because of fragility and thinness of the sample.

(a)

(d)

(b)

(e)

(c)

(f)

Figure 4.20. SEM images of the surfaces (a-c) and cross sections (d-f) of cCSG-0
(a,d), cCSG-0.5 (b,e) and cCSG-3 (c,f) films.
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4.3.2.4. Conductivity
A comparison between electrical conductivity of cCSG and CSG samples at different
graphene concentrations is represented in Figure 4.21. Electrical conductivity of the
composite films was measured using a four-point probe resistivity measurement
system as described previously in 4.2.2.6 .
The conductivity of cCSG sample is slightly increased to 10-5 S m-1 on addition of
0.5 wt.% graphene content. The conductivity keeps increasing on addition of
graphene and reaches to around 1.4E-2 S m-1 in the cCSG composite with 3 wt.%
CCG. The conductivity of covalently linked composites was found to be around one
order of magnitude lower than that of the non-covalent ones. It is likely that CCG
sheets are fixed harder inside the polymer matrix after covalent attachment, so they
would not be able to interact with other graphene sheets that resulted in lower
conductivity compared to non-covalent samples.

Figure 4.21. Conductivity measurements of () cCSG and () CSG samples. The
conductivity of pristine chitosan is taken to be approximately 1E-850.
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4.3.2.5. Swelling Studies
The swelling properties of cCSG films with 0, 0.5, 1.5 and 3 wt.% graphene contents
are represented in Figure 4.22. The measurements and calculations were carried out
following the method explained in Section 4.2.2.7.
The swelling has an increasing rate in the first 24 hours and levels off after that.
cCSG-0 film swells more than 1000% in the first hour and more than 1220% in 48
hours. As was observed in the CSG samples, the swelling rate can be controlled by
the addition of the hydrophobic graphene. The swelling percentage of cCSG
composites was found to decrease with increasing the graphene content when cCSG
samples with 0.5, 1.5 and 3 wt.% graphene contents swell around 550, 330 and 282%
respectively, after 48 hours.
The swelling rate of the cCSG samples was found to be higher than the CSG
matrices. CSG-0 swells around 500% after 48 hours that is almost 2.5 times less than
what was achieved by cCSG-0 (1220%.) cCSG graphene composites also swell
faster than CSG graphene samples within the same period. Based on Barbucci et al.
findings, formation of several hydrogen bonds could reduce the water uptake of the
gels66. The lower swelling rate in CSG samples could be due to presence of
protonated carboxylic groups and formation of several hydrogen bonds that reduced
the water uptake of the hydrogels66. On the other hand, the formation of covalent
links and the lack of hydrogen bonds among the hydrogel components led to higher
swelling rates in cCSG samples.
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Figure 4.22. Swelling characteristics of cCSG with different graphene content in DI
water over 48 hours.

4.3.2.6. Mechanical Properties
To prepare samples for mechanical testing, the samples with 0, 0.1, 0.5, 1.5 and 3
wt.% CCG were cut into strips with a width of 3 mm and a length of 20 mm. The
tensile properties of the samples were measured at a constant rate of 5 mm min-1.
Typical stress-strain curves for cCSG films with different graphene concentrations
are represented in Figure 4.23. The tensile strength, modulus and elongation at break
as a function of CCG content are summarized in Table 4.4.
As for the CSG samples, the addition of graphene has an increasing effect on tensile
strength and Young’s modulus of the cCSG samples. Only 0.1 wt.% addition of
graphene caused a 22% improvement in tensile strength of cCSG films. With 0.5 and
1.5 wt.% incorporation of graphene, the tensile strength values reached more than 34
and 54 MPa, respectively. The tensile strength of the cCSG was further improved to
more than 61 MPa on addition of 3 wt.% graphene , corresponding to an increase of
150% compared to cCSG-0.
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Similarly, The Young’s modulus of cCSG films was also improved by the
incorporation of graphene. The Young’s modulus of cCSG-0 films was found to be
around 462 MPa that by more than 260% to around 1.7 GPa on addition of up to 3
wt.% graphene.
The elongation at break of the samples decreases with increasing the graphene
content . cCSG-0 stretched to an elongation of up to 17% that decreased gradually to
around 6% in cCSG-3. This lower break elongation could be due to higher graphene
contents as well as covalent attachment between graphene sheets and polymer chains
that confine the chains movements.
Compared to the samples prepared via the mixing method (CSG), covalent
attachment has not significantly enhanced the mechanical properties of the chitosan
samples. In some samples the mechanical properties of cCSG samples are even
slightly lower than that of CSG samples.

Figure 4.23. Stress-strain curves of cCSG samples in the dry state
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Table 4.4. Mechanical properties of cCSG samples with different graphene contents

Sample

Tensile
Strength

Elongation at
Break (%)

(MPa)

Young’s
Modulus
(MPa)

cCSG-0

24.4±1.2

17.8±0.6

462±23

cCSG-0.1

29.9±1.1

11.1±1.2

649.66±20

cCSG-0.5

34.5±1.5

8.7±0.7

690.87±24

cCSG-1.5

54.3±0.9

9.4±0.2

995.39±19

cCSG-3

61.4±1.8

5.8±0.7

1665.3±41

4.4. Conclusion
Preparation of a suitable material for biomedical applications with appropriate
processability and improved mechanical and electrical properties using a natural
polymer was the main aim of this chapter. Chitosan, a semi-crystalline natural
polymer with good biocompatibility and biodegradability, is an ideal candidate to be
used as polymer matrix. As the first step, graphene/chitosan composites with CCG
content varying from 0.1 to 3 wt.% were prepared through a facile and quick mixing
approach using lactic acid as crosslinker. A series of samples were also produced
using acetic acid as a control group. Strong hydrogen bond interactions between
chitosan, lactic acid and graphene led to increased reinforcement of the synthesized
composites. Chitosan lactic acid crosslinked composites were significantly reinforced
by addition of graphene sheets and showed increased conductivity and swelling
properties compared to the control group. The addition of 3 wt.% graphene greatly
improved the tensile strength and Young’s modulus of CSG samples by more than
135 and 217% respectively in their dried state and 60 and 65% respectively in their
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swollen state. The electrical conductivity of the chitosan could also be enhanced by
orders of magnitude from 1E-8 S m-1 in pure chitosan to 1.33E-1 S m-1 on addition of
3 wt.% graphene. Furthermore, CSG composites showed conductivity consistently
one order of magnitude higher than those made with acetic acid that can be attributed
to better dispersion of graphene nanosheets inside the polymer matrix and formation
of greater number of hydrogen bonds.
CSG film with no CCG swelled relatively fast in water when it swelled up to 400%
in the first 10 min and up to 500% within 6 hours. The swelling rate of the samples
can be controlled by addition of graphene as swelling rate decreases with increasing
the graphene content.
These CSG composites were shown to be suitable candidates for developing
structures for tissue engineering. The feasibility of developing scaffolds was
investigated through printing the material into 3D structures using extrusion printing.
The composites could successfully be printed into multilayer 3D scaffolds and fibres
of different diameters demonstrating the processability of the composites. The
biocompatibility of the composites was confirmed through culturing cells on CSG
films and scaffolds. The composites showed excellent biocompatibility with
fibroblast cells exhibiting good proliferation, adherence and viability on the
graphene/polymer surfaces.
Following the improvements achieved in the properties of PCl after covalent
attachment with graphene (Chapter 3), preparation of covalently linked
graphene/chitosan was also investigated. However, the covalent attachment did not
lead to significant improvement in the properties of the chitosan samples, so the
biocompatibility and processability of the composites were not further pursued. More
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optimization needs to be done on the preparation method to improve the properties of
the covalently linked graphene/chitosan composites.
Table 4.5 is a comparison between the chitosan samples prepared in this work with
those reported in the literature. The chitosan samples reported in the literature exhibit
no conductivity as GO, an insulating material, has been used as filler. There are also
no reports on the processability of such composites into, for example, 3D scaffolds.
Although the GO/chitosan composites typically show better mechanical properties
than those developed here using CCG, a valid comparison of the the data in Table 4.5
is difficult as a different filler and crosslinker as well as polymers with different
molecular weights are used in each study. However, considering the percentage of
improvement relative to the relevant pristine polymer, the CSG composites prepared
in this work are superior to the GO composites reported in the literature.
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Table 4.5. The mechanical properties and electrical conductivity of the chitosan
composites with GO and CCG as filler.
Mechanical properties
Polymer
molecular
weight

Filler
(content)

Composite
type

(improvement relative to the

Conductivity
(improvement

pristine polymer)

relative to the

Tensile

Young’s

Elongation

strength

modulus

at break

Reference

neat polymer)

Graphene
sheets

No tensile test is reported, the

(directNA

current

Film

arc-

mechanical properties were
measured through nanoindentation

NA

Fan et
al.40

method

discharge
method)
Mv:
600,000

GO (1%)

Film

(g/mol)

89.2

2.17

MPa

GPa

(122%)

(64%)

55%

NA

Yang et
al.41

Dry
state:

Mw:
8000–

GO (18%)

Film

20000

137.5

Dry state:

MPa

3.5%

(35%)

NA

NA

Wet

Wet state:

state:

5.5%

Han et
al.18

44 MPa
(200%)
Mw:
355000

 120
GO (5%)

Film

MPa

NA

NA

NA

Shao et
al.42

(174%)
Dry
state:
68 MPa
Medium(
Mw 

Mix CCG
(3%)

(217%)
Film
Wet

24000)

state:
372 kPa

Dry state:
1.35 GPa
(135%)
Wet state:
520 kPa
(60%)

Dry state:
5.6%

Wet state:

1.33E-2 S m-1
(7 orders of
magnitude)

This
thesis

52%

(62%)
1.4E-2 S m-1
Medium

Covalent

(Mw 

CCG

24000)

(3%)

Film

61 MPa

1.7 GPa

(150%)

(260%)

NA: Not available
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5.8%

(7 orders of
magnitude)

This
thesis

In this work, biocompatible composites with controllable swelling rates were
successfully developed using graphene, lactic acid and a natural polymer, chitosan.
Addition of graphene improved the mechanical and electrical properties of the
natural polymer while retaining its inherent biocompatibility and processability. The
graphene/chitosan composites developed in this work appeared to have excellent
potential for use in biomedical applications and particularly in tissue engineering
fields.
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5. Preparation and Characterization of Methacrylated
Chitosan Composites with Graphene and Graphene
Oxide
5.1. Introduction
Natural polymers have always been an attractive choice for preparation of materials
for

biomedical

applications

due

to

their

apparent

biocompatibility

and

biodegradability. Chitosan is a naturally occurring polymer with a structure similar to
the polysaccharides of the human body1. The excellent bicompability, processablity
and swelling properties of chitosan make it a favorable candidate for developing
hydrogels for biomedical applications2-4.
To form hydrogel matrices, polymer chains in chitosan must be crosslinked, either
non-covalently or covalently. Covalent links in chitosan chains are usually formed
using crosslinking agents or photo-sensitive functional groups2, 3. Non-covalently and
chemically crosslinked chitosans possess some disadvantages that restrict their
application in certain biomedical fields. Crosslinking agents are usually cytotoxic
and need to be used in combination with different reactive species, initiators, or
catalysts3, 5. Moreover, the polymers crosslinked through non-covalent bonds or
crosslinking agents are rigid to begin with, meaning they cannot be used for many in
vivo applications, such as filling complex 3D voids created due to injury. However,
photocrosslinking using photo-sensitive functional groups as a route to chitosan
hydrogels does not suffer from the disadvantages described above, and has attracted
most interest due to its lower cost, higher production speed, better safety and ease of
formation3.
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It was shown in the previous chapter that the preparation of chitosan biocomposites
using graphene and lactic acid resulted in considerable improvement in mechanical
properties and conductivity of the polymer while retaining its biocompatibility and
processability. However, the composite preparation process had to be followed by
several washing steps to remove all lactic acid residues, as cells do not proliferate
well in acidic condition. In this chapter, the feasibility of developing chitosan
composites will be investigated through developing photocrosslinkable chitosan.
Functionalizing the polymer chains is the first step in the preparation of
photocrosslinkable chitosan. The most commonly used moieties for modifying
polysaccharides and making them photocrosslinkable are acrylates, and among them
methacrylates are the material of choice due to their better biocompatibility.
Furthermore, it has been shown that the methacrylated polymers exhibit higher
photocuring rate and better mechanical properties compared to the polymers
functionalized with other acrylates6.
There are also some reports on developing acrylated polysaccharides using other
chemicals such as acryloyl chloride and N-methylolacrylamide (NMA); however,
both of them are rarely used in biomedical applications because of their high
toxicity6. Therefore, methacrylate remains the best choice for modifying
polysaccharides for biomedical applications.
After coupling of a photo-sensitive functional group to the polymer backbone, the
functionalized polymer will be exposed to UV light for crosslinking of the polymer
matrix in the presence of a photoinitiator. UV-crosslinking of the polymer takes
place through free radical chain polymerization; therefore it is necessary to use a
photoinitiator to initially generate free radicals upon exposure to UV light7. Irgacure
2959 (2-hidroxy-1-[4-(2-hidroxyethoxy)phenyl]-2-methyl-1-propanone) is the most
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commonly used photoinitiator in development of UV-crosslinkable biomaterials8-11.
Upon exposure to UV, Irgacure 2959 generates benzoyl and alkyl radicals that are
reactive enough to initiate the polymerization9.
The biocompatibility of the photoinitiator is an important issue since the material is
supposed to be used in biomedical applications. Williams et al.12 studied the
biocompatibility of different photoinitiators including Irgacure 2959. The results of
the research showed that Irgacure 2959 is well tolerated by a wide range of cell
types.
There have been several studies on the preparation of photocrosslinkable natural
polymers via methacrylation. Chitosan13-16, alginate17, and gelatin8 are the favored
polymers in this regard due to their excellent biocompatibility and processability.
However, little work has been reported on the preparation of UV-curable
biocomposites using natural polymers and carbonaceous materials to date. Although
there is some work on the preparation of UV-crosslinkable gelatin composites using
graphene oxide18, 19 and carbon nanotubes20, to the best of our knowledge, this study
is the first to develop photocrosslinkable chitosan composites using graphene oxide
(GO) and chemically converted graphene (CCG).
While CCG is the filler of choice, it seemed appropriate to investigate the
development of GO/ChiMA composites given the lack of previous work. GO
dispersion is always a useful alternative due to its high stability and homogeneity21,
as well as its excellent reinforcing properties despite its lack of conductivity.
Furthermore, it has been shown that GO has an improving effect on the cell growth22.
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5.2. Preparation of Graphene Oxide/ Methacrylated Chitosan Composites
5.2.1. Discussion of Composite Preparation
The synthesis of methacrylated chitosan was the first step taken in this work to
develop UV-crosslinkable GO composites. The method of synthesis was developed
and optimized by Dr. Sanjeev Gambhir (in the IPRI, UOW laboratories) based on
similar procedures reported in the literature for the preparation of methacrylated
gelatin and chitosan8,

14

. Methacrylation of chitosan was carried out by dissolving

chitosan in acid at 60oC under stirring. After the addition of methacrylate anhydride,
the mixture was stirred at 68oC overnight. Then, the pH of the mixture was adjusted
to 7 using ammonia and the mixture dialyzed in deionized (DI) water for 4 days. The
solution was freeze dried to give solid methacrylated chitosan (ChiMA), a white
spongy material that is water soluble. The degree of methacrylation of chitosan, that
was found to be around 70%, was determined and calculated using 1H NMR
spectroscopy by Dr. Gambhir. The properties of the ChiMA was investigated along
with the composites developed using GO and CCG.
The schematic of the methacrylation of chitosan is illustrated in Figure 5.1.
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Figure 5.1. Schematic of the methacrylation of chitosan and development of ChiMA.

GO was synthesized by modified Hummers method24 and was dispersed in water via
stirring and sonication to prepare a GO dispersion with the desired GO content.
Owing to their high hydrophilicity, GO nanosheets disperse and exfoliate easily and
homogenously in water and many other polar solvents21, 23.
To prepare the ChiMA composites with different GO content, required amount of
ChiMA was dissolved in deionized (DI) water or the GO dispersion followed by
addition of the photoinitiator (Irgacure 2959; CIBA chemical). After stirring and
mild sonication, the solution was cast into a petri dish and was dried at room
temperature overnight in the dark to avoid any crosslinking. The dried film was then
exposed to UV light for 10 min for UV-crosslinking. ChiMA samples were labeled
as ChiMA 0.1GO, ChiMA 0.5GO, ChiMA 1.5GO and ChiMA 3GO, according to the
weight percentage of the GO content per ChiMA weight, with ChiMA 3GO
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containing 3 wt.% GO. The schematic of the development of ChiMA composite with
GO is represented in Figure 5.2 and all the prepared samples are listed in Table 5.1.
Table 5.1. GO/ChiMA samples prepared with different GO contents.
Graphene contents

Sample label

(wt.%)
0

ChiMA

0.1

ChiMA 0.1GO

0.5

ChiMA 0.5GO

1.5

ChiMA 1.5GO

3

ChiMA 3GO

Figure 5.2. Schematic of the preparation of a GO/ChiMA Composite.

Preliminary tests showed that addition of photoinitiator to the GO dispersion results
in partial agglomeration of the dispersion. Therefore, the polymer was first dissolved
well in the GO dispersion under stirring and mild sonication followed by slow
addition of the photoinitiator that did not lead to GO agglomeration. The exposure
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time to the UV light is also a crucial parameter. Considering that the polymer
becomes insoluble in water after crosslinking, the water solubility of the UVirradiated samples was used as a measure to find the appropriate UV exposure time
for crosslinking.
Pristine ChiMA films with a thickness around 200 microns were exposed to UV
irradiation for 1, 2, 3, 5 and 10 min on both sides, transferred into water which was
stirred for a week. The samples UV irradiated for 1-3 min were partially dissolved in
water after a few days, indicating that this exposure time is not enough to fully
crosslink the samples. Five minute UV irradiation was found to be the optimum
crosslinking time as the UV treated samples were resistant to water for several days.
However, considering that the presence of GO sheets decrease the effectiveness of
the UV generation of free radicals18, a 10 min UV irradiation was chosen as the
optimum exposure time for the preparation of the ChiMA samples. The GO/ChiMA
samples with GO (3 wt.%) was irradiated for 10 min and found to still be insoluble in
water after a week. Indeed, the sample was left in water for several weeks and did
not dissolve.
5.2.2. Characterization
5.2.2.1. Thermogravimetric Analysis
Thermogravimetric analysis (TGA) of ChiMA, ChiMA film after UV irradiation, and
GO/ChiMA composites with 0.5, 1.5 and 3 wt.% GO content are shown in Figure
5.3.
The TGA curves indicate that all samples show a similar decomposition temperature
that is between 210-216 oC. There is around 10% weight loss at up to 90 oC for
pristine ChiMA that can be contributed to the loss of water contained in the ChiMA
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because of its hygroscopic nature. The major loss of mass of ChiMA occurs at
approximately 215 oC.
Crosslinked ChiMA shows two main weight loss regions, the first one up to 150 oC,
and the second one is at around 215 oC that is to the degradation of the polymer.
However, the final residual weight percent of the crosslinked ChiMA is around 10%
higher than that of non-crosslinked ChiMA, presumably as a result of a reduction in
the loss of the amido functionalities that have stabilized through crosslinking.
Addition of GO has not significantly changed the decomposition temperature of the
polymer. However; considering 10% weight loss as the point of comparison, the
thermal decomposition temperature (T 0.1) for the crosslinked ChiMA samples is
increased from 104 oC in ChiMA to around 215 oC for GO/ChiMA composite with 3
wt.% GO. This temperature increase can be due to the moisture trapped inside the
crosslinked structure of ChiMA. As evidenced by the scanning electron microscopy
(SEM), the inner structure of the ChiMA samples become condensed after
crosslinking and on increasing the GO content, therefore the water could get trapped
inside the crosslinked structure not being able to get released easily. Furthermore,
increasing the GO content makes the sample less hygroscopic and more resistant to
thermal decomposition.
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Figure 5.3. TGA curves of ChiMA, ChiMA film after UV irradiation and ChiMA
composites with 0.5, 1.5 and 3 wt.% GO content.

5.2.2.2. Scanning Electron Microscopy
SEM images from the surface and the cross section of freeze dried ChiMA, ChiMA
film before and after UV irradiation and GO/ChiMA composites with 1.5 and 3 wt.%
GO content are shown in Figure 5.4. To prepare samples for cross-sectional images,
samples were frozen in liquid nitrogen and were fractured before coating.
Figure 5.4a shows the highly porous freeze dried ChiMA sample. This porous
sponge-like structure exhibits a wide pore size distribution with spherical pores. The
surface (Figure 5.4 b,c) and cross-sectional images (Figure 5.4 f,g) of ChiMA films
look very similar before and after UV crosslinking; however, the cross-sectional
images of the crosslinked ChiMA seems more dense, presumably as a result of the
formation of the stable network after UV irradiation.
The addition of GO causes no obvious changes to the film surfaces (Figure 5.4 d,e),
indicating homogenous dispersion of GO sheets in the ChiMA matrix without
observable aggregation. Comparing the cross-sectional images of the samples
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(Figure 5.4 h,i), the inner structure of the composites are similar to but possibly more
stratified and condensed than that of ChiMA, comparable to what was observed in
chitosan samples from the previous chapter.
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Figure 5.4. SEM images of surface (a-e) and cross section (f-i) of ChiMA freeze
dried structure (a), ChiMA before UV crosslinking (b,f), ChiMA after UV
crosslinking (c,g), ChiMA 1.5GO (d,h) and ChiMA 3GO (e,i) films. The scale bar
represents 1 µm.
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5.2.2.3. X-ray Diffraction
Figure 5.5 shows the X-ray diffraction (XRD) patterns of chitosan and ChiMA films
before and after UV crosslinking. To prepare the ChiMA samples, 500 µl of the
ChiMA dispersion was deposited on a quartz substrate followed by evaporation of
water at room temperature.
Pure chitosan shows two major crystalline peaks at 2θ = 10.7°and 2θ = 21.2°

25, 26

.

Methacrylation of chitosan resulted in down shift of the peaks. The increase in the
effective d-spacing from 8.26 Å in chitosan to 10.04 Å for ChiMA is undoubtedly
due to the attachment of the methacrylate group to the polymer chains that leads to a
decrease in the crystallinity of the chitosan. Furthermore, there is a reduction in
diffraction intensity at 2θ = 10.7° as well as a broadening of the peak at 2θ = 20.1°
after methacrylation and UV irradiation, indicating that the addition of MA
suppressed the crystallization of the chitosan to some extent as observed for the
reacetylation of pure chitosan by Ogawa et al27.

Figure 5.5. XRD spectra of chitosan and ChiMA films before and after UV
irradiation.
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Figure 5.6 Shows the XRD patterns for GO, ChiMA film (after UV crosslinking) and
ChiMA composites with 1.5 and 3 wt.% GO. The GO shows a significant (002) peak
at around 10.6 ° and a d-spacing of 8.37 Å. This large interlayer distance of the GO
is due to the presence of hydroxyl, epoxy, and carboxyl groups. The diffraction peaks
of GO disappeared in the XRD patterns of the composites, indicating the exfoliation
and dispersion of GO nanosheets inside the polymer matrix. The diffraction angles of
the composites are similar to the pure ChiMA, indicating that addition of GO has
barely changed the chemical structure of the ChiMA. In composites with higher GO
contents, a slight decrease can be observed in the intensity of the crystalline peak at
2θ = 8.8°, due to the decrease in the crystalline degree of the ChiMA with increasing
filler content.

Figure 5.6. XRD spectra of ChiMA, GO, and ChiMA composites with 1.5 and 3
wt.% GO.
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5.2.2.4. Raman Spectra
The Raman spectra of chitosan, ChiMA and ChiMA film after crosslinking are
shown in Figure 5.7. Raman spectra were collected on 10 mg chitosan powder and
ChiMA as well as on ChiMA film after UV irradiation.
As discussed in Chapter 4 Section 4.2.2.4, in chitosan, the peak at 898 cm-1 is
attributed to NH2 wagging. The multiple peaks around 1099 cm-1 can be attributed to
ether bonds, and the stretching of glycosidic bonds and the band at 1377 cm-1 is
associated with methyl group bends29. In the spectrum of the pristine ChiMA, the
appearance of the peak at 1650 may be attributed to formation of amide I after
methacrylation, in agreement with FTIR results (vide infra). As assigned by Zajac et
al.30, the peak at 1600 cm-1 is due to the residual NH2 (Amide II) in both ChiMA and
chitosan. Since the intensity of Raman bands can be affected by intermolecular
effects31, the intensity of the amide peaks increases after crosslinking, reflecting the
structural differences as a result of the crosslinking.
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Figure 5.7. Raman Spectra of chitosan and ChiMA samples before and after UV
irradiation.

Figure 5.8 shows the Raman spectra of ChiMA 0.5GO and ChiMA 3GO composites
compared to Raman spectra of GO. Raman spectra were collected on GO flakes and
GO/ChiMA films.
The Raman spectra of GO displays a D band at 1347 cm-1 and a G band at 1609 cm-1
(the details on Raman spectrum of GO is discussed in Chapter 3, Section 3.2.2.5.).
The largest peaks due to ChiMA films (1099 cm-1 and 1377 cm-1, Figure 5.7) are
hardly visible in the composites as the intensity of the GO peaks are substantially
higher. Compared to the Raman spectrum of GO, the D and G bands of the
GO/ChiMA composites are shifted toward lower wavelength, close to that of CCG
(see Chapter 3, Figure 3.6), after crosslinking, which may be because of some
reduction of GO during the UV irradiation.
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Figure 5.8. Raman spectra of GO and ChiMA composites with 0.5 and 3 wt.% GO.

5.2.2.5. Fourier Transform Infrared Spectroscopy
The Fourier transform infrared (FTIR) spectra of chitosan, ChiMA, ChiMA film after
UV, GO and GO/ChiMA composites with 1.5 and 3 wt.% GO are shown in Figure
5.9.
The FTIR spectrum of chitosan is discussed in Chapter 4, Section 4.2.2.5. The peaks
at around 1573 cm-1 and 3400 cm-1 are attributed to N–H bending of amine and the
N–H stretching vibration of the NH2 groups respectively. The signal at 1658 cm-1 is
assigned to the C=O stretching of the –NHCO- group. The absorption peaks from
1037 to 1153 cm-1 represent primary and secondary alcohol groups as well as the
primary amine in chitosan. In the pristine ChiMA, a new peak at 1642 cm-1 may be a
result of the C=O stretch of the amide formed after methacrylating chitosan, with the
original amide C=O barely shifted from 1658 to 1656 cm-1. However, alkenyl
stretches also occur in this region making definite assignment difficult.
Given to the presence of the two types of amide in ChiMA, it is reasonable to assume
that peaks at 1550 cm-1 and 1582 cm-1 may be attributed to the NH bands of the two
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amide groups. There are also three sharp peaks between 2958 to 2962 cm-1 that may
correspond to an increased number of methyl groups attached to the chitosan after
methacrylation.
After crosslinking the ChiMA with UV, the alkenyl C=C stretch band should
disappear and indeed the band at 1642 cm-1 does so suggesting that it should be
assigned to the C=C stretch. This appears to be the cause for the band at 1642 cm-1 in
pristine ChiMA. However, both bands at 1550 and 1582 cm-1 also disappear,
replaced by a band at 1560 cm-1. This is likely due to the increased rigidity of the
amide group in the cross-linker of the crosslinked ChiMA leading to a change in the
N-H and C-N contributions to this amide II band32. On adding the GO, the methyl
peaks as well as the primary amine peaks at 3464 cm-1 become broader and shorter
that can be attributed to their interactions with functional groups of the GO. The two
amide bands at 1560 cm-1 and 1656 cm-1 found in the crosslinked ChiMA are still
prominent in the GO/ChiMA composites.
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Figure 5.9. FTIR spectra of chitosan, ChiMA samples, GO and ChiMA composites
with 1.5 and 3 wt.% GO content.

5.2.2.6. Swelling Studies
The swelling characteristics of the ChiMA samples were determined by swelling the
samples of ChiMA or ChiMA composites in DI water at room temperature with the
swelling %, Esr, calculated using the following equation
Esr = [(Ws - Wd)/ Wd] × 100
where Esr is the percent swelling of the sample (%), Ws denotes the weight of the
sample in swollen state and Wd is the initial weight of the sample. The results are
presented in Figure 5.10.
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ChiMA sample swells more than 260% in 48 hrs. The swelling rate of ChiMA is
relatively fast in the first 10 min when the film swells more than 245%. After 10 min,
the swelling rate keeps increasing slowly until it levels off after 1 hour.
Addition of GO decreases the swelling rate of ChiMA, presumably due to the
decrease in the number of available amino and hydroxyl groups of the polymer and
the reinforcing effect of GO. GO forms hydrogen bonds with hydrophilic groups of
ChiMA that makes the polymer matrix compact with less space for water uptake,
resulting in a decrease in the swellability of the composites33. This reduced ability for
take up water with increasing GO content is likely due to the more compact structure
of GO composites as evident in their SEMs (Figure 5.4)

33

. The maximum swelling

percentage of GO composites with 0.5, 1.5 and 3% GO was found to be around 150,
116 and 107% respectively.

Figure 5.10. Swelling characteristics of ChiMA, and ChiMA composites with 0.5,
1.5 and 3 wt.% GO in deionised water over 48 hours.
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5.2.2.7. Mechanical Properties
The mechanical properties of both dry and swollen ChiMA and ChiMA composites
were investigated and typical stress-strain curves for ChiMA films with different GO
contents are shown in Figure 5.11 and Figure 5.12. The detailed data of the
mechanical properties is listed in Table 5.2 and Table 5.3. To prepare samples for
mechanical property tests, the samples were cut into strips with a width of 3 mm and
a length of 20 mm. The tensile properties of the samples were measured at a constant
rate of 5 mm min-1.
Figure 5.11 and Table 5.2 provide the mechanical properties of the samples in the
dry state and show that the addition of GO has significantly improved the mechanical
properties of ChiMA. The increasing tensile strength and Young’s modulus with
increasing GO content indicate homogenous dispersion of GO sheets in the
composite matrix as well as strong interaction between GO and the polymer chains.
The tensile strength of the ChiMA film was found to be around 49 MPa that
increased by increasing the GO to around 75 MPa in the composite with 3wt.% GO.
An improvement in Young’s modulus of the samples was also observed. The
Young’s modulus increased from 1.8 GPa in ChiMA film to 3.2 GPa in ChiMA
3GO. The addition of GO has not significantly decreased the elongation at break of
the samples, indicating highly homogenous dispersion of GO nanosheets inside the
polymer matrix.
The mechanical properties of these crosslinked samples are also better than what was
achieved from CSG samples in the previous chapter. The tensile strength and
Young’s modulus of the crosslinked ChiMA are respectively, around 130% and
216% higher than that of CSG-0 sample. The tensile strength and Young’s modulus
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of the ChiMA 3GO composite was found to be 75 MPa and 3.2 GPa respectively,
compared to 68 MPa and 1.4 GPa in CSG sample with 3% CCG.

Figure 5.11. Stress-strain curves of ChiMA samples with different GO contents
in the dry state.

Table 5.2. Mechanical properties of ChiMA samples with different GO contents in
the dry state.
Sample
Tensile Strength
Elongation at Break Young’s Modulus
(MPa)

(%)

(GPa)

ChiMA

47.8 1.6

3.7 0.4

1.80.1

ChiMA 0.1GO

50.6  1.2

3.20.2

2.50.1

ChiMA 0.5GO

57.3 2.1

3.10.3

2.80.2

ChiMA 1.5GO

61.2 2.8

3.60.2

2.90.2

ChiMA 3GO

75.5 2.2

4.20.4

3.30.1

Figure 5.12 and Table 5.3 show the mechanical properties of the ChiMA samples in
their wet state. Similar to their dry state, the tensile strength and Young’s modulus of
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the composites are both enhanced as the GO content increases. The tensile strength
of the ChiMA is around 684 kPa and this can be improved by more than 89% to
around 1.3 MPa on addition of 3 wt.% GO. The Young’s modulus of ChiMA also
continued to improve with an increasing wt.% of GO.

Figure 5.12. Stress-strain curves of ChiMA samples with different GO contents in
the wet state.
Table 5.3. Mechanical properties of ChiMA samples with different GO contents in
the wet state.
Tensile Strength

Elongation at

Young’s Modulus

(kPa)

Break (%)

(MPa)

ChiMA

683.5 27.5

21.2 1.7

3.20.1

ChiMA 0.1GO

791.1  38.2

15.71.7

5.70.1

ChiMA 0.5GO

844.3 52.7

14.82.1

5.70.2

ChiMA 1.5GO

958.3 32.6

14.71.2

7.30.2

ChiMA 3GO

1295.623.1

15.50.8

9.20.3

Sample
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5.2.2.8. Scaffold Printing and Multi layer Construct
To study the processability of the developed ChiMA composites, the feasibility of
developing multilayer scaffolds and cylindrical constructs was investigated.
The GO/ChiMA composite with 3 wt.% GO was successfully printed into 10 × 10
mm 3D scaffolds with 10 to 30 layers and pore sizes of around 500 µm by Dr.
Johnson Chung in our laboratory.
To fabricate the scaffolds, an aqueous dispersion of GO/ChiMA composite was
printed using a CNC milling machine onto a glass slide positioned in a precipitating
bath of isopropyl alcohol. The dimensions and number of layers can be varied based
on the application. The printed scaffolds then were exposed to UV irradiation for 10
min to crosslink the sample. The scaffolds were then washed in several steps with
ethanol/phosphate buffered saline (PBS) solutions until they were in PBS alone. The
printed scaffolds retain their structure for a long time in PBS, indicating the
successful crosslinking of the samples. Figure 5.13 illustrates printed scaffolds after
printing in isopropyl alcohol (a,b) and after 10 days in PBS (c).
(a)

(c)

(b)

Figure 5.13. ChiMA 3GO scaffolds fabricated by extrusion printing (a, b) after
printing in isopropyl alcohol and (c) after 10 days in PBS.
ChiMA solutions were also developed in the form of cylindrical hydrogel disks that
are suitable constructs for compression tests (Figure 5.14). A aqueous ChiMA
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solution with 6 wt.% ChiMA as well as a GO/ChiMA composite solution with 3
wt.% GO were used for fabrication of this structure
To prepare the first layer of hydrogel, 500 μL of the solution was placed into a
cylindrical mould and exposed to UV light for 10 min. The second layer of hydrogel
was directly fabricated on top of the first hydrogel layer. This procedure was
repeated until a multi-layer hydrogel construct of 1 cm thickness was fabricated.

Figure 5.14. Multilayer ChiMA and GO/ChiMA constructs.

5.2.2.9. Biocompatibility
The biocompatibility of ChiMA samples was also investigated by Dr. Johnson
Chung in our laboratory through cell growth inhibition, viability and cell culture tests
using L929 murine fibroblasts (Figure 5.15 and Figure 5.16). The cell growth
inhibition test determines the effects of material extracts on the growth of
mammalian cells. Figure 5.15a shows the cell ratio in media containing ChiMA and
ChiMA 3GO compared to null (the cell culture media) and latex (as negative
control). It is evident that the cell ratio in ChiMA and GO/ChiMA composite is very
similar to that of the control. Figure 5.15b shows the percentage of cell viability. The
percentage of alive cells in media containing ChiMA and ChiMA 3GO samples is
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very close to the control, indicating that the leaching materials are not toxic. The
results confirm the lack of toxicity and good biocompatibility of the ChiMA and
GO/ChiMA composites.

ChiMA

ChiMA

Figure 5.15. Biocompatibility measurement of ChiMA and ChiMA 3GO samples via
(a) cell growth inhibition and (b) viability tests using L929 murine fibroblasts.
Figure 5.16 shows the cell culture results obtained from seeding fibroblast (L-929)
cells on ChiMA (a) and ChiMA 3GO (b) films. In ChiMA film, cells are not adhered
to the film surface properly and an agglomeration of cells is observed on the surface
of the film. The presence of dead cells (red points) around the cell agglomeration
areas are due to poor adhesion of the cells to the surface resulting in their death.
However, the number of live cells (green points) is considerably higher than that of
dead ones, indicating the biocompatibility of the material. Cells show considerably
better adhesion and proliferation on the surface of ChiMA 3GO film, indicating that
the addition of GO has improved the proliferation and adhesion of cells. Poor
adhesion of cells to the ChiMA surface might be due to the lack of optimization in
the cell culture procedure due to time constraints. Optimising the test conditions
would likely improve the cell adhesion and proliferation.
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(b)

(a)

Figure 5.16. Microscope images of L-929 fibroblast cells growing on a (a) ChiMA
film and (b) ChiMA 3GO with a live/dead stain.

GO/ChiMA composites prepared in this section showed enhanced mechanical and
thermal properties while retaining the inherent processability of the polymer. It was
shown that the synthesized composites are biocompatible and can be processed into
3D scaffolds. However, GO is electrically insulating, so it is not a good candidate for
the development of conducting biocomposites. Conductivity can be an added
advantage for biocomposites based on the recent finding that the electrical
stimulation

of

electro-responsive

cells

can

enhance

their

growth

and

differentiation34-36

5.3. Preparation of Graphene/Methacrylated Chitosan Composites
5.3.1. Discussion of Composite Preparation
In the previous chapter (Chapter 4) it was shown that aqueous CCG is a suitable filler
for the development of processable conducting biocomposites. Therefore, the
previously used CCG dispersion was utilized to develop conducting ChiMA
composites.
CCG/ChiMA composites were developed through the solution blending technique.
The aqueous CCG dispersion was synthesized as described in the experimental
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chapter. Compared to the synthesis of GO/ChiMA samples, the development
CCG/ChiMA composites was more challenging as the stability of the aqueous CCG
was more readily affected than the GO dispersion. Addition of a photoinitiator to the
CCG dispersion before dissolving the polymer in it resulted in agglomeration of the
CCG. Therefore, to prepare a homogeneous composite, the polymer was dissolved in
the CCG dispersion under stirring and mild sonication followed by slow addition of
the photoinitiator. It was difficult to obtain a homogenous CCG/ChiMA solution
with a CCG content higher than 3 wt.% without agglomeration. Furthermore,
incorporating more than 3 wt.% CCG into ChiMA resulted in a huge drop in polymer
film flexibility and the development of a brittle composite. As a result, 3 wt.% CCG
was chosen as the maximum CCG content for developing composites.
To prepare the samples, ChiMA was dissolved in water or the required amount of
aqueous CCG dispersion under stirring and mild sonication followed by addition of
the photoinitiator. The mixture was then cast into a petri dish to evaporate the water
overnight in the dark to obtain ChiMA films. The dried films were then exposed to
UV light for UV-crosslinking. CCG/ChiMA films were labeled as ChiMA 0.1CCG,
ChiMA 0.5CCG, ChiMA 1.5CCG and ChiMA 3CCG, according to the weight
percentage of the CCG content (Table 5.4), with ChiMA 3CCG containing 3 wt.%
GO. The crosslinking reaction is very similar to that shown in Figure 5.2 for the GO
composites.Table 5.4.
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Table 5.4. CCG/ChiMA samples prepared with different CCG contents
Graphene content (wt.%)

Sample label

0

ChiMA

0.1

ChiMA 0.1CCG

0.5

ChiMA 0.5CCG

1.5

ChiMA 1.5CCG

3

ChiMA 3CCG

To find the optimum UV irradiation time for crosslinking the CCG/ChiMA
composites, ChiMA 3CCG films were exposed to UV light for 3, 5 and 10 min. The
crosslinked samples were then transferred to 50 ml DI water and were kept under
stirring for one week. The samples with 3 and 5 min exposure time were partially
dissolved in water after one week, while the composites exposed to UV for 10 min
did not dissolve in water and retained their structure for several weeks, indicating
that a 10 min UV irradiation is sufficient to make stable crosslinked CCG/ChiMA
composites.
5.3.2. Characterization
5.3.2.1. Thermogravimetric Analysis
The TGAs of ChiMA, ChiMA film after UV irradiation, and CCG/ChiMA
composites with 0.5, 1.5 and 3 wt.% CCG content are represented in Figure 5.17.
TGAs were performed on 10 mg samples with a heating rate of 5 oC min-1 under a
nitrogen atmosphere.
The decomposition profile of CCG/ChiMA composites is very similar to the samples
prepared by GO in Section 5.2. All samples show a similar decomposition
temperature that is around 210-218 oC preceded by initial water loss. The residual
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weight percent increases with increasing CCG content as a result of the improved
thermal stability of the samples mainly due to crosslinking.
Considering 10% weight loss as the point of comparison, the thermal decomposition
temperature (T 0.1) for the crosslinked ChiMA is at 104oC, while the T 0.1 for
CCG/ChiMA composite with 3% CCG increases more than twice to 224oC,
indicating that increasing the CCG content makes the sample less hygroscopic and
more resistant to thermal decomposition similar that observed in the GO/ChiMA
samples. T 0.1 for CCG/ChiMA composites are higher than that of composites
prepared by GO. For GO/ChiMA composites, the T 0.1 temperatures are between
172 to 215 oC while this temperature range is increased to 215 to 224 oC for the
CCG/ChiMA composites. The enhanced thermal stability of the ChiMA-CCG
samples are likely due to the presence of CCG nanosheets that are deoxygenated and
graphitized and less hygroscopic compared to GO37, 38.

Figure 5.17. TGA curves of ChiMA, ChiMA film after UV irradiation and ChiMA
composites with 0.5, 1.5 and 3 wt.% CCG content.
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5.3.2.2. Scanning Electron Microscopy
Figure 5.18 shows the SEM images from surface and cross section of ChiMA film
after UV irradiation and CCG/ChiMA composites with 0.5, 1.5 and 3 wt.% CCG
content. The samples were prepared for SEM following the method explained in
Section 5.2.2.2.
The surface of the ChiMA composites is very smooth without any observable CCG
aggregation or agglomeration, indicating a homogenous dispersion of CCG
nanosheets inside the ChiMA matrix. Similar to what was observed in the cross
sectional SEM images of GO/ChiMA composites, the inner structure of the
composite films become more stratified and condensed on increasing the graphene
content as a result of the interaction between the CCG nanosheets and the ChiMA
polymer chains.
A very noticeable feature of the cross-sectional images of the composites is the
homogenous dispersion and alignment of the graphene sheets in the form of oriented
layers embedded in the matrix polymer. It is clear in Figure 5.18i that the CCG
sheets are ordered and aligned in a uniform orientation, accounting for the improved
conductivity and significant enhancement in Young’s modulus of the CCG/ChiMA
composites (viva infra).
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Figure 5.18. SEM images of surface (a-d) and cross section (e-i) of ChiMA after UV
crosslinking (a,e), ChiMA 0.5CCG (b,f), ChiMA 1.5CCG (c,g) and ChiMA 3CCG
(d,h,i) films. The scale bar in images (a) to (g) represents 1 µm.
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5.3.2.3. X-ray Diffraction
The XRD patterns of ChiMA and ChiMA composites with 1.5 and 3 wt.% CCG are
shown in Figure 5.19 . To prepare the samples for XRD analysis, the aqueous
ChiMA or CCG/ChiMA dispersion was deposited on a quartz substrate followed by
evaporation of water at room temperature.
The diffraction angles of the CCG/ChiMA composites are similar to the pure ChiMA
and GO/ChiMA composites represented in Section 5.2.2.3. No shift or any
significant change was observed in the XRD pattern of the CCG/ChiMA composites,
indicating that the addition of CCG has not changed the chemical structure of the
ChiMA. As for the GO/ChiMA composites, there is a slight decrease in the intensity
of the crystalline peak at 2θ =8.8o in composites with higher CCG contents, which is
most likely attributed to the decrease in the crystalline degree of the ChiMA due to
the higher CCG content.

Figure 5.19. XRD spectra of ChiMA, ChiMA 1.5CCG and ChiMA 3CCG.
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5.3.2.4. Raman Spectra
Raman spectra of CCG and CCG/ChiMA composites with 1.5 and 3 wt.% CCG
content shown (Figure 5.20 were obtained from CCG powder and on the films of
ChiMA composites.
The Raman spectra of CCG displays the typical D and G band at 1328 cm-1 and 1583
cm-1, respectively as described in Chapter 3, section 3.2.4. The typical D and G band
of CCG are the only visible peaks in the Raman spectra of CCG/ChiMA composites
and the intensity of the bands scale up when increasing the graphene content. This is
consistent with what was observed for CCG/PCl, CSG and GO/ChiMA composites.
There is not a significant change in the position and ID/IG ratio of the D and G bands,
indicating that the incorporation of ChiMA and the UV crosslinking of the
composites have not significantly affected the structure of the CCG sheets.

Figure 5.20. Raman Spectra of CCG and ChiMA composites with 1.5 and 3 wt.%
CCG.
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5.3.2.5. Fourier Transform Infrared Spectroscopy
FTIR spectra of chitosan, ChiMA, ChiMA film after UV, and CCG/ChiMA
composites with 1.5 and 3 wt.% GO are shown in Figure 5.21 measured over the
range 400 to 4000 cm−1.
FTIR spectra of CCG/ChiMA composites are very similar to that of the GO/ChiMA
samples discussed in detail in Section 5.2.2.5. Briefly, a new peak can be identified
at 1656 cm-1 after methacrylation that can be attributed to amide groups formed after
methacrylating chitosan. Alkenyl stretches also falls in this region making definite
assignment difficult. There sharp peaks can also be observed within 2958 to 2962
cm-1 that are attributed to increased number of methyl groups attached to the chitosan
after methacrylation.
Similar to GO/ChiMA composites, the bands at 1642, 1550 and 1582 cm-1 disappear,
replaced by a band at 1560 cm-1 after crosslinking with UV. This can be due to
formation of crosslinks via -C=CH2 groups as well as increased rigidity of the amide
group in the cross linker of the crosslinked ChiMA.
Addition of CCG did not cause any significant change in FTIR spectra of crosslinked
ChiMA film. The NH2 peaks at 3464 cm-1 are shorter and broader after addition of
CCG that can be due to interaction between CCG and NH2.

247

Figure 5.21. FTIR spectra of chitosan, ChiMA samples and composites with 1.5 and
3 wt.% CCG content.

5.3.2.6. Conductivity
The conductivity of CCG/ChiMA composites at 0.1, 0.5, 1.5 and 3 wt.% CCG
content was measured using a four-point probe resistivity measurement system (JG
293015 Jandel) and are shown in Figure 5.22. The pure ChiMA sample did not show
any measurable conductivity and there is no report on the conductivity of ChiMA in
the literature. It is believed that the conductivity of ChiMA should be close to
chitosan, that is around 1E-8 S m-1.
The conductivity of the samples increases on increasing the CCG content by around
one order of magnitude. The conductivity of the ChiMA 0.1CCG composite is ~ 2E4 S m-1 that increases to ~ 1.5E-3 S m-1 and 2E-2 S m-1 on increasing the CCG
content to 0.5 and 1.5 wt.% respectively. The highest conductivity of 2.5E-1 S m-1
was achieved in the ChiMA composite with 3 wt.% CCG. Thus, the conductivity of
248

ChiMA could be increased by around 7 orders of magnitude on addition of 3 wt.%
CCG.

Figure 5.22. Conductivity measurements of CCG/ChiMA composites at 0.1, 0.5, 1.5
and 3 wt.% CCG content.

5.3.2.7. Swelling Studies
The swelling characteristics of the ChiMA samples were determined by swelling the
samples in DI water at room temperature with the swelling %, Esr, calculated using
the equation described in Section 5.2.2.6.
Although ChiMA swells by more than 260% in 48 hrs, its swelling rate decreases on
increasing the CCG content. The decrease in the swelling rate of the ChiMA by
increasing the CCG content is clearly due to the hydrophobic nature of CCG. The
swelling percentage of CCG composites with 0.5, 1.5 and 3 wt.% CCG is around
205, 186 and 160% respectively in 48 hrs. A sharp increase in swelling percentage is
observed in the first 5 min for all composites. The swelling rate slows down after 5
min and almost reaches equilibrium in 5 hrs. The CCG/ChiMA composites show
higher swelling rates compared to the GO/ChiMA samples. This higher swelling rate
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may be due to a lower degree of crosslinking in the CCG/ChiMA composites, as a
less crosslinking will result in greater swelling 39. Less crosslinking in CCG/ChiMA
composites is expected as a result of the light absorbing and rigid CCG sheets that
exhibit a shielding effect against UV light decreasing its penetration18, 40.

Figure 5.23. Swelling characteristics of ChiMA, and ChiMA composites with 0.5,
1.5 and 3 wt.% CCG in deionised water over 48 hours.
5.3.2.8. Mechanical Properties
Figure 5.24 and Figure 5.25 show typical stress-strain curves for ChiMA films with
different CCG contents in their wet and dry state. Table 5.5 and Table 5.6 represent
the detailed data of the mechanical properties. To prepare samples for mechanical
properties tests, the samples were cut into strips with a width of 3 mm and a length of
20 mm. The tensile properties of the samples were measured at a constant rate of 5
mm min-1.
The mechanical properties of the composites in their dry state exhibit an enhancing
trend upon increasing the CCG content. The tensile strength of the ChiMA is around
48 MPa that increases to more than 75 MPa in the composite with 3 wt.% CCG,
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corresponding to more than 57% improvement in tensile strength of the polymer.
Similar to tensile strength, the Young’s modulus of the polymer also significantly
improved on addition of CCG. The Young’s modulus of ChiMA is around 1.83 GPa
that increased to more than 3.8 GPa in composite with 0.1 wt.% CCG content. It
means that addition of just 0.1% CCG improved the stiffness of the composite
remarkably by more than 110%. Higher CCG loading further enhance the Young’s
modulus of the polymer. The Young’s modulus of the ChiMA 3CCG was found to
around 4.6 GPa, corresponding to more than 140% improvement in the Young’s
modulus of the polymer. The elongation at break of the composites gradually
decreases with CCG loading that is due to the interaction between CCG and the
matrix, restricts the movement of the polymer chains.

Figure 5.24. Stress-strain curves of ChiMA samples with different CCG content in
the dry state.
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Table 5.5. Mechanical properties of ChiMA samples with different CCG contents in
the dry state.
Tensile Strength

Elongation at Break

Young’s Modulus

(MPa)

(%)

(GPa)

ChiMA

47.8 1.6

3.7 0.4

1.80.1

ChiMA-CCG 0.1

51  1.7

2.10.3

3.90.1

ChiMA-CCG 0.5

56.3 1.6

2.410.3

3.90.3

ChiMA-CCG 1.5

64.6 2.4

2.70.5

4.00.2

ChiMA-CCG 3

75.7 2.6

1.80.3

4.60.2

Sample

Figure 5.25 and Table 5.6 present the mechanical properties of ChiMA samples in
their swollen state. Similar to their dry state, mechanical properties of the samples
are enhanced on increasing the CCG content. Addition of just 0.5 wt.% CCG
improved the tensile strength and Young’s modulus of ChiMA by more than 67%
and 40%, respectively. The mechanical properties could be enhanced further on
addition of 3 wt.% CCG. The tensile strength and Young’s modulus are improved
from around 684 kPa and 3.17 MPa respectively, to around 1.5 and 6.6 MPa in
ChiMA 3CCG.
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Figure 5.25. Stress-strain curves of ChiMA samples with different CCG contents at
dry state.
Table 5.6. Mechanical properties of ChiMA samples with different CCG contents in
the wet state.
Tensile Strength

Elongation at

Young’s Modulus

(kPa)

Break (%)

(MPa)

ChiMA

683.5 28

21.2 1.7

3.20.1

ChiMA-CCG 0.1

831.218

22.10.9

3.50.1

ChiMA-CCG 0.5

1145.348

21.71.1

4.50.2

ChiMA-CCG 1.5

1312.3 36

22.12.1

4.80.1

ChiMA-CCG 3

1510.4 52

21.41.1

6.60.4

Sample

5.3.2.9. Scaffold Printing
Processing biocomposites into structures suitable for cell growth is one of the major
applications of biomaterials in tissue engineering field. Considering the remarkable
improvements achieved in the mechanical properties and conductivity of the ChiMA
on increasing the CCG content , the processability of the CCG/ChiMA composites
was investigated through printing a CCG/ChiMA dispersion into multilayer scaffolds
by Dr. Johnson Chung in our laboratory. The CCG/ChiMA composite with 3 wt.%
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CCG could successfully be printed into 10 × 10 mm 3D scaffolds with 10 to 30
layers and pore sizes of around 500 µm. To fabricate a solid 3D structure, the
aqueous composite dispersion was printed using a CNC milling machine onto a glass
slide positioned in a precipitating bath of isopropyl alcohol. The printed scaffold was
then exposed to UV irradiation for 10 min followed by washing in several steps with
ethanol/PBS solutions until they were in PBS alone. Figure 5.26 illustrates a
CCG/ChiMA scaffold with 3 wt.% CCG content after printing in isopropyl alcohol
(a) and after crosslinking and 10 days in PBS (b,c). It is evident that the scaffold
retained its structure after 10 days that indicates successful crosslinking of the
composite.

(b)

(a)

2 cm

(c)

Figure 5.26. ChiMA 3CCG scaffolds fabricated by extrusion printing (a) after
printing in isopropyl alcohol and (b,c,) after 10 days in PBS.
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5.3.2.10. Biocompatibility
Figure 5.27 shows the data from the biocompatibility experiments of CCG/ChiMA
films carried out by Dr. Johnson Chung using L929 murine fibroblasts. Figure 5.27a
indicates that the cell ratio of ChiMA 3CCG composite is very close to control (null)
and even slightly better than pure ChiMA and ChiMA 3GO that represented in
5.2.2.9. Figure 5.27b demonstrates that the cell viability percentage is very close to
the control in both ChiMA and CCG/ChiMA composite. The results indicate that
there is no toxicity in the components of the ChiMA 3CCG film and the ChiMA
samples are quite biocompatible and suitable for cell growth.

Figure 5.27. Biocompatibility measurement of ChiMA and ChiMA 3CCG samples
via (a) cell growth inhibition and (b) viability tests using L929 murine fibroblasts.

Figure 5.28 shows the cell culture results obtained from seeding fibroblast (L-929)
cells on ChiMA (a) and ChiMA 3CCG (b) films. As was mentioned in 5.2.2.9, cells
are not adhered to the surface of ChiMA film properly and agglomeration of cells is
observed on the surface of the film. This result might be improved through
optimization of the cell culture procedure. On the other hand, good adherence and
proliferation of fibroblast cells was achieved on ChiMA film with 3 wt.% CCG,
indicating the excellent effect of graphene addition on improvement of the material
surface for adhesion and proliferation of cells.

255

(a)

(b)

Figure 5.28. Microscope images of L-929 fibroblast cells growing on a (a) ChiMA
film and (b) ChiMA 3CCG with a live/dead stain.

5.4. Conclusion
Due to the wide application of UV-crosslinkable materials in the biomedical field,
this chapter was dedicated to the investigation of the development of novel UVcrosslinkable biocomposites using GO and CCG as fillers in a methacrylated
chitosan as matrix. To prepare a UV-crosslinkable matrix, methacrylate, a UVsensitive functional group, was attached to the chitosan backbone.
GO/ChiMA composites with different GO contents were developed through a
solution blending method and the composite films were exposed to UV light for
crosslinking. SEM images confirmed the homogenous dispersion of GO nanosheets
inside the polymer matrix and the presence of GO inside the matrix did not hinder
the UV crosslinking reaction. The mechanical properties of ChiMA could be
enhanced greatly on incorporation of GO in both dry and wet state. The tensile
strength and Young’s modulus of ChiMA increased by more than 57% and 80%,
respectively, in the dry state, and more than 89% and 190% respectively, in the wet
state on addition of 3 wt.% GO. ChiMA film swells more than 260% in 48 hrs. The
swelling rate could be controlled by the addition of GO as increasing the GO
decreased the swelling rate. Addition of GO did not significantly affect the
processability or UV crosslinking of the ChiMA samples negatively and the ChiMA
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3GO dispersion could be processed into multilayer structures and scaffolds.
Biocompatibility of the ChiMA samples was also confirmed through cell growth
inhibition and viability tests using L929 murine fibroblasts.
While it has been shown here that it was possible to develop processable UVcrosslinkable composites with improved mechanical properties using GO; however,
developing similar composites with the advantage of conductivity is valuable, as it
has been shown that electrical stimulation can improve the cell growth. Therefore,
development of ChiMA composites using aqueous CCG was investigated. SEM
results confirmed homogenous dispersion and good alignment of CCG sheets inside
the polymer matrix. Similar to what was achieved with GO/ChiMA composites, the
mechanical properties of ChiMA were improved significantly on addition of CCG.
The tensile strength of ChiMA was increased by more than 58% and its Young’s
modulus was enhanced by more 140% on addition of 3 wt.% CCG in dry state. In the
wet state, the ChiMA 3CCG composite exhibited a tensile strength and Young’s
modulus that are 120% and 108% respectively, higher than neat ChiMA film. As
expected, the conductivity of ChiMA could be improved by incorporating CCG. The
conductivity of ChiMA 3CCG composite was found to be around 2.5E-1 S m-1,
corresponding to 7 orders of magnitude improvement compared to pristine chitosan.
The swelling rate of ChiMA can be controlled by incorporation of CCG, and
CCG/ChiMA composites swell slightly higher than GO/ChiMA samples. This higher
swelling rate in CCG/ChiMA composites can be attributed to a lower degree of
crosslinking due to the presence of dark and rigid CCG sheets in their matrices.
Similar to GO/ChiMA composites, CCG/ChiMA samples are biocompatible to
fibroblast (L-929) cells and could be processed into multilayer 3D scaffolds using
extrusion printing technique.
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The developed GO/CCG composites with improved conductivity and mechanical
properties as well as excellent processability are promising UV-crosslinkable
conductive materials for biomedical applications.
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6. General Conclusion and Future Work
6.1. General Conclusion
The main aim of this project was to develop biocompatible, processable
biocomposites for biomedical applications. Two biodegradable polymers, namely
synthetic PCl and natural chitosan were chosen as matrices. Chemically converted
graphene (CCG) as a dispersion (aqueous or DMF-dispersed CCG) was used as the
main filler in this work due to its excellent properties and its potential to enhance the
mechanical and electrical properties of the polymers. Graphene oxide (as an aqueous
dispersion) was also investigated in one section as a filler.
Chapter 3 describes the preparation and characterization of graphene/PCl
composites and reports on the effect of the graphene content on the composite
properties. Two approaches were taken to synthesize composites; a mixing method in
which the polymer was mixed with the CCG dispersion (mixPCl-CCG) and a
covalent attachment method whereby the polymer chains were covalently linked to
CCG sheets (cPCl-CCG).
The homogenous dispersions of CCG in cPCl-CCG composites led to the
development of composites with much better flexibility compared to mixPCl-CCG
samples. The addition of 5 wt.% CCG increased the tensile strength and Young’s
modulus by more than 70% and 170% respectively. The conductivity of PCl was also
improved by around 12 orders of magnitude on addition of 5 wt. % CCG in mixPClCCG composites.
The microwave-assisted synthesis of graphene/PCl composites was also investigated
Microwave irradiation resulted in the reduction of GO and formation of the
graphene/PCl composite; however, the mechanical properties of the composites were
inferior to the samples prepared by mixing or covalent attachment.
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The graphene/PCl composites were enzymatically degraded using pseudomonas
lipase. cPCl-CCG composites showed much slower degradation rate at higher CCG
content indicating good attachment between CCG and polymer chains.
The cPCl-CCG composites were processed into fibres and 3D structures using
additive fabrication. The analysis of mechanical properties of the composite fibres
showed more than a 50% increase in tensile strength and up to a 144% improvement
in Young’s modulus on the addition of less than 5 wt.% CCG content. The
biocompatibility tests showed good adhesion and proliferation of cells on the cPClCCG, mPCl-rGO and extruded fibres confirmed the biocompatibility of the
developed composites.
In this chapter, it was concluded that incorporation of graphene can result in a great
improvement in the electrical and mechanical properties of the polymer while
retaining its processability and biocompatibility. The microwave-assisted synthesis
of graphene/PCl composites was also found to be a quick and facile alternative for
the development of graphene biocomposites.
After the successful development of a biocompatible processable graphene
biocomposite using PCl, the fabrication of graphene biocomposites using a natural
polymer, chitosan, was investigated in Chapter 4. Graphene/chitosan composites
(CSG) with CCG content varying between 0.1 to 3 wt.% were developed using lactic
acid as crosslinker. The composites were prepared by both mixing and covalent
attachment methods. In the mixing method, the addition of 3 wt.% CCG improved
the tensile strength and Young’s modulus of chitosan by more than 217% and 135%
respectively, in its dry state. The conductivity of the polymer was also improved by
around 7 orders of magnitude on addition of 3 wt.% CCG. CSG composites also
showed improved mechanical properties in their swollen state where the tensile
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strength and Young’s modulus were increased by more than 60% in the CSG-3
composite.
The CSG films exhibited excellent biocompatibility as L-929 fibroblast cells adhered
and proliferated well on the surface of the films. The developed CSG composite
could be processed into fibres of different sizes and 3D scaffolds through extrusion
printing, indicative of the excellent processability of the composites. Cell culture
studies on a scaffold showed good adhesion and proliferation of cells throughout the
scaffold layers.
The development of covalently linked graphene/chitosan was also investigated.
Similar to what was observed in CSG samples, the addition of CCG resulted in an
enhancement in conductivity and mechanical properties of the samples. However, the
covalently linked composite did not show any significant improvement in properties
compared to the non-covalent samples.
It was shown in this chapter that addition of graphene to a natural polymer like
chitosan could result in a processable material with enhanced electrical and
mechanical properties, which is a suitable substrate for biomedical applications.
Compared to acetic acid that is the most commonly used acid in preparation of
chitosan films, lactic acid is less cytotoxic and was found to be much less disruptive
to the graphene dispersion. The conductivity and swelling rate of CSG samples were
found to be higher than that of a control group containing acetic acid. Graphene
incorporation could also be utilized to control the swelling rate of the samples.
Due to the important role of UV-crosslinkable materials in the biomedical field, the
development of a novel UV-crosslinkable biocomposite became the subject of the
investigation in Chapter 5. A UV-crosslinkable chitosan-based polymer (ChiMA)
was developed by attaching a UV-sensitive group, methacrylate, to the chitosan
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backbone. The biocomposites were prepared using GO and CCG at different
concentrations as filler. The tensile strength and Young’s modulus of ChiMA was
greatly improved in both dried and swollen state on addition of 3 wt.% filler.
Moreover, the ChiMA composite with 3 wt.% CCG exhibited a conductivity of
around 2.5E-1 S m-1, which corresponds to 7 orders of magnitude improvement in
conductivity of the neat chitosan. The biocompatibility of both the GO/ChiMA and
CCG/ChiMA composites was confirmed through cell growth inhibition and viability
tests using L929 murine fibroblasts. Furthermore, the cell growth experiments
showed that the addition of CCG could improve the adhesion and proliferation of
cells on the surface of the sample. Both GO/ChiMA and CCG/ChiMA could be
printed into 3D scaffolds, indicating good processability of the biocomposites.
It was demonstrated in this chapter that GO and CCG can be utilized to develop
biocompatible UV-crosslinkable composites with enhanced mechanical and electrical
properties as well as appropriate processability. Both GO/ChiMA and CCG/ChiMA
could successfully be crosslinked through UV irradiation; however, swelling studies
showed that CCG/ChiMA samples swell more than GO/ChiMA composites, which
could be attributed to a lower degree of crosslinking in the CCG/ChiMA samples due
to a “shielding” effect of the CCG.
Overall, novel biodegradable and processable CCG and GO biocomposites with
enhanced electrical and mechanical properties were developed in this work. All
samples could be processed into 3D scaffolds that are pivotal structures in tissue
engineering field. These novel biocomposites demonstrate great promise for use in
biomedical fields and applications, particularly in tissue engineering.
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6.2. Future work
In this research, some challenges were encountered that could be further investigated
in future work. Some of the challenges could not be overcome in this work due to
time constraints.
The microwave-assisted technique was found to be a facile and quick technique for
preparation of graphene composites. This process could be optimized to improve the
mechanical properties of the resultant graphene/PCl composites. The role of catalyst,
reaction time, temperature, and other reaction properties on the preparation and
characteristics of the composites can also be investigated.
Preliminary studies showed that the PCl-CCG composites are promising materials to
be spun into fibres using wet-spinning and electro-spinning methods. These methods
could be adopted as well to develop other suitable structures for biomedical
applications such as mats and fibres for drug delivery systems.
The development of covalent attachments between chitosan chains and CCG sheets
could also be optimized to develop biocomposites with enhanced properties.
The synthesis of ChiMa and ChiMA composites has more room for improvement.
Studies could be done to gain more control over the methacrylation of chitosan and
crosslinking of the composites.
The ChiMA and ChiMA composite solutions are suitable materials for fibre
spinning. The development of ChiMA fibres could be investigated using different
methods such as wet- and electro-spinning.
In terms of biocompatibility, the developed biocomposites could also be studied in
vivo so as to achieve the ultimate aim of this research program, the incorporation of
graphene-based biocomposites into constructs for tissue engineering.
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